United States
Environmental Protection
Agency
                     Office of Prevention, Pesticides
                     And Toxic Substances      September 1992
                     (H-7508W)
<&EPA  Reregistration
         Eligibility Document
         (RED)
                       5WRS-93-229
Zinc Salts

-------
ZINC SALTS REREGISTRATION ELIGIBILITY TEAM

Office of Pesticide Programs:

Biological and Economic Analysis Division
Jim Saulmon              Biological Analysis Branch
Eric Maurer               Economic Analysis Branch

Environmental Fate and Effects Division
Katherine Valente          Ecological Effects Branch
Sylvia Termes             Environmental Fate and Groundwater Branch
Jean Holmes              Science Analysis and Coordination Staff
Health Effects Division
Linda Kutney
Pat McLaughlin
Jim Yowell

Registration  Division
Sami Malak
Olga Odiott
Mary Matzer
Joanne Miller
Chemical Coordination Branch
Toxicology Branch II
Occupational and Residential Exposure Branch
Registration Support Branch
Registration Support branch
Herbicide Fungicide Branch
Herbicide Fungicide Branch
Special Review and Reregistration Division
Bruce Sidwell             Accelerated Reregistration Branch
Mark Wilhite              Accelerated Reregistration Branch

Policy and Special Projects Staff
Jean Frane                Analyst

Office of General Counsel

Jim Curtin                 Attorney

Office of Compliance Monitoring

Beverly Updike

-------
                        TABLE OF CONTENTS

EXECUTIVE SUMMARY

I. INTRODUCTION

n. CASE OVERVIEW

      A.    CHEMICAL OVERVIEW

      B.    USE PROFILE

      C.    REGULATORY HISTORY

m. SCIENCE ASSESSMENT OF ZINC SALTS

      A.    PRODUCT CHEMISTRY ASSESSMENT

      B.    HUMAN HEALTH ASSESSMENT

           1. Hazard Assessment

                 a. Acute and Subchronic Toxicity
                 b. Chronic Toxicity and Carcinogenicity
                 c. Other Toxicological Effects

           2. Exposure Assessment

                 a. Dietary Exposure
                 b. Occupational and Residential Exposure
C.
           3. Risk Assessment

           ENVIRONMENTAL ASSESSMENT
                 a. Environmental Fate and Transport
                 b. Environmental Fate Assessment

           2. Ecological Effects

                 a. Ecological Hazard
                 b. Ecological Effects Risk Assessment
                                                             3

                                                             4

                                                             5



                                                             6

                                                             6
                                                             6
                                                             8
                                                             9
                                                              10
                                                              11
11
                                                              11
                                                              12
                                                              12
                                                              13

-------
IV. RISK MANAGEMENT AM) REREGISTRATION DECISION FOR ZINC
SALTS
      A.    DETERMINATION OF ELIGIBILITY                          14

      B.    REGULATORY POSITION                                   15

V. ACTIONS REQUIRED BY REGISTRANTS

      A.    ADDITIONAL GENERIC DATA REQUIREMENTS               15

      B.    PRODUCT SPECIFIC DATA REQUIREMENTS                  15

      C.    LABELING REQUIREMENTS                                16

VI.   APPENDICES

      APPENDIX A - Use Patterns Subject to Reregistration

      APPENDIX B - Table of the Generic Data Requirements and Studies Used to Make
             the Reregistration  Decision

      APPENDIX C - Citations Considered to be Part of the Data Base Supporting the
             Reregistration of Zinc Salts

      APPENDIX D - List of Available Related Documents

      APPENDIX E - Pesticide Reregistration Handbook

      APPENDIX F - Generic Data Call-In

           Attachment A - Chemical Status Sheet

           Attachment B - Generic DCI Response Forms (Form A) plus Instructions

           Attachment C - Requirements Status and Registrants' Response Forms
                          (Form B) plus Instructions

           Attachment D - List of all Registrant(s) sent this DCI

           Attachment E - Cost Share/Data Compensation Forms

-------
APPENDIX G - Product Specific Data Call-In

      Attachment A - Chemical Status Sheet

      Attachment B - Product Specific DCI Response Forms (Form A) plus
                 Instructions

      Attachment C - Requirements Status and Registrants'  Response Forms
               (Form B) plus Instructions

      Attachment D - EPA Grouping of End Use Products for meeting Acute
                    Toxicology Data Requirements.

      Attachment E - EPA Acceptance Criteria

      Attachment F - List  of all Registrant(s) sent this DCI

      Attachment G - Cost Share/Data Compensation Forms
                                  in

-------
                  GLOSSARY OF TERMS AND ABBREVIATES

a.i.          Active Ingredient

CAS         Chemical Abstracts Service

CSF         Confidential Statement of Formula

EEC         Estimated Environmental Concentration.  The estimated pesticide concentration
             in an environment, such as a terrestrial ecosystem.

EP          End-Use Product

EPA         U.S. Environmental Protection Agency

FIFRA       Federal Insecticide, Fungicide, and Rodenticide Act

FFDCA      Federal Food, Drug, and Cosmetic Act

HDT        Highest Dose Tested

LQo         Median Lethal Concentration.  A statistically derived concentration of a
             substance that can be expected to cause death in 50% of test animals.  It is
             usually expressed as the weight of substance per weight or volume of water or
             feed, e.g., mg/1 or ppm.

LDj0         Median Lethal Dose.  A statistically derived single dose that can be expected
             to cause death in 50% of the test animals when administered by the route
             indicated (oral, dermal,  inhalation).  It is expressed as a weight of substance
             per unit  weight of animal, e.g., mg/kg.

Ldlo         Lethal Dose-low. Lowest Dose at which lethality occurs

LEL         Lowest Effect Level

MP          Manufacturing-Use Product


MRID       Master Record Identification (number).  EPA's system of recording and
             tracking studies submitted.

N/A         Not Applicable

NPDES      National Pollutant Discharge Elimination System.


                                         iv

-------
GLOSSARY OF TERMS AND ABBREVIATIONS (cont.)




NOEL       No Observed Effect Level




OPP        Office of Pesticide Programs



ppm        Parts Per Million



TD         Toxic Dose. The dose at which a substance produces a toxic effect




TC        Toxic Concentration, The dose at which a substance produces a toxic effect

-------
EXECUTIVE SUMMARY

       The active ingredients covered in this document include zinc chloride, zinc oxide and
zinc sulfate monohydrate (hereafter referred to as zinc sulfate). Products containing these
active ingredients are used as herbicides, fungicides and bacteriostats  for the control of moss,
mildew and fungi on structures and adjacent outdoor areas, in carpet, and in pressure treated
lumber. This Reregistration Eligibility Document (RED) addresses the eligibility for
reregistration of products containing these active ingredients for the above mentioned use
sites only.

       Formulations for zinc oxide include an end use industrial preservative for
incorporation into nylon carpet fibers to inhibit bacterial and fungal spoilage, a powder for
control of moss growth on walkways, patios and ornamental lawn use; a metal strip attached
to roofs where it releases soluble oxide which inhibits moss growth; and an ingredient for
pressure treatment of lumber. Zinc chloride is  formulated as a solution or soluble concentrate
for application to walkways and patios for control of moss.  Zinc sulfate is formulated as a
soluble concentrate also for control of moss on and around buildings.

      . The U.S.  EPA (hereafter referred to as "the Agency") has determined that the uses of
these three active ingredients as they are currently registered will not cause unreasonable risk
to humans or the environment.  Therefore the zinc salts are eligible for reregistration.  The
Agency is requiring additional studies on physical chemistry as confirmatory data and for
purposes of labeling to complete the generic data base.

       Before reregistering the products containing these zinc salts, the Agency is requiring
that product specific data and revised labeling be submitted  within eight  months of the
issuance of this document.  These data include product chemistry and acute toxicology
testing.  After reviewing these data and any revised labels and finding them acceptable, the
Agency will reregister a product based on whether or not that product meets the requirements
in Section 3(c)(5) of FIFRA.

-------
r.
INTRODUCTION
       In 1988, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) was
amended to accelerate the reregistration of products with active ingredients registered prior to
November 1,  1984.  The amended Act provides a schedule for the  reregistration process to
be completed  in nine years.  There are five phases to the reregistration  process. The first
four phases of the process  focus on identification of data requirements to support the
reregistration  of an active ingredient and the generation and submission of data to fulfill the
requirements.  The fifth phase is a review by the U.S. Environmental Protection Agency
(referred to as "the Agency") of all data submitted to support reregistration.

       FIFRA Section 4(g)(2)(A) states that in  Phase 5 "the Administrator shall determine
whether pesticides containing such active ingredient are eligible for registration" before
calling in data on products and either reregistering products or taking "other appropriate
regulatory action." Thus,  reregistration  involves a thorough review of the scientific data
base underlying a pesticide's registration. The purpose of the Agency's review is to reassess
the potential hazards arising from the currently registered uses of the pesticide; to determine
the need for additional data on health and environmental effects;  and to determine whether
the pesticide meets the "no unreasonable adverse effects" criterion  of FIFRA.

       This document presents the Agency's decision regarding the reregistration eligibility
of the registered uses of zinc chloride, zinc oxide and zinc sulfate.  The document consists of
six sections. Section I is the introduction.  Section II describes these zinc salts, their uses,
data requirements and regulatory history. Section HI discusses the human health and
environmental assessment based on the data available to the Agency.  Section IV presents the
reregistration decision for zinc salts.  Section V discusses the reregistration requirements  for
zinc salts.  Finally, Section VI is the Appendices which support this Reregistration Eligibility
Document. Additional details concerning the Agency's review of applicable data are
available on request.'
    1 EPA's reviews of data on the set of registered uses considered for EPA's analysis may be
obtained from the OPP Public Docket, Field Operations Division (H7506C), Office of Pesticide
Programs, EPA, Washington, DC 20460.

-------
II.    CASE OVERVIEW






A.    Cfiemical Overview



The following active ingredients are covered by this Reregistration Eligibility Document:



o     Common Name:  Butter of zinc



      Chemical Name: Zinc chloride



      CAS Registry Number:  7646-85-7



      Office of Pesticide Programs Chemical Code:  087801



      Empirical Formula:  ZnCl2








o     Common Name:  Flowers of zinc; philosopher's wool; zincite (mineral); zinc white



      Chemical Name: Zinc oxide



      CAS Registry Number:  1314-13-2



      Office of Pesticide Programs Chemical Code:  088502



      Empirical Formula:  ZnO
      Common Name:  Dried zinc sulfate



      Chemical Name: Zinc sulfate monohydrate



      CAS Registry Number:  7446-19-7



      Office of Pesticide Programs Chemical Code: 527200



      Empirical Formula:  ZnSO4 H2O

-------
B.     Use Profile

The following is information on the current registered uses with an overview of use sites and
application methods. A detailed table of these uses of zinc chloride, zinc oxide and zinc
sulfate is in Appendix A.

For zinc chloride:
       Type of Pesticide:   Herbicide and preservative

       Use Sites:           Terrestrial non-food, Outdoor residential

       Target Pests:        Moss, fungi

       Formulation Types
       Registered:
Soluble concentrate - 6.2% zinc chloride
Ready to use liquid -26% zinc chloride
       Method and Rates
       of Application:      Equipment - Hose-end sprayer; non-aerosol pump; tank type
                           sprayer, sprinkler can.

                           Method and Rate - Apply (sprinkle or spray) 3 gallons per 100
                           sq.ft.
                          Timing - When needed.
For zinc oxide:
       Type of Pesticide:  Fungicide, herbicide, bacteriostat

       Use Sites:          Terrestrial non-food, outdoor residential, indoor non-food

       Target Pests:                     Moss, fungi, bacteria

       Formulation Types
       Registered:         Wettable powder- 20.76% zinc oxide;
                          Metal strip- 99.1 %  zinc
                          Powder- 99% zinc oxide (formulation intermediate)
                          Powder-99.4% zinc oxide (industrial preservative)

       Method and Rates
       of Application:     Equipment - sprinkler can (for wettable powder); galvanized
                          nails (for metal strip)

-------
                           Method and Ratg - Dissolve 1 Ib. in 5 gallons of water. For
                           metal strip, apply along all roof peaks using galvanized or
                           aluminum nails.

                           Timing - When needed.

 For zinc sulfate:
       Type of Pesticide:   Herbicide

       Use Sites:           Terrestrial non-food. Residential outdoor

       Target Pest:        Moss

       Formulation Types
       Registered:         Wettable powder- 99% zinc sulfate monohydrate

       Method and Rates
       of Application:      Equipment - Apply by hand or use sprinkling can or pump-type
                           sprayer.

                           Method and Rate - Apply as a powder along the ridge of the
                           roof; dissolve in 5-10 gallons  of water to cover 600 sq. ft.  for
                           gravel or paved surfaces.
                           Timing - When needed.
C.
Reeulatorv History
       Pesticidal products containing zinc salts were first registered in the United States in
1973.  The uses include moss control in areas where moss growth is profuse due to high
precipitation rates, primarily in the Northwestern U.S.  Zinc oxide is also incorporated into
carpet  fibers as a bacteriostatic and fungistatic agent and as an ingredient in a solution for
pressure treatment of wood.

     The major use of zinc salts in the United States is non-pesticidal, as a fertilizer
micronutrient. Other uses include as an electrolyte in dry cell batteries, as an animal feed
additive, as a galvanizer and as an emulsion-breaker.
ffl.    SCIENCE ASSESSMENT OF ZINC SALTS

       The Agency has conducted a thorough review of the scientific data base for zinc salts
for the purposes of determining the reregistration eligibility of these pesticides. These
finding are summarized below. The complete references cited in the text are in the
Bibliography (Appendix C).

-------
A.     physical Chemistry Assessment

             Zinc chloride is a clear, very deliquescent salt.  It has a boiling point of
       260°C and at room temperature it is completely soluble in water.  The vapor pressure
       is 1.5 mmHg and the pH is 5.4.  Outstanding generic physical chemistry data
       requirements are listed in Section V.

             Zinc oxide is an odorless white or yellowish-white powder. It has a melting
       point of 2010°C and its density is 0.481 gm/crn3. It is relatively insoluble in water,
       has a pH of 7.37 and is stable.

             Zinc sulfate monohydrate is an odorless white solid. It has a  melting point of
       600°C and a density of 1.121 gm/cmj. It is soluble in water up to 35% and is stable.
       Additional physical chemistry data requirements are listed in Section V

             Zinc metal is an odorless bluish-white lustrous solid. It has a melting point of
       419°C and a density of 7.169 gm/cm1. It is insoluble and has a low  stability in the
       natural environment, easily forming the solid phases ZnO, Zn(OH)2  and Zn303 and
       soluble zinc ions.
B.  HUMAN HEALTH ASSESSMENT
1.  Toxicology - Data Base

             The lexicological data base on zinc oxide, zinc chloride, and zinc
       sulfate is adequate and will support reregistration eligibility.

             a. Acute Toxicity

             Zinc oxide:
                             ACUTE TQXICITY VALUES
TEST
Oral LD50--rat
Dermal LDSO-rabbit
Eye effects-rabbit
Skin effects-rabbit
RESULT (mg/kg)
>5000
>5000
mild irritant
non-irritant
TOXICITY |
CATEGORY J
IV !
111 !
Ill :
IV l

-------
       The TDlo was reported as 6846 mg/kg in an oral test in rats (I).
An oral LD50 in mice was reported as >7950 mg/kg (2). One report
states that 500 mg applied for 24 hours produced mild irritation on skin
or eyes of rabbits. A TClo reported for human inhalation was 600
mg/m3 of zinc oxide (1).
Zinc chloride:
               ACUTE TOXICITY VALUES
TEST
Oral LD50--rat
Inhalation LClo— human
Eye effects
Skin effects
RESULT (mg/kg)
350
4800 mg/m3/30min
Corrosive
Corrosive
TOXICITY
CATEGORY
II
III
I
I
      Acute oral tests found the LD50 was 350 mg/kg in rats and in
      mice, and 200 mg/kg in guinea pigs (1). The human TClo for
      inhalation has been reported as 4800 mg/mj/30  minutes (1).
Zinc sulfate:
               ACUTE TOXICITY VALUES
TEST
Oral LD50--rat
Eye effects-rabbit
Skin effects
RESULT (mg/kg)
>2949
severe irritation
very slight irritation
TOXICITY
CATEGORY
III
I
IV
      Acute oral tests found the LDlo was 333 mg/kg in rats and 2000
      mg/kg in rabbits; the LD50 was  >2949 mg/kg in rats and 1891
      mg/kg in mice (1,2). Another acute oral study found the LD50
      was 1374  mg/kg in rats (3).  The oral TDlo for humans is
      reported to be 45 mg/kg/7 days (continuous), 106 mg/kg, and
      180 mg/kg/6 weeks (intermittent) (1, 2). A dermal irritation
      study in rabbits with  99% zinc sulfate found very slight
      irritation.  In one study, severe irritation was found when 0.09g
      of 99% zinc sulfate was applied to rabbit eyes. In another study,

-------
       the application of 420 ug zinc sulfate to the rabbit eye found
       moderate irritation (1).

       b.  Subchronic Toxicity

       There was no evidence of toxicity in humans fed 10 mg/kg/day
       of zinc sulfate for up to 3 months (3).

       c.  Metabolism

       Zinc is an essential element in human nutrition and is involved
in the nutrition of all plants and animals.  It is an integral component of
several metalloenzymes in various metabolic systems and is present in
every cell (3).  In test animals, 8-10 percent of ingested zinc was
absorbed in the intestine and the rest excreted  in the feces (3).

       Ingestion of large amounts of zinc  salts induces a variety of
metabolic changes,  with inhibition of some enzymes, effects on
excretion, and a reduction in size and hemoglobin content of red blood
cells (microcytic hypochromic anemia) (3).

       It has been calculated that the consumption of zinc salts added to
food may be 0.50 mg of elemental zinc per person per day and the
intake of zinc occurring naturally in food  may be 5 to 22 mg per day
(3).
       d. Chronic Toxicity, Carcinogenicity

       In some long-term studies, extending for one year and over
three generations of rats, zinc chloride, oxide, and sulfate showed no
effects at levels up to 0.25 percent of the diet (3). In other studies,
zinc sulfate caused hematological changes in rats and dogs fed about
100 ppm in the diet (3).

       No evidence of carcinogenicity was found in  feeding zinc oxide
(at 34.4 mg zinc  per day) to rats for 29 weeks.  Carcinogenicity has
been reported in  mice given zinc chloride in drinking water, but the
reports were  not  complete and controls were  not used consistently.  In
another report, mice given up to 5,000 ppm of zinc as zinc sulfate in
drinking water showed no evidence of carcinogenicity and no
differences between treated and  control groups  (3).

-------
       e. Reproductive and Developmental Toxicity

       When 6846 mg/kg of zinc oxide was given to pregnant rats on
days 1-22 of pregnancy, there were increased stillbirths and effects on
growth of the young (2).

        When rats were given 333 mg/kg zinc sulfate orally on days l-
18 of pregnancy, there was post-implantation mortality (2). Teratologic
studies with oral zinc sulfate in three species of animals were negative
for effects on pregnancy, maternal or fetal survival, or abnormalities.
In these studies mice were given up to 30 mg/kg/day for days 6-15 of
gestation, rats were given up to 42.5 mg/kg/day for days 6-15 of
gestation, and hamsters were given up to 88 mg/kg/day for days 6-10
of gestation (3).

       f. Mutagenicity

       Positive results with zinc oxide have been reported  in some
studies.  DNA damage in Escherichia coli occurred at 3000 ppm, and
unscheduled DNA synthesis occurred in guinea pigs after exposure  to
5300 ug/tnV3 hours/6 days in an inhalation study (1, 2).

       Positive results with zinc chloride also  have been reported in
several studies.  Mutagenic effects were seen at 90 mmol/L in a
microsomal mutagenicity assay with Salmonella lyphimurium.
Unscheduled DNA synthesis in human lymphocytes occurred at 180
umol/L and at 360 umol/L. DNA inhibition was seen in human
lymphocytes. In cytogenetic analyses, effects were seen in mice treated
orally with 18 g/kg for 30 days and in human lymphocytes treated with
300 umol/L. Effects also were seen  in a host-mediated assay with mice
and Salmonella typhimurium at 6 mg/kg and at 180 umol/L in an
oncogenic transformation assay using hamster  embryos (1).

       Positive results have been seen with zinc sulfate in  some studies,
including a  Drosophila melanogaster sex chromosome assay with an
oral 5mmol/L dose and a mutation assay with Saccharomyces cerevisiae
at 100 mmol/L. DNA inhibition was seen in human HeLa cells at 1
umol/L/4 hours and oncogenic transformation occurred at  200 umol/L
with hamster embryo (1, 2).

-------
2.  Dietary Exposure
              There are no pesticidal food uses for zinc.  Zinc is widely
       distributed in plants, animals and food, and is a normal part of
       metabolism in all living organisms.

           The Food and Drug Administration lists these zinc salts as
       generally recognized as safe for use in food as dietary supplements and
       as nutrients: zinc oxide in 21 CFR 182.5991 and 182.8991, zinc
       chloride in 21 CFR 182.5985 and 182.8995, and zinc sulfate in 21
       CFR 182.5997 and 182.8997.
3.  Occupational and Residential Exposure
          The lexicological data base on these zinc salts is adequate and will
       support reregistration. Therefore, no new exposure data are necessary.
       Based on the application methods (specified and implied) and the
       formulation types, the potential for significant eye, inhalation and
       dermal exposure to concentrated solutions or  dusts exists for mixers,
       loaders, and applicators. Accordingly,  the zinc  salt labels must
       consistently reflect any potential eye and  skin hazard (Danger, Warning
       or Caution Signal Words) and recommend appropriate protective
       equipment (protective eyeware [goggles or face shield],  long sleeved
       shirts and long-legged pants,  waterproof  gloves, shoes and  socks).
       However, there is no reason to expect  reasonable pesticide usage to
       constitute any hazard beyond ordinary  non-pesticidal exposure to zinc
       salts if label directions are followed, and the  Agency believes that the
       uses of these products do not represent an unreasonable hazard to
       workers.
4.  Risk Assessment

           The lexicological data on these zinc salts in public literature are
       adequate for assessing risk to humans. Accordingly, additional studies
       are not required for the reregistration of present uses of these salts.
       Although some positive mutagenicity studies have been  reported,  there
       is no indication of mutagenic effects in normal living organisms from
       everyday exposure. Living organisms have long been exposed to  the
       components of these zinc salts without such exposure being attributed to
                                     10

-------
c.
       mutagenicity. Zinc is widely distributed in plants, animals and soils and
       is normally present in food.  Zinc is a normal part of metabolism in all
       living organisms. These zinc salts are also added ingredients in foods.
           There is no reason to expect appropriate pesticide usage to
       constitute any hazard beyond ordinary exposure from non-pesticidal
       sources.  There are no significant exposure concerns other than those
       addressed by appropriate label precautions for eye and dermal
       protection for the mixers, loaders, and applicators. Refer to section V
      . for product labeling requirements.
Environmental Assessment
       1.
       Environmental Fate
             The Agency is relying on data available in the scientific
       literature to assess the environmental fate and transport of zinc salts as
       used in pesticidal compounds. No data were submitted by  registrants.

             a.     Environmental Fate and Transport

                    Zinc chloride and zinc sulfate are very soluble in water;
             zinc oxide is relatively insoluble. The dissolution of zinc
             compounds in water results in the formation of various species
             of zinc ions which, in the absence of complexing or chelating
             agents, is dependent on pH.  Zinc oxide is less soluble than zinc
             chloride or zinc sulfate, but dissolves in more acidic media to
             form ZnOH* and [Zn(H2O)6]2* . In a more basic pH, zinc oxide
             dissolves to form [Zn(OH)3]' and [Zn(OH)4]2'. In natural waters
             (both freshwater and seawater), identification of which species
             of zinc ion is present is difficult due to the presence of organic
             and inorganic natural complexing agents.

                    Based on calculations using equilibrium constants and in
             the absence of organic complexing agents, [Zn(H2O)6)]2+,
             ZnOH* and Zn(OH)2 are the predominant species in freshwater.
             Zn-chloro complexes may also be present in seawater.

                    The availability of zinc to plants and other organisms in
             soil decreases with increased soil pH. Several components of
             soil (clay minerals, mineral oxides and  hydroxides, carbonates
             and organic matter) can absorb zinc (predominantly as ZnOH*).
             Zinc therefore can be considered as relatively immobile in most
                                    11

-------
       b.
Environmental Fate Assessment
               Zinc is necessary to ail forms of life and any toxicity
       associated with zinc can  be attributed to the presence of "free"
       zinc and not to total zinc concentration. The Agency has
       concluded that the addition of zinc to the environment in the
       form of zinc salts  used as pesticides will not result in a
       significant increase in "free"  zinc. This conclusion is based on
       indications that "free" zinc is immobilized  by various organic
       and inorganic substances and by formation of insoluble phases.
       thereby making it  less bioavailable. Therefore, the terrestrial use
       of the pesticidal products containing the zinc salts covered in
       this document is not likely to result in the  movement of "free"
       zinc in soils, and there are no additional environmental fate data
       required for the reregistration of the zinc salts.
2.     Ecological Effects

       Ecological effects data have been submitted for zinc oxide only.
Published information also was used by the Agency to assess the risk
posed by the use of pesticides containing zinc to non-target organisms.

       a.      Ecological Hazard

       1.  Ecological Effects Data

              Avian toxicity studies were submitted by registrants.
       Since most of the applied zinc salts will transform (or become
       immobile in soil) to zinc oxide/hydroxide, and since the use of
       these products  is on a relatively low volume basis, the avian
       studies for zinc oxide are sufficient for the other active
       ingredients. An acute oral toxicity study in bobwhite quail
       provided an LDW of 606  mg/kg. In an acute dietary study in
       bobwhite quail, the LC50 was greater than 5000 ppm. These
       studies provide sufficient  information to classify the acute
       toxicity of zinc salts as slightly  to practically non-toxic to birds.
       Published studies show that coturnix quail fed  a diet containing
       1.5% zinc oxide  had reproductive effects (4). Mallards fed a
       diet of 3,000-12,000 ppm zinc  showed decreased feed
       consumption and body weight (5) and laying hens showed
       decreased egg production, shell  strength and hatchability on a
       diet containing 20,000 ppm zinc (6).
                              12

-------
       b.     Environmental Fate Assessment

               Zinc is necessary to all forms of life and any toxicity
       associated with zinc can be attributed to the presence of "free"
       zinc and not to total zinc concentration. The Agency has
       concluded that the addition of zinc to the environment in the
       form of zinc salts used as pesticides will not result in a
       significant increase in "free"  zinc. This conclusion is based on
       indications that "free" zinc is immobilized by various organic
       and inorganic substances and by formation of insoluble phases,
       thereby making it less bioavailable (). Therefore, the terrestrial
       use of the pesticidal products containing the zinc salts covered in
       this document is not likely to result in the movement of "free"
       zinc in soils, and there are no additional environmental fate data
       required for the reregistration of the zinc  salts.
2.     Ecological Effects

       Ecological effects data have been submitted for zinc oxide only.
Published information also was used by the Agency to assess the risk
posed by the use of pesticides containing zinc to non-target organisms.

       a.     Ecological Hazard

       I. Ecological Effects Data

              Avian toxicity studies were submitted by registrants.
       Since most of the applied zinc salts will transform (or become
       immobile in soil) to zinc oxide/hydroxide, and since the use of
       these products  is on a relatively low volume basis, the avian
       studies for zinc oxide are sufficient for the other active
       ingredients. An acute oral toxicity study in bobwhite quail
       provided an LDW of 606 mg/kg. In an acute dietary study in
       bobwhite quail, the LC*, was greater than 5000 ppm. These
       studies provide sufficient  information to classify the acute
       toxicity of zinc salts as slightly to practically non-toxic to birds.
       Published studies show that coturnix quail fed  a diet containing
       1.5% zinc oxide had reproductive effects (4). Mallards fed a
       diet of 3,000-12,000 ppm zinc  showed decreased feed
       consumption and body weight (5) and laying hens showed
       decreased egg production, shell  strength and hatchability on a
       diet containing 20,000 ppm zinc (6).

              Studies submitted to the Agency, as well as published
                              12

-------
literature, were used to assess the toxicity of these zinc salts to
non-target organisms in aquatic or estuarine ecosystems;
however, the results were highly variable. The LCjo for bluegill
sunfish was greater than 320 ppm but was  1.1 ppm in rainbow
trout in studies submitted to the Agency, while the 96 hr LC50
reported in the literature ranged from 1.2-17.9 ppm  for
freshwater  fish (7,8).  Acute toxicity in  Daphnia magna was
greater than 1000 ppm (i.e. practically non-toxic) in a study
submitted to the Agency. Data from the literature were variable,
indicating that zinc may be highly toxic to freshwater
invertebrates (9). However, in two  published studies, the 96 hr
LCs<, values ranged from 0.25-18.4 ppm in freshwater
invertebrates (7,8). In conclusion, although the data  showed
extreme variability of results, at least two of the studies
indicated that zinc oxide may be highly toxic to both freshwater
fish and freshwater invertebrates.

       b.     Ecological Effects Risk Assessment

              Zinc is relatively non-toxic to avian populations
       and is used as a feed additive for animals. Given the use
       patterns and frequency of application of pesticidal
       products containing these  zinc salts,  it is unlikely that
       zinc would be available in toxic amounts to avian or
       other non-target animal and  insect populations in
       terrestrial environments as a result of their use. Although
       zinc may be toxic to aquatic organisms in some
       environments, based on the  environmental fate
       assessment, aquatic exposure resulting from the use of
       these products is expected to be negligible. Therefore,
       the  Agency has determined that  these products, as they
       are  currently registered, pose no unreasonable risk to the
       environment.
              The textile industrial preservative use of zinc
       oxide results in indirect discharge of effluent containing
       zinc into natural waters.  An assessment of the risk posed
       to aquatic organisms resulting from this route of
       exposure is under the purview of the Agency's Office of
       Water and  will not be covered in this document.
       Although the aquatic toxicity studies showed variability
       in results, they are adequate to determine the appropriate
       label statements for this industrial preservative. The
       required label precaution statement is included in section
       V.
                       13

-------
IV.  RISK MANAGEMENT AND RERECfSTRATION DECISION FOR ZCVC SALTS

A.  Determination of Eligibility

             Section 4(g)(2)(A) of FIFRA calls for the Agency to determine, after
       submission of relevant data concerning an active ingredient, whether products
       containing the active ingredient are eligible for registration.  The Agency has
       completed its review of data from the open literature and generic data submitted by
       registrants, and has determined that the data are sufficient to support reregistration of
       products containing zinc salts.  Appendix B identifies the generic data that the Agency
       reviewed as part of its determination of reregistration eligibility of zinc salts, and lists
       the submitted studies that the Agency found acceptable.

             The data identified in Appendix B were sufficient to allow the Agency to
       assess registered uses of zinc salts and to determine that these uses can be used
       without resulting in unreasonable adverse effects to humans and the environment.
       The Agency therefore finds that products containing zinc salts as an active ingredient
       are eligible for  reregistration.  The reregistration of particular products is addressed in
       Section V of this document.

             The Agency made its reregistration eligibility determination based upon the
       target data base required for reregistration, the current guidelines for conducting
       acceptable studies to generate such data and the data identified in Appendix B.
       Although the Agency has found that current products containing zinc salts are eligible
       for reregistration, it should be understood that the Agency may take appropriate
       regulatory action, and/or require the submission  of additional data to support the
       registration of products containing zinc salts, if new information comes to the
       Agency's attention or if the data requirements for reregistration (or the guidelines for
       generating such data) change.

             The following is a  summary of the regulatory positions and rationales for zinc
       salts.  Where labeling revisions are imposed,  specific language is set forth in Section
       V of this document.

       Eligibility Decision

             The Agency has sufficient information on the human health effects of zinc salts
       and on its potential for causing effects in fish and wildlife and the environment when
       used to control  moss and fungus growth in outdoor residential areas, on structures,  in
       pressure-treated lumber and incorporated into fibers used in carpet. The Agency
       concludes that products containing zinc salts for these uses are eligible for
       reregistration.  Only certain generic physical chemistry data studies on zinc salts still
       are needed as confirmatory information.  The Agency has determined that zinc salt
       containing products, labeled and used as specified  in this Reregistration Eligibility
                                           14

-------
       Document, will not pose unreasonable risks or adverse effects to humans or the
       environment.

       Eligible and Ineligible Uses

              The Agency has determined that all registered uses are eligible for
       reregistration at this time.

B. Regulatory Position

       Tolerances and Action Levels

              There are no  registered food uses or tolerances for products containing zinc
       salts as an active ingredient.


V.  ACTIONS REQUIRED BY REGISTRANTS

       This section is designed to assist the registrant by providing data requirements and
responses necessary for the reregistration of manufacturing-use and end-use products.

A. Additional Generic Data Requirements

              The generic data base supporting the reregistration of zinc salt-containing
       products has been reviewed and determined to be substantially complete. Although
       some of the generic product chemistry data requirements are acceptable,  additional
       data are required as confirmatory.  These are  part of the generic Data Call-in. These
       generic data requirements are listed in Appendix F.

B.  Product specific data requirements

       1.      Additional Product-Specific Data Requirements

              Based on the reviews of the generic data for zinc salts, the products containing
       zinc salts are eligible for reregistration.  Section 4(g)(2)(B) of FIFRA calls for the
       Agency to obtain any needed product-specific  data regarding the pesticide after a
       determination of eligibility has been made.  The product specific data requirements
       are listed in Appendix G, the Product Specific Data Call-in Notice.

              Registrants must review previous data submissions to ensure that they meet
       current EPA acceptance criteria (Appendix G; Attachment  E) and if not, commit to
       conduct new studies.  If the registrant believes that previously submitted data meet
       current testing standards, then  study MRID numbers should be cited according to the
       instructions in the Requirement Status and Registrants Response Form provided for
       each product.
                                           15

-------
C. Labeling Requirements for Manufacturing and End-Use Products
             End-Use Produces

             The labels and labeling of all products must comply with EPA's current
       regulations and requirements as specified in 40 CFR §156.10. Labels must
       consistently reflect any potential eye and skin hazard (Danger. Warning or Caution
       Signal Words) and recommend appropriate protective equipment (protective eyeware
       [goggles or face shield],  long sleeved shirts and long-legged pants, waterproof gloves.
       shoes and socks). Please follow the instructions in the Pesticide Reregistration
       Handbook with respect to labels and labeling.

             Manufacturing use (Includes Industrial Preservatives)

             In addition to the above requirements for end-use products, labels and labeling
       of all manufacturing use products must contain the following statement:

             "This pesticide is toxic to fish and  aquatic invertebrates. Do not discharge
       effluent containing this product into lakes, streams,  ponds, estuaries, oceans or public
       waters unless this product is specifically identified and addressed in an NPDES
       permit. Do not discharge this product into sewer systems without previously notifying
       the sewage treatment plant authority. For guidance, contact your State Water Board or
       Regional Office of U.S.  EPA."
                                           16

-------
      APPENDIX A

Table of Zinc Salts Use Patterns
   Subject to Re registration

-------












fl\
•o
X
0
fl
!'•
I


i
!
1*1 1
ill J
ii!

1
j

o




























1
;'
J



1
i
i















1
J
HI
i
d
M

























N-FOOD/NON-FEED USES
O















I
§
2
OL
O
o
UJ
M
3
I
||
§•
S
TILES/TEXTILE FIBERS/CORDAGE (nylc
X
Bf




u
Q.
n
O
c
0
1
§
u
1

?


not
specified
	
i*
S1

.



i
u>


s
Induitrial preveivative treatment; not <
label; during manufacture.














DENTIAL
tn
): OUTDOOR RE
tii
|
O
Ul
3

Ul
CO
tu

£
s
BEHOLD/DOMESTIC DWELLINGS OUT
0




•J
1
i
u
V
a
i
£
<*
3
C


3
i!
&

S c
IA ST
7 x

c



1



Dust, shaker can, when needed





u
9
a
ta
i
u
o
a
tn
i
a

i


not
specified

not specified

,



i



i
e
'£





u
1
o
a
1
i
a

o


not-
specified

cy ff
in "
s!

§



Q
1



Sprinkle, watering can, when needed











CL
O
or
u
§
o
u.
Z
O
TERRESTRIAL Is
at
o.
O
oc
o
Ul
(/)

U)
LU
oc
H

oc
(A
^AGRICULTURAL OUTDOOR BUILDING
0




a
a
a
§

5
3-
o
^
•j
D
a

2


u
1
i

S if
If) »
03

S



|



Dust, shaker can, when needed





u

c
o
9
a.
VI
§
a
«
0
c


u
1
1

s •=
in *

a
c



g
1



i
c
u
e
3
£
I









U
n
o
o

7
O
Z
<
c

^OUP(S): TERRE!
a
Ul
in
%
0
OE
Ul
1
5
O
OC
u
I-AGRICULTURAL RIGHTS OF WAY/FE
O





3-
i

a
VI
a
c
£
in
1


i

ll
<=<

c



9



e
"I
e

-------
















0)
*x
0
o
c
N
















|.
H
1 S




1'i
a


i * *
'!'

:*j
1
1
i

|]
J -2
1


I
i
}J
]

j



J
1
i
,«
Si




































1


l
*

1



'
3





























f

u
e
a
i
0
I
o
c
u
1
i

a r
N O1
u> <*
* •*
*> 5




g


1



Sprinkle, watering can, whan naadad














_p
7
S
01
OC
t OUTDOOF

O
O
u.
O
£

OC
U)
oc
oc
IU
£
J^
oc
u
IU
3

§
VED AREAS (PRIVATE ROADS/SIDEWA

-------











0)
•o
•c
5
•"^•"
u
c
N













-ll
ii i
rl


Iji i
*
»
III }
•I* •
:•»
*

i


•i


I1

i
i




•
i
i
i
i




o
CL
1

1
o
e
il
a.

nol
specified


dose cannol
be calculaled


s

,J
u
M



1
C
•prayer.
|





Q
e
Q.
m
g
u
9
e
c
ll
a

not
specified


dose cannol
be calculaled


•

si
U
(A



1
i
*
e
u
1









a.
cc
o
o
o
o
u.
TRIAL NON-
VI

cc
Ul
§
iu
s
e
IU
. §
5
Q
BC
g
£
5
*
i
oc
_)
M-AGRICULTURA
O




0
a
at
i
tt
I
1
o
g

u
1
i
.
	
not specified


S

3
SE



1
e
!
!



















j
g
a
(/>
ac
oc
2
K
HS/PATIOS USE
2




a
a.
»
0
c
u
1
s
u
•Jl
I

nol
specified


dose cannol
be calculated


•

,,
v>



1
e
1
£
i
i





0
a
(a
0
c
0
1
1
u
a
i

?
U
a.
M


dose cannot
be calculated


•

t-
5



|
e
«
£
•o
M
O
8
I
&





U
Q.
M
O
0
a
U)
a
c
u
1
i

u
&
a
c


dose cannot
be calculated


§

ai
U
V)



needed
e
I
|
1
i















SIDENTIAL
cc
): OUTDOOR
in
o_
R
S
o
IU
VI
3
vt
EWALK
Q
1
O
OC
s
ED AREAS CPRIV
>
a.




o
s.
•J)
i
v
p.
6
1
9
C

U
1
i


dose cannol
be calculaled


e
c

=i
U



?
?
e
1
•prayer.
1
1
>
•
s-





u
s-
i

v»
8
u
1
3
C

O
C


dose cannol
be calculaled


«

3
t-
£



^
1
e
e
.c
1
>
a
s-





U
1
X
•j
3.
-
|
S

1
o


dose caniiul
be calculaled


•

_,
y



T3
B
e .
1
sprayer.
i
1
i
a





a
g
3-
2
o
a
3
0
a
V)
i

1


dose cannot
be calculated


•

,,
u
VI



"2
1
I
1
t
c
U
1
1
5.
w



























i
a
n
e
I
i
 5  °
£  ac

-------
•''  f"  111

-------
             APPENDIX B

 Table of The Generic Data Requirements and
Studies Used to Make the Reregistration Decision

-------
                               GUIDE TO APPENDIX B

    Appendix B contains listings of data requirements which support the reregistration for the
zinc  salts  covered by this  Reregistration  Eligibility document.  It  contains  generic  data
requirements that apply to zinc salts in all products, including data requirements for which a
"typical formulation" is the test substance.

    The data table is organized in the following format:

    1.  Data Requirement (Column 1).  The data requirements are listed in the order in which
they appear in 40 CFR  Pan 158.  the reference numbers accompanying each test refer to the test
protocols  set in the Pesticide assessment Guidelines,  which are available from the National
Technical Information Service, 5285 Port Royal Road, Springfield, VA 22161 (703) 487-4650.

    2.  Use Pattern (Column  2).  This column indicates  the use patterns for which the data
requirements apply.  The following letter designations are used for the given use patterns:

             A  Terrestrial food
             B  Terrestrial feed
             C  Terrestrial non-food
             D  Aquatic food
             E  Aquatic non-food outdoor
             F  Aquatic non-food industrial
             G  Aquatic non-food residential
             H  Greenhouse food
             I   Greenhouse non-food
             J   Forestry
             K  Residential
             L  Indoor food
             M  Indoor non-food
             N  Indoor medical.
             O  Indoor residential

    3.  Bibliographic citation  (Column 3). If the Agency has acceptable data in its files, this
column lists the  identifying  number of each study.   This normally  is the Master Record
Identification (MRID)  number, but may be a  "GS" number if no MRID number has been
assigned.  Refer to  the Bibliography appendix for a complete citation of the study.

-------
    £

    1
    2

    S3
    CM.
    O

    ,«

    I
    *•
    V)

    ?

   £
    4*
flQ €

B^
a |
z §
Ezj E


s*
^1

  I
  *«J
  3

 .5
 a
 3
CA

5

s
            00

            JO
00
   oo
^   ^
O   'O

f.   £
              OO
jy   g  (N   —  _  _


i   I  1   I  I  I
•»   -*  5   9  «  3
        *
        5
        u
  'C   ">
  a   -ts


  t   I

o
§
i
I
i
i
s.
1

h.
O
S
£
a
,  =  .a
                          •??   -s  «
                      VD
                          n

                          CJ
                                   <*3  ro
                                   vO  \0
                                               S   g  i.
                             00  2  2
                                                      CO
                             <
                             53

-------
 J!
 w

 S
 <•_
 o

 .2
 I
5
 If
     41
QQ  —
                                                                            T »/-.
                                                                            rt •£)
                                                                            P; (N
                                                                            ^tar "^
                                                                            — CJ
                                                                            •^ Tf
                                                                   o «*-.
                                                                   r- r-
                                                                                            .2

                                                                                             3-
                                                                                             'd
                                                                                             s
gf
§1
a.  £
    00
   s,
   a
                          1

                          1
                          S
                         8
                                                     a
                                                     x
                                                     O
                                                     u
                                  I

                                  I


                                  I
§
 S
S
 a
•o
                                           1
                                            r
                                                 S
                                                 ev

 L.
.a
 S >«
 a-s
uS
                                      I
                                           _    °
                                           '   -S

                  tot
                                      a

                           3    I   ^
                           ti    I   *   -8
                           ««    <   S   <
•=«£
 4i
 « s«
s-g
 o*2
.£ a
 e <2
.S 3
                                                              $T
                                                           1
                                                                                            2
                                                                                            VI
                                                                                            s  1
                                                                                           -
                                                                                       
-------









fifl

^%
^^
o
as
u
Pu
a<














:«
i

^
s .1
o 3
c c
0 ^
1
"55
V5
£
•1
u
£ E
u
•— rt
s **
E .5
.1
"5
£
1
i
•^
a
1
a.
3
&

I
,i
i
06
_ _ (S| — fl
O O O OS
CM >C 'O CM vO
^~ CM CM *""^ CM
•* Tf Tf •* f
r^ r- P* ^ £
•* rr  cs
* i i
^? \^j ^Q

Tf */^ ^ t?"; Tt ^^ S V^ ""^ *^*» ^
C^ "O C*J "«^ C'i *O *** *O CM '•fc ^J
^CN — CN ..^ 5^ -^
-------











aa
S
z
a
eu










C/5

CJ
(C

^^J c
c
_ '•"'
^ {^
S £
L
««
u
i
2 1
S |
S ^]
OJ Ji
"5
&
1
"5
5
1
en
«•
I
>•*
!
(X










q
I
0
£
£
.
1
i
1
, :§ 1 'S .1 o
•~ * 3 •- *s c
>. -3 2 1 'E 1 1 1.
8 3 l i i 1 l e
1 1 i I i i 1 i
Jai^llEy
HaaaCBk.s
._ o o o -c *C u i:
J3<< i ' '
(0*00000000000000





>*>
'-i
|
^



—
"*








Genotoxic Effects

o
\r-.
—



— •
<






Q
a
Dietary Toxicily -
c
2
oc
n
ri
v*.
*/*.
*""*
T*
r-i
ri
i/-.
—



=
<




•=
s.
'2,
S
V
^
ri
r-

-------
      V)

      e
      f
      4J
ea  £

x  a

«f
^   2
B   §
O«   g
flj   3

«f
           I
O
 gp

'€
 2.
 Q.
3
3

                                                      r-t
                                                            CN
                            r-
                            (N
                                            s?
                                                  30    30
                                                  »/l    V^
                                                  r>    r~-
                                          O     S    §     £!    Ci     ~
                                          ^     35    so     35    5c     S
                                          ,<     30    00     30    30     —
                                          r™     tn    ITS     (/-.    v,     o
                                          <     ^    r>     p--    r-     n
                                 B
o
i
                                 v)
                                                             8
X
•»
i
Chemical
- 5
•cl
h &•
ll
-- a
Beginning
Manufacti
0.
E
^»
v_
O
O
Formulati
'irt
>,
CQ
<
^
Preiimina
J
j

"o
s
Certificati
vt
O
S
S
'f»
1
<



1


f*\
Wi
s
•g,
£

                                         a" 7
                       Oi    —

                       3    S
                                                                         S
                                                                            
-------

      c
      .2
               «N
  ^
  e
so J
i!
  I
  I
  a
         en


£
s
a -
1
8
S £
0 r^
r^» *>^«


i
|
>
s
§
i
remenis have been waived
'3
r
5
a
S
11 environm
1
i
i
s
A
V)
S
u
.§
1
f3
.1 1-

o '^
S 'i
- |


a
i
i
j
*
00
i
u
J=
e
a
1
3
1
u
S
'§>
o
            NO
                  tot

-------
            APPENDIX C

       ZINC SALTS BIBLIOGRAPHY

Citations Considered to be Part of the Data Base
  Supporting the Reregistration of Zinc Salts

-------
                              GUIDE TO APPENDIX C

1.     CONTENTS OF BIBLIOGRAPHY.  This bibliography contains citations of all studies
       considered relevant by EPA in arriving at the positions and conclusions stated elsewhere
       in  the  Reregistration  Eligibility Document.   Primary  sources  for  studies in this
       bibliography have been the body or data submitted to EPA and its predecessor agencies
       in support of past  regulatory  decisions.  Selections from other sources  including the
       published literature, in those instances where they have been considered, are included.

2. .    UNITS OF ENTRY.  The unit of entry  in this bibliography is called a "study".  In the
       case  of  published  materials,  this corresponds closely  to an  article.  In the case  of
       unpublished  materials submitted to  the Agency, the  Agency has sought to identify
       documents at a level  parallel  to the  published article from within the typically  larger
       volumes in which they were submitted.  The resulting "studies" generally have a distinct
       title (or  at least a single subject), can stand alone for purposes of review and can  be
       described'with a conventional  bibliographic citation. The Agency has also attempted to
       unite basic documents and commentaries upon them, treating them as a single study.

3.     IDENTIFICATION OF  ENTRIES.   The entries in  this bibliography are  sorted
       numerically by Master Record Identifier, or "MRID number".  This number is unique
       to the citation, and should be  used whenever a specific reference is required.  It is not
       related to the six-digit "Accession Number" which has  been used to identify volumes of
       submitted studies (see paragraph 4(d)(4)  below for further explanation). In a few cases,
       entries added to the bibliography late in the review may be preceded by a nine character
       temporary identifier.  These entries are  listed after all MRID entries.  This temporary
       identifying number is also to be used whenever specific reference is needed.

4.     FORM OF ENTRY.  In addition to the Master  Record Identifier (MRID), each entry
       consists  of a citation containing standard elements followed,  in the case of material
       submitted to EPA, by a description of  the earliest known submission.  Bibliographic
       conventions  used  reflect  the  standard of the American National Standards Institute
       (ANSI), expanded to provide for certain special needs.

       a.     Author.  Whenever the author could confidently be identified, the Agency has
             chosen  to show a  personal author.   When no individual  was identified,  the
             Agency has shown an identifiable laboratory or testing facility as the author.
             When no author or laboratory could be identified, the Agency has shown the first
             submitter as the author.

       b.     Document date.  The  date of the study  is taken directly from the document.
             When the date is followed by a question mark, the bibliographer has deduced the
             date from the evidence contained in the document.  When the date appears as
             (19??), the Agency was unable to determine or estimate the date of the document.
       c.     Title.  In some cases, it has been necessary for the Agency bibliographers to
             create or enhance a document title.  Any such editorial insertions are contained

-------
      between square brackets.

d.    Trailing parentheses. For studies submitted to the Agency in the past, the trailing
      parentheses include  {in addition to  any self-explanatory  text) the following
      elements describing the earliest known submission:

      (1)    Submission date.   The date of the  earliest known submission appears
             immediately following the word "received."

      (2)    Administrative number.  The  next  element immediately following the
             word "under" is the registration number, experimental use permit number.
             petition number,  or other  administrative number  associated  with the
             earliest known submission.

      (3)    Submitter.   The third  element is the submitter.   When  authorship is
             defaulted to the submitter, this element is omitted.

      (4)    Volume Identification (Accession  Numbers).  The  final element  in the
             trailing parentheses identifies the EPA accession number of the volume in
             which  the  original submission of  the  study  appears.   The  six-digit
             accession number follows the symbol "CDL," which  stands for "Company
             Data  Library."   This accession  number is  in turn followed  by  an
             alphabetic suffix which shows the relative position of the study within the
             volume.

-------
                                APPENDIX C
                       ZINC SALTS BIBLIOGRAPHY
MR ID	CITATION
00155224    McAllister, W.; Bowman, J.; Cohle, P. (1985) Acute Toxicity of Zinc Oxide to
                   Bluegill Sun fish (Lepomis wacroc/i/rus): Static Acute Toxicity Report No.
                   AB-85-134 prepared by Analytical Bio-chemistry Laboratories Inc.

00155225    Beavers, J.; (1985) Zinc Oxide: A Dietary LC50 Study with the Bobwhite: Final
                   Report Project No.  139-224. Unpublished study prepared by Wildlife
                   International Ltd.

00155226    Beavers, J. (1985) Zinc Oxide: An Acute Oral Toxicity Study with the Bobwhite:
                   Final report Project No. 139-224. Unpublished study prepared by Wildlife
                   International Ltd.

00155227    Forbis, A.; Georgie, L.; Burgess, D. (1985) Acute Toxicity of Zinc Oxide to
                   Daphnia magna:  Static Acute Toxicity Report No. 33229. Unpublished
                   Monsanto  Study No. AB-85-136 prepared by Analytical Bio-Chemistry
                   Laboratories,  Inc.

00155228    McAllister, W.; Bowman, J.; Cohle, P. (1985) Acute Toxicity of Zinc oxide to
                   Rainbow Trout (Salmo gairdneri):  Static  Acute Toxicity  Report No.
                   33228.  Unpublished Monsanto  Study  no. AB-85-135 prepared  by
                   Analytical Bio-Chemistry Laboratories Inc.

41672401    Waltz, D. (1990)  Product Chemistry of Zinc Oxide. Unpublished study prepared
                   by David Waltz Imports.

41758801    Klettke,  M.;  (1991) Product Chemistry: Zinc Chloride. Unpublished study
                   prepared by Chas. H. Lily Corp.

41758802    Klettke,  M.;  (1991) Product Chemistry: Zinc Chloride. Unpublished study
                   prepared by Chas. H. Lily Corp.

41777901    Geiselman, S. (1991) Phase 3 Submission of Zinc Oxide: Product Identity and
                   Composition. Unpublished study prepared by Monsanto Corp.

41777902    Geiselman, S. (1991) Phase 3 Submission of Zinc Oxide: Analysis and
                   Certification  of  Product  Ingredients.  Unpublished study prepared  by
                   Monsanto  Corp.

41777903    Geiselman, S. (1991) Phase 3 Submssion of Zinc Oxide: Physical and Chemical
                   Characteristics. Unpublished study prepared by Monsanto Corp.

-------
MRID
                               APPENDIX C
                       ZINC SALTS BIBLIOGRAPHY
CITATION
42126501     Palmer, E. (1991) Product Chemistry Studies for Zinc Oxide. Unpublished study
                   prepared by American Chemet Corp.

42126502     Palmer, E. (1991) Product Chemistry Studies tor Zinc Oxide. Unpublished study
                   prepared by American Chemet Corp.

42126503     Palmer, E. (1991) Product Chemistry Studies for Zinc Oxide, Unpublished study
                   prepared by American Chemet Corp.

42233803     Glaza, S.  (1988) Primary Eye irritation Study of Zinc Sulfate Monohydrate in
                   Rabbits. Lab project No. HLA 80200644. Unpublished study prepared by
                  Hazelton Labs.  America. Inc.

42233804     Glaza, S.  (1988) Primary Dermal Irritation Study of Zinc Sulfate Monohydrate
                   in Rabbits. Lab Project No. HLA 80200645.  Unpublished study prepared
                   by Hazelton Labs. America, Inc.

42252501     Mischkot, J. (1991) Physical and Chemical properties of Zinc Sulfate
                  Monohydrate. Unpublished study prepared by Retta Mfg., Inc.
       The following are sources from the open literature cited in this document:

(1)    Sax, N.; Lewis, R. (1989) Dangerous Properties of Industrial Materials. 7th
             Edition. Van Nostrand Reinhold, New York.

(2)    NIOSH (1987) Registry of Toxic Effects of Chemical Substances. Washington,  DC.

(3)    FASEB, 1973. "Evaluation of the Health Aspects of Certain Zinc Salts as Food
             Ingredients." SCOGS-21.

(4)    Hussein, A.; Cantor, A.; Johnson, T. (1988) Use of High Levels of Dietary Aluminum
             and Zinc for Induction Pauses in Egg Production in Japanese Quail. Poultry
             Science 67:1157-65.

(5)    Gasaway,  W.; Buss S. (1972) Zinc Toxicity in the Mallard  Duck. Journal of Wildlife
      Management 36(4): 1107-1117.

(6)    Palafox, A.; Ho-A, E. (1980) Effect of Zinc Toxicity in Laying White Leghorn Pullets
             and Hens. Poultry Science 59:2024-28.

-------
(7)     United States Environmental Protection Agency (1987) Ambient Water Quality Criteria
             for Zinc-1987. Office of Water Regulations and Standards, Criteria and Standards
             Division, Washington,  DC

(8)     Hudson, R.; Tucker, R. ;  Haegele,  M. (1984) Handbook of Toxicity of Pesticides to
             Wildlife. 2nd ed. United Satates Fish and Wildlife Service, Resource Publication
             No.  153, Washington,  DC.

(9)     United States Atomic Energy, (1973) Toxicitv of Power Plan|£hemicals to Aquatic Lite.
             Compiled by C. Becker and T. Thatcher, Battelle Inc. Richland, WA,
                                           19

-------
                               APPENDIX D

                     List of Available Related Documents

      The following is a list of available documents related to zinc salts.  Its purpose is to
provide a path to more detailed information if it is needed.  These accompanying documents are
part of the Administrative Record for zinc salts and are included in the EPA's Office of Pesticide
Programs Public Docket.

      1.     Health and Environmental Effects Science Chapters

      2.     Detailed  Label Usage Information System (LUIS) Report

      3.     Zinc salts RED Fact Sheet

      4.     PR Notice 91-2 (included  in  this  appendix) pertains to  the Label Ingredient
             Statement

-------
                 UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
                            WASHINGTON, O.C. 80460
                           PR KOTICE  91-2
                                             OFFCCOF
                                           KSTCOeS AND TOXIC
                                             SUBSTANCES
NOTICE TO MANUFACTURERS, PRODUCERS, FORMULATORS,
         AND REGISTRANTS OF PESTICIDES
ATTENTION:  Persons Responsible  for Federal Registration of
            Pesticide  Products.

SUBJECT:    Accuracy of Stated Percentages for  Ingredients
            Statement
I.   PURPOSE:
     The  purpose  of this  notice is  to  clarify the  Office  of
Pesticide  Program's  policy  with respect to  the  statement  of
percentages   in   a  pesticide's  label's  ingredient   statement.
Specifically,  the  amount   (percent  by weight)  of  ingredient(s)
specified in  the  ingredient statement  on the  label must be stated
as the nominal concentration of such ingredient (s), as that term is
defined  in   40   CFR 158.153(i).  Accordingly,   the Agency  has
established the nominal concentration as the only acceptable label
claim for the amount of active ingredient  in  the product.

II.  BACKGROUND
                                       *
     For some time the Agency has accepted two different methods of
identifying  on the label  what  percentage  is  claimed  for  the
ingredient(s) contained in a pesticide.  Some  applicants claimed a
percentage which  represented  a level  between the  upper and  the
lower  certified   limits.    This was  referred to as the  nominal
concentration.  Other applicants claimed  the lower limit as  the
percentage  of the ingredient (s) that would be expected to  be
present in their  product at the end of the product's shelf-life.
Unfortunately, this led to a great deal of confusion among   the
regulated industry, the regulators, and the consumers as to exactly
how much of a given ingredient was in a given  product.   The Agency
has established the nominal concentration as  the only  acceptable
label claim for the  amount  of  active ingredient  in the  product.

     Current regulations require that the percentage listed in  the
active ingredient statement be as precise as possible  reflecting
good manufacturing practices  40 CFR 156.10(g)(5).  The  certified
limits  required  for  each active   ingredient   are intended   to
encompass any such "good manufacturing  practice"  variations 40  CFR
158.175(c)(3).
                                                          Printed on RKyctod Paper

-------
                                2.
 The upper and lower certified limits, which must  be proposed in
 connection with a product's registration, represent the amounts'of
 an ingredient that nay legally be present 40 CFR 158.175. The lower
 certified limit is used  as the enforceable lower limit  for the
 product composition according to FZFRA section 12(a)(l)(C), while
 the nominal concentration  appearing on the  label would  be the
 routinely achieved concentration used for  calculation of dosages
 and dilutions.

     The  nominal  concentration would in fact  state  the greatest
 degree of accuracy that is warranted with respect to actual product
 composition because the nominal concentration would be the amount
 of active ingredient typically found in the product.

     Zt is important for registrants to note that certified limits
 for active ingredients  are  not  considered to  be  trade  secret
 information  under  FZFRA  section  10(b).   In  this  respect  the
 certified limits will  be  routinely  provided by EPA to States for
 enforcement purposes, since the nominal concentration appearing on
 the label  may not  represent  the  enforceable composition  for
 purposes  of section 12(a)(l)(C).

 ZZZ. REQUIREMENTS

     As described below under Unit V. " COMPLIANCE SCHEDULE," all
 currently registered products as well as all applications for new
 registration must comply with this Notice by specifying the nominal
 concentration  expressed as a percentage by weight  as  the label
 claim in the ingredient (s) statement and equivalence  statements if
 applicable  (e.g.,  elemental  arsenic,  metallic zinc, salt  of an
 acid).  Zn addition, the requirement for performing sample analyses
 of five or more representative samples must  be fulfilled. Copies of
.the raw  analytical data must  be  submitted with  the  nominal
 ingredient  label  claim.  Further  information  about  the analysis
 requirement may be found  in the 40  CFR 158.170.  All  products are
 required  to provide  certified  limits  for each  active,  inert
 ingredient, impurities of toxifcological  significance(i.e., upper
 limit (s)  only), and on  a case by case basis as specified  by EPA.
 These limits are  to  be set based on representative  sampling and
 chemical analysis(i.e., quality control)  of the product.

     The format .of the ingredient statement must conform to 40 CFR
 156-Labeling Requirements For Pesticides and Devices.

     After July 1, 1997, all pesticide ingredient statements must
be Changed to nominal concentration.

-------
 APPENDIX F
Generic Data Call-In

-------
                              3.
 ZV.   PRODUCTS  THAT REQUIRE EFFICACY DATA

      All pesticides are required to be efficacious.  Therefore,
 the  certified  lover limits nay not be lover then the minimum
 level to achieve efficacy.  This is extremely important for
 products which are intended to control pests which threaten the
 public health,  e.g., certain antimicrobial and rodenticide
 products.  Refer to 40 CFR 158.640.

      Zn  those  cases where efficacy limits have been established,
 the  Agency vill not accept certified lover limits which are below
 that level for the shelf life of the product.

 V.   COMPLIANCE SCHEDULE

      As  described earlier, the purpose of this Notice is to make
 the  registration process more uniform and more manageable for
 both the agency and the regulated community.  It is the Agency's
 intention to implement the requirements of this notice as
 smoothly as possible so as not to disrupt or delay the Agency's
 high priority programs, i.e., reregistration, nev chemical, or
 fast track (FIFRA section 3(c)(3)(B).  Therefore,
 applicants/ registrants are expected to comply with the
 requirements of this Notice as follows:

          (1)   Beginning July 1, 1991, all nev product
                registrations submitted to the Agency
                are to comply vith the requirements of this
                Notice.

          (2)   Registrants having products subject to
                reregistration under FIFRA section 4 (a) are to
                comply vith the requirements of this Notice vhen
                specific products are called in by the Agency
                under Phase V of the Rereglstration Program.

          (3)   All other products/applications that are
                not subject to (1) and (2) above vill have until
               July 1, 1997, to comply vith this Notice.
                Such applications should note "Conversion
                to Nominal Concentration" on the application
                form. These types of amendments vill not be
               handled as "Fast Track" applications but
               vill be handled as routine requests.

VI.  FOR FURTHER INFORMATION

     Contact Tyrone Aiken for information or questions concerning
this notice  on (703)  557-5024.
                                Anne E. Lindsay, Director
                                Registration Division (H-7505

-------
f T-Stt \          UNFTED STATES ENVIRONMENTAL PROTECTION AGENCY
I V\i/V f                     ufAeiaueTML Be  MUM
                           WASHINGTON, D.C. 9MM
                       DATA CALL-IN NOTICE
                                                         omceof
                                                       Ksrcoes AM> TOXIC
 CERTIFIED MATT,                                          CUUTANCES
 Dear Sir or Madam:


 This Notice requires  you  and other registrants of pesticide
 products containing the active  ingredient  identified in
 Attachment  A of this  Notice,  the  Data Call-In Chemical  Status
I Sheet.  to submit certain  product  specific  data as noted herein to
 the  U.S.  Environmental Protection Agency  (EPA, the Agency).
 These data  are necessary  to  maintain the continued registration
 of your product(s) containing this active  ingredient.   Within 90
 days after  you receive this  Notice you must respond  as  set forth
 in Section  III below.  Your  response must  state:

      1.  How you will  comply  with  the requirements set forth in
         this Notice and its  Attachments A  through G; or

      2.  Why you believe you  are exempt from the requirements
         listed in this Notice and in Attachment C,
         Requirements  Status  and Registrant's Response Form, (see
         section III-B); or

      3. Why you believe EPA  should not require your  submission
        of  product specific  data  in the Banner specified by this
        Notice (see section  III-D).

      If you do not respond to this Notice, or if  you do not
 satisfy EPA that you will comply  with its  requirements  or  should
 be exempt or excused from doing so, then the registration  of your
 product(s)  subject to this Notice will be  subject to suspension.
 We have provided a list of all of your products subject to this
 Notice in Attachment B, pata  Call-in Response Form,  as  well as a
 list  of all  registrants who were  sent this Notice (Attachment F).

     The authority for this Notice is section 3(c)(2)(B) of the
 Federal Insecticide, Fungicide and Rodenticide Act as amended
 (FIFRA), 7 U.S.C. section 136a(c)(2)(B).   Collection of this
 information  is authorized under the Paperwork Reduction Act by
OMB Approval No. 2070*0107 (expiration date 12-31-92).

-------
       This Notice is divided into six sections and seven
 Attachments.  The Notice itself contains information and
 instructions  applicable to all Data Call-in Notices.  The
 Attachments contain specific cheaical information and
 instructions.  The six sections of the Notice are:
     Section Z
     Section ZX
     Section ZZZ
              Why You Are Receiving This Notice
              Data Required By This Notice
              CoDpliance With Requirements Of This
              Notice
Section IV  - Consequences Of Failure To Comply With
              This Notice
Section V   - Registrants' Obligation To Report
              Possible Unreasonable Adverse Effects
Section VI  - Inquiries And Responses To This Notice

The Attachments to this Notice are:

A  - Data Call-In Chemical Status Sheet
B  - Data pall-In Response Form
C  - Requirementsgtatqs and Registrant's Response Form
D  - EPA Grouping of End-Use Products for Meeting Acute
     Toxicology Data Requirements for Rereaistration
E -  EPA Acceptance Crj.teri,a
F  - List of Registrants Receiving This Kotice
C  - Cost; Share and Data Compensation Fonts, and Product
           le Data ieort Fen
SECTION I.  WHY YOU ARE RECEIVING TffIS KQTICE

   .  The Agency*has reviewed existing data for this active
ingredient and reevaluated the data needed-to support continued
registration of the subject active ingredient.  The Agency has
concluded that the only additional data necessary are product
specific data.  No additional generic data requirements are being
imposed.  You have been sent this Notice because you have
product(s) containing the subject active ingredient.

SECTION II.  CATA REQUIRED BY THIS NOTICE

II-A.  DATA REQUIRED

     The product specific data required by this Notice are
specified in Attachment C, peguireae^ts Status and Registrant's
ResponseFprn.  Depending on the results of the studies required in
this Notice, additional testing aay be required.

-------
 II-B.  ffTHEPVU F9g SUBMISSION OF DATA

      You ar* required to submit the data or otherwise satisfy the
 data requirements specified in Attachment C, yeguirenanfcs status
 and Registrant's Resnonaa Porn, vithin the timeframes provided.
 II-C.  TESTING PROTOCOL

      All studies required under this Notice must be conducted in
 accordance with test standards outlined in the Pesticide Assessment
 Guidelines for those studies for which guidelines have been
 established.
    •r
      These EPA Guidelines are available from the National Technical
 Information Service (NTIS), Attn: Order Desk,  5285  Port Royal Road,
 Springfield, Va 22161 (tel: 703-487-4650).

      Protocols approved by the Organization for Economic
 Cooperation and Development (OECD) are also acceptable if the OECD-
 recommended test standards conform to those specified  in the
  esticide Data Requirements regulation (40 CFR f 158.70).   When
 using the OECD protocols, they should be modified as appropriate so
 that the data generated by the study will  satisfy the  requirements
 of 40 CFR f 158.  Normally, the Agency will not extend deadlines
 for complying with data requirements when  the studies  were  not
 conducted in accordance with acceptable standards.   The OECD
 protocols are available from OECD, 1750 Pennsylvania Avenue N.W.,
 Washington, D.C. 20006.

      All new studies and proposed protocols submitted  in response
 to this Data Call-In Notice must be in accordance with Good
 Laboratory Practices [40 CFR Part 160.3(a)(6)].

 II-D.  REGISTRANTS RECEIVING PREVIOUS SECTION 3feW2WS^ NOTICES
        ISSUED BY THE AGENCY

        Unless otherwise noted herein, this Data Call-in dees  not in
 anv wav supersede or change the requirements of any previous  Data
 Call-infal. or any*other agreements entered into with  the Agency
 pertaining to such prior Notice.  Registrants must  comply with the
 requirements of all Notices to avoid issuance of a  Notice of  Intent
 to Suspend their affected products.
SECTION III.   COH?LIANCE WITH REQUIREMENTS OF THIS NOTICE

kIII""A.   ff.CHE.DVEE, FOR RESPONDING TO THE ACEKCY

      The appropriate responses initially required by this Notice
for product specific data must be submitted to the Agency within 90
days  after your receipt of  this Notice.  Failure to adequately
respond to this Notice  within 90 days of your receipt will be a
basis for issuing a  Notice  of Intent to Suspend  (NOIS) affecting

-------
 your products. This and other bases for issuance of NOIS due to
 failure to comply with this Notice are presented in Section IV-A
 and IV-B.

 III-B.  OPTIONS FOR RESPONDING TO THE ACENCV

     The options for responding to this Notice for product specific
 data are: (a) voluntary cancellation, (b) agree to satisfy the
 product specific data requirements imposed by this Notice or (c)
 request a data vaiver(s).  . . ; •
                            ' «•
     A discussion of how to respond if you choose the Voluntary
 Cancellation option is presented below.  A discussion of the
. .various options available for satisfying the product specific data
 requirements of this Notice is contained in Section III-C.  A
 discussion of options relating to requests for data waivers is
 contained in Section III-D.

     There are two forms that accompany this Notice of which,
 depending upon your response,  one or both oust be used in your
 response to the Agency.  These forms are the Pata-Call-In Response
 Fprm.  and the Requirements Status and Registrant's Response form.
 Attachment S and Attachment C.  The Dqta Call-In Response Form must
 be submitted as part of every response to this Notice.  In
 addition, one copy of the Requirements Status and Registrant's
 Response Fora  must be submitted for each product listed on the
 Data Call-In Response Fora unless the voluntary cancellation option
 is selected or unless the product is identical to another (refer to
 the instructions for completing the Data Call-In Response Form in
 Attachment B).   Please note that the company's authorized
 representative is required to  sign the first page of the Data Call-
 in Response Form and Requirements Status and Registrant's Response
 £OXQ (if this form is required)  and initial any subsequent pages.
 The forms contain separate detailed instructions on the response
 options.   Do not alter the printed material.  If you have questions
 or need assistance in preparing your response, call or write the
 contact person(s)  identified in Attachment A.

     1.  Voluntary Cancellation  - You may avoid the requirements of
 this Notice by requesting voluntary cancellation of your product(s)
 containing the active ingredient  that is the subject of this
 Notice.  If you wish to voluntarily cancel your product,  you aust
 submit  a completed Data Call-in Response Form.  Indicating your
 election of this option.   Voluntary cancellation is item number 5
 on the  pata  Call-In Response Form.  If you choose this option,  this
 is the  only fora that you are  required to complete.

     If  you choose to voluntarily  cancel your product,  further sale
 and distribution of your product  after the effective date of
 cancellation must be in accordance  with the Existing Stocks
 provisions of this Notice  which are contained in Section iv-c.

-------
       2. Satisfying the product SpecificData Requirements  of thi,s
         .  There are various options available to satisfy the product
   specific data requirements of this Notics.   These options are
   discussed in Section III-C of this Kotice and coaprise  options l
   through 6 on the Requirement^ Status and Registrant's Response Fonp
   and item numbers 7a and 7b on.the Data Call-in Reanonae Fora.
   Deletion of a use(s) and the low volume/minor use option  are not
   valid options for fulfilling product specific data requirements.

       3. Request for Product specific Pate Waivers.  Waivers for
   product specific data are discussed in Section III-D of this notice
   and are covered by option 7 on the Requirements Status  and
   Registrant's Response Form.  If you choose  this option, you Bust
   submit both fores as veil as any other information/data pertaining
   to the option chosen to address the data reguirenent.

   ZZZ-C  SATISFYING THE PATA REQUIREMENTS OF  THIS NOTICE

        If you acknowledge on the Data Call-in Response Fora that you
   agree to satisfy the product specific data  requirements (i.e. you
^select option 7a or 7b), then you nust select one of the  six
•poptions on the Requirements Status and Registrant's Response Form
 •related to data production for each data requirement.   Your option
   selection should be entered under item number 9,  "Registrant
   Response."  The six options related to data production  are the
   first six options discussed under item 9 in the instructions for
   completing the Requirements Status and Registrant's Response Form.
   These six options are listed immediately below with information in
   parentheses to guide registrants to additional instructions
   provided in this Section.   The options are:

        (1)   I will generate and submit data within the specified
             timeframe (Developing Data)
        (2)   Z have entered into an agreement  with one or  sore
             registrants to develop data jointly (Cost Sharing)
        (3)   Z have aade offers to cost-share  (Offers to Cost Share)
        (4)   Z an submitting an existing study that has not  been
             submitted previously to the Agency by anyone  (Submitting
             an Existing Study)
        (5)   Z am submitting or citing data to upgrade a study
             classified by EPA as partially acceptable and upgradeable
             (Upgrading a Study)
        (6)   Z aa citing an existing study that EPA has classified as
             acceptable or an existing study that has been submitted
             but not reviewed by the Agency (Citing an Existing Study)

       Option 1.  Developing  Data —  Zf you choose to develop the
    guired data it aust be in confonuance with Agency deadlines and
    th other Agency requirements as referenced herein and in the
   attachments.  All data generated and submitted aust comply with the
   Good Laboratory Practice (GLP)  rule (40 CFR  Part 160), be conducted
   according  to the pesticide Assessment Guidelines  (PAG), and be in
   conforaance with the  requirements of PR Notice 86-5.

-------
     The tine frames  in the Requirements gtatus and Registrant! s
 Response Torn are the tine fraaas that the Agency is allowing for
 the submission of completed study reports.  The noted deadlines run
 frea the date of the receipt of this Notice by the registrant.  If
 the data are not submitted by the deadline, each registrant is
 subject to receipt of a Notice of Intent to Suspend the affected
 registration(s).

     If you cannot submit the data/reports to the Agency in the time
 required by this  Notice and. intend to seek additional tiae to Beet
 the requirements (s), you Bust submit a request to the Agency which
 includes: (1)  a detailed description of the expected difficulty and
 (2) a proposed schedule including alternative dates for meeting
 such requirements on a step-by-step basis.  You must explain any
 technical or laboratory difficulties and provide documentation from
 the laboratory performing the testing.  While EPA is considering
 your request,  the original deadline remains.  The Agency will
 respond to your request in writing.  If EPA does not grant your
 request,  the original deadline remains.  Normally, extensions can
 be requested only in cases of extraordinary testing problems beyond
 the expectation or control of the registrant.  Extensions will not
 be given in submitting the 90-day responses.  Extensions will not
 be considered if  the request for extension is not made in a timely
 fashion;  in no event shall an extension request be considered if it
 is submitted at or after the lapse of the subject deadline.

      Option 2. Agree te Share in Cost to Develop Data —Registrants
 may fioly. choose this option for acute toxicity data and certain
 efficacy data  ajjd, only if EPA has indicated in the attached data
 tables  that your  product and at least one other product are similar
 for purposes of depending on the saae data.  If this is the case,
 data  aay be generated for just one of the products in the group.
 The registration  number of the product for which data will be
 submitted must be  noted in the agreement to cost share by the
 registrant  selecting this option.  If you choose to enter into an
 agreement to share in the cost of producing the required data but
 will  not  be  submitting the data yourself, you Bust provide the name
 of the  registrant *rho will be submitting the data.  You Bust also
 provide EPA with documentary evidence that an agreement has been
 formed.   Such evidence Bay be your letter offering to join in an
 agreement and the other registrant's acceptance of your offer,  or a
 written statement by the parties that an agreement exists.  The
 agreement to produce the data need not specify all of the terms of
 the final arrangement between the parties or the mechanism to
 resolve the terms.  Section 3(c)(2)(B)  provides that if the parties
 cannot resolve the terms of the agreement they may resolve their
 differences through binding arbitration.
    Option 3. pffer te Share in the Cgst._.of P%ta Development  •—
This option only applies to acute toxicity and certain efficacy
data as described in option 2 above.  If you have Bade an offer to
pay in an attempt to enter into an agreement or amend an existing
agreement to meet the requirements of this Notice and have been

-------
 unsuccessful, you may request EPA (by selecting  this  option) to
 exercise its discretion not to suspend your registration(s),
 although you do not comply with the data  submission requirements of
 this Notice.  EPA has determined that as  a  general policy, absent
 other relevant considerations, it will not  suspend the registration
 of a product of a registrant vho has in good faith sought and
 continues to seek to enter into a joint data development/cost
 sharing program, but the other registrant(s) developing the data
 has refused to accept your offer.  To qualify for this option, you
 must submit documentation to the Agency proving  that  you have made
 an offer to another registrant (vho has an  obligation to submit
 data) to share in the burden of developing  that  data. You must
 also submit to the Agency a completed EPA Form 8570-32,
 Certification of Offer to Cost Share in the Development of Data,
 Attachment G.  In addition,  you must demonstrate that the other
 registrant to whom the offer was made has not accepted your offer
 to enter into a costsharing agreement by  including a  copy of your
 offar.and proof of the other registrant's receipt of  that offer
 (such as a certified mail receipt).   Your offer  must, in addition
 to anything else,  offer to share in the burden of producing the.
 data upon terms to be agreed or failing agreement to  be bound by
 binding arbitration as provided by PIFRA  section 3(c)(2)(B)(iii)
 (and must not qualify this offer.    The other registrant must also
 inform EPA of its  election of an option to  develop and submit the
 data required by this Notice by submitting  a Data Call-In Response
 form and a Requirements Status and Registrant's  Response Form
 committing to develop and submit the data required by this Notice.

     Zn order for you to avoid suspension  under this option, you may
 not -withdraw your  offer to share in the burdens  of developing the
 data.   In addition,  the other registrant  must fulfill its
 commitment to develop and submit the data as required by this
 Notice.   If the other registrant fails to develop the data or for
 some other reason  is subject to suspension, your registration as
 veil as that of the other registrant vill normally be subject to
 initiation of suspension proceedings,  unless you commit to submit,
 and do submit the  required data in the specified time frame.  In
 such cases,  the Agency generally vill not grant  a time extension
 for submitting the data.

     Option 4.  Submitting an  Existing Study — If you  Choose to
 submit  an existing study in  response  to this Notice,  you must
 determine that the study satisfies the requirements imposed by this
 Notice.   You may only submit a  study that has not been previously
 submitted to the Agency or previously cited by anyone.  Existing
 studies  are  studies  which  predate issuance of this Notice.  Do not
 use  this option if you are submitting data to upgrade a study. (See
 Option  5).

     You  should be  aware that  if the Agency determines that the
 study is  not  acceptable, the Agency vill require you to comply with
 this Notice, normally without an extension of the required date of
 submission.  The Agency may determine at any time that a study is
not valid and needs to be  repeated.

-------
                                8

    To Beet the requirements  of the DCZ Notice for submitting an
existing study, all of the  foil owing three criteria must be clearly
    a.  You Bust certify at the time that the existing study is
    submitted that the raw data and specimens from the study are
    available for audit and review and you Bust identify where they
    are available.  This Bust be done in accordance with
    the requirements of the Good Laboratory Practice (CLP)
    regulation, 40 CFR Part 160. As stated in 40 CFR 160.3 (j)
    * »[r]aw data1 Beans any laboratory worksheets, records,
    memoranda, notes,  or exact copies thereof, that are the result
    of  original observations and activities of a study and are
    necessary for the reconstruction and evaluation of the report
    of  that study.  In the event that exact transcripts of raw data
   -have been prepared (e.g., tapes which have been transcribed
    verbatim,  dated,  and verified accurate by signature) , the exact
    copy or exact transcript may be substituted for the original
    source as raw data.  'Raw data* may include photographs,
    microfilm or microfiche copies, computer printouts, magnetic
    media,  including dictated observations, and recorded data from
    automated instruments."  The term "specimens", according to 40
    CFR 160. 3 (X),  means  "any material derived from a test system
    for examination or analysis."

    b.  Health  and safety studies completed after May 1984 must also
    contain all GLP-required quality assurance and quality control
    information,  pursuant  to the requirements of 40 CFR Part 160.
    Registrants must  also  certify at the time of submitting the
    existing study that  such CLP information is available for post-
    May 1984 studies by  including an appropriate statement on or
    attached to the study  signed by an authorized official or
    representative of  the  registrant.

    c.  You  must certify  that each study fulfills the acceptance
    criteria for the Guideline relevant to the study provided i
    the FZFRA  Accelerated  Reregistration Phase 3 Technical Guidance^
    and that the study has been conducted according to the
    Pesticide  Assessment Guidelines (PAG)  or meets the purpose of
    the PAG (both  available from NTIS).  A study not conducted
    according  to the PAG Bay be submitted to the Agency for
    consideration  if the registrant believes that the study clearly
    aeets the  purpose  of the PAG.  The registrant is referred to 40
    CFR 158.70 which states the Agency's policy regarding
    acceptable protocols. Zf you wish to submit the study, you
    Bust, in addition to certifying that the purposes of the PAG
    are Bet by the study, clearly articulate the rationale why you
    believe the study meets the purpose of the PAG, including
    copies  of  any supporting information or data.   Zt has been the
    Agency's experience that studies completed prior to January
    1970 rarely satisfied the purpose of the PAG and that necessary
    raw data are usually not available for such studies.

-------
ft
    Zf you submit an existing study, you Bust certify that the
•tudy aeets all requirements of the criteria outlined above.

    Zf you know of a study pertaining to any requireaent in this
Notice which does not Beet the criteria outlined above but does
contain factual information regarding unreasonable adverse effects,
you aust notify the Agency of such a study.  Zf such  study is in
the Agency's files, you need only cite it along with the
notification. Zf not in the Agency's files, you Bust submit a
summary and copies as required by PR Notice 86-5.
                            V

   . Option 5. Upgrading a study — Zf a study has been classified
as partially acceptable and upgradeable, you aay subait data to
upgrade that study.  The Agency vill review the data submitted and
determine if the requireaent is satisfied.  Zf the Agency decides
the requireaent is not satisfied, you may still be required to
subait new data normally without any time extension.  Deficient,
but upgradeable studies will normally be classified as
suppleaental.  However, it is iaportant to note that not all
studies classified as supplemental are upgradeable.  Zf you have
questions regarding the classification of a study or whether a
 tudy may be upgraded, call or write the contact person listed in
 .ttachaent A*  Zf you submit data to upgrade an existing study you
must satisfy or supply information to correct All deficiencies in
the study identified by EPA.  You must provide a clearly
articulated rationale of how the deficiencies have been remedied or
corrected and why the study should be rated as acceptable to EPA.
Your submission aust also specify the MRZO number(s) of the study
which you are attempting to upgrade and aust be in conformance with
PR Notice 86-5.

    Do not submit additional data for the purpose of upgrading a
study classified as unacceptable and determined by the Agency as
not capable of being upgraded.

    This option should also be used to cite data that has been
previously submitted to upgrade a study, but has not yet been
reviewed by the Agency.  You must provide the KRID number of the -
data submission as well as the KRID number of the study being
upgraded.

    The criteria for subaitting an existing study, as specified in
Option 4 above, apply to all data submissions intended to upgrade
studies.  Additionally your submission of data intended to upgrade
studies Bust be accompanied by a certification that you comply with
each of those criteria as well as a certification regarding
protocol compliance with Agency requirements.
      Option 6. Cluing Existing Studies — Zf you choose to cite a
  study that has been previously submitted to EPA, that study must
  have been previously classified by EPA as acceptable or it must be
  a study which has not yet been reviewed by the Agency.  Acceptable

-------
               . i,
                                 10

 toxicology studies generally will have been classified as "core-
 guideline* or "core minimum.11  For all other disciplines the
 classification would be  "acceptable."  Kith respect to any studies
 for which you vish to select this option you must provide the MRID
 number of the study you  are citing and, if the study has been
 reviewed by the Agency,  you Bust provide the Agency's
, classification of the study.

     If you are citing a  study of which you are not the original
 data submitter, you must submit a completed copy of EPA Form
 8570-31,  Certification with Reapaet to Data
  .-•  Registrants who select one of the above 6 options must meet all
 of  the requirements described in the instructions for completing
 the Data Call-in Response Form and the Requirements Status qnd
 Registrant's Response Form, as appropriate.

 III-D  REQUESTS FOR DATA WAIVERS

     If you request a waiver for product specific data because you
 believe it is inappropriate, you must attach a complete
 justification for the request, including technical reasons, data
 and references to relevant EPA regulations, guidelines or policies.
 (Note: any supplemental data must be submitted in the format
 required by PR Notice 86-5) .  This will be the onlv opportunity to
 state the reasons or provide information in support of your
 request.  If the Agency approves your waiver request, you will not
 be  required to supply the data pursuant to section 3(c)(2)(B) of
 FIFRA.  If the Agency denies your waiver request, you must choose
 an  option for meeting the data requirements of this Notice within
 30  days of the receipt of the Agency's decision.  You must indicate
 and submit the option chosen on the Requirements Status and,
 Registrant's Response Form.  Product specific data requirements for
 product chemistry, acute toxicity and efficacy (where appropriate)
 are required for all products and the Agency will grant a waiver
 only under extraordinary circumstances.   You should also be aware
 that submitting a waiver request will not automatically extend the
 due date for the study in question.  Waiver requests submitted
without adequate supporting rationale will be denied and the
 original due date will remain in force.

 IV.  CONSEQUENCES OF FAILDRE TO COMPLY WITH THIS NOTICE

 JV-A NOTICE OF INTENT TO SUSPEND

    The Agency may issue a Notice of Intent to Suspend products
subject to this Notice due to failure by a registrant to comply
with the requirements of this Data Call-In Notice,  pursuant to
FIFRA section 3(c)(2)(B).   Events which  may be the basis for
issuance of a Notice of Intent to Suspend include,  but are not
limited to,  the following:

-------
                                 11

     1.   Failure to respond as required by this Notice within 90
     days of your receipt of this Notice.

     2.   Failure to submit on the required schedule an acceptable
     proposed or final  protocol if such is required to be submitted
     to  the Agency for  review.

     3.   Failure to submit on the required schedule an adequate
     progress report en a study if required by this Notice.

     4.   Failure to submit on the required schedule acceptable
     data as required by this Notice.

     5.   Failure to take a required action or submit adequate
    .-• information pertaining to any option chosen to address the data
     requirements (e.g.,  any required action or information
     pertaining to submission or citation of existing studies or
     offers,  arrangements,  or arbitration on the sharing of costs or
     the formation of Task Forces, failure to comply with the terms
     of  an agreement or arbitration concerning joint data
     development or failure to comply with any terms of a data
     waiver).

     6.   Failure to submit supportable certifications as to the
     conditions of submitted studies, as required by Section XII-C
     of  this Notice.

     7.  Withdrawal of an offer to share in the cost of developing
     required data.

     8.  Failure of the  registrant to whom you have tendered an offer
     to  share in the cost of developing data and provided proof of
     the registrant's receipt of such offer either to:

     a.  Inform EPA of  intent to develop and submit the data
     required by this  Notice on a pata Call-In Response Form and a
     Requirements Status and Registrant's Response Form;

     b.  Fulfill the commitment to develop and submit the data as
     required by this  Notice; or

     c.  Otherwise take  appropriate steps to meet the requirements
     stated in this Notice,  unless you commit to submit and do
     submit the required  data in the specified time frame.

     9.   Failure to take  any required or appropriate steps, not
    mentioned above, at  any time following the issuance of this
    Notice.

  MB.   BASIS  FOR PETERMIWATIQN THAT SUBMITTED STPDY TS
    The Agency may determine that a study (even if submitted within
the required time) is unacceptable and constitutes a basis for

-------
                                 12

 issuance of a Notice of Intent to Suspend.  The grounds for
 suspension include, but are not limited to, failure to meet any of
 the following:

     1.   EPA requirements specified in the Data Call-In Notice or
     other documents incorporated by reference (including, as
     applicable, EPA Pesticide Assessment Guidelines, Data Reporting
     Guidelines, and GeneTox Health Effects Test Guidelines)
     regarding the design, conduct, and reporting of required
     studies.  Such requirements.include, but are not limited to,
    . those relating to test .material, test procedures, selection of
     species, number of animals, sex and distribution of animals,
  *   dose and effect levels to be tested or attained, duration of
 . ..  test,  and, as applicable, Good Laboratory Practices.
     2.  EPA requirements regarding the submission of protocols
     applicable), including the incorporation of any changes
     required by the Agency following review.
(if
    3.  EPA requirements regarding the reporting of data, including
    the manner of reporting, the completeness of results, and the
    adequacy of any required supporting (or raw) data, including,
    but not limited to, requirements referenced or included in this
    Notice or contained in PR 86-5.  All studies must be submitted
    in the form of a final report; a preliminary report will not be
    considered to fulfill the submission requirement.

xv-c  EXISTING STOCKS or SUSPENDED OR c*N£ifllfLfP PRODUCTS

    EPA has statutory authority to permit continued sale,
distribution and use of existing stocks of a pesticide product
which has been suspended or cancelled if doing so would be
consistent with the purposes of the Act.  •

    The Agency has determined that such disposition by registrants
of existing stocks for a suspended registration when a section
3(c)(2)(B) data request is outstanding would generally not be
consistent with the Act's purposes.  Accordingly, the Agency
anticipates granting registrants permission to sell, distribute, or
use existing stocks of suspended product(s)  only in exceptional
circumstances.  If you believe such disposition of existing stocks
of your product(s) which may be suspended for failure to comply
with this Notice should be permitted, you have the burden of
clearly demonstrating to EPA that granting such permission would be
consistent with the Act. You must also explain why an "existing
stocks" provision is necessary,  including a statement of the
quantity of existing stocks and your estimate of the time required
for their sale,  distribution, and use.  Unless you meet this burden
the Agency will  not consider any request pertaining to the
continued sale,  distribution, or use of your existing stocks after
suspension.

    Zf you request a voluntary cancellation of your product(s)  as a
response to this Notice and your product is in full compliance with

-------
                                 13

 all Agency requirement*,  you will  have,  under »ost circumstances,
 one year from the date your 90 day response to this Notice  im due,
 to sell, distribute,  or use existing stocks.  Normally, the Agency
 vill allow persons other  than the  registrant such as independent
 distributors, retailers and end users to sell, distribute or use
 such existing stocks  until the stocks are exhausted.  Any sale,
 distribution or use of stocks of voluntarily cancelled products
 containing an active  ingredient for vhicb the Agency has particular
 risk concerns yill be determined en a case-by-case basis.

     Requests for voluntary .cancellation  received after the  90 day
 response period required  by.this Notice  vill not result in  the
 Agency granting any additional time to sell, distribute, or use
 existing stocks beyond a  year from the date the 90 day response was
 due unless you demonstrate to the  Agency that you are in full
 compliance with all Agency requirements,  including the requirements
 of this Notice.  For  example,  if you decide to voluntarily  cancel
 your registration six months before a 3  year study is scheduled to
 be submitted, all progress reports and other information necessary
 to establish that you have been conducting the study in an
 acceptable and good faith manner must have been submitted to the
 Agency,  before EPA vill consider granting an existing stocks
 provision.
 SECTION V.  REGISTRANTS' OBLIGATION TO REPORT
            UNREASONABLE ADVERSE EFFECTS

    Registrants are reminded that FIFRA section  6(a)(2) states that
 if at any time after a pesticide is registered a registrant has
 additional factual information regarding unreasonable adverse
 effects on the environment by the pesticide, the registrant shall
 submit the information to the Agency.  Registrants must notify the
 Agency of any factual information they have, from whatever source,
 including but not limited to interim or preliminary results of
 studies, regarding unreasonable adverse effects  on man or the
 environment.  This requirement continues as long as the products
 are registered by the Agency.
SECTION VT.  INQUIRIES AND RESPONSES TO THIS NOTICE

    If you have any questions regarding the requirements and
procedures established by this Notice, call the contact person(s)
listed in Attachment A, the Data Call-in Chemical Status Sheet.
                               •
    All responses to this Notice (other than voluntary cancellation
requests) must include a completed Data Call-in Response Form and a
 ompleted Requirements Status and Registrant's ResponseForm
 Attachment B and Attachment C) and any other documents required by
this Notice, and should be submitted to the contact person(s)
identified in Attachment A. If the voluntary cancellation option is
chosen, only the pata Call-In Reypon^e Ferm need be submitted.

-------
                                14
    The Office of Compliance Monitoring (OCM)  of the Office of
Pesticides and Toxic Substances (OPTS), EPA, will be monitoring the
data being generated in response to this Notice.
                             Sincerely yours.
    A  -
    B  -
    C  -
    D  •

    E -
    F  •
    G  •
                   ..Daniel M. Barolo, Director
                  .*' Special Review and
                      Reregistration Division

               Attachments

Data Call-In Chemical Status Sheet
Data ^all-in Response Pern
Requirements Status and Registrant's Response Form
EPA Grouping of End-Use Products for Meeting Acute
Toxicology Data Regyireaen^ta for Rereoistration
EPA Acceptance Criteria
List of Registrants Receiving This Notice
Cost Share and Data Compensation Forms, and Product
Specific Data Report Form

-------
    ATTACHMENT A




CHEMICAL STATUS SHEET

-------
             ZINC SALTS: DATA CALL-IN CHEMICAL STATUS SHEET
INTRODUCTION
                                                         .     *

       You have  been  sent this Generic Data Call-In  Notice because you  have product(s)
containing zinc chloride or zinc sulfate.

       This Generic Data Call-in Chemical Status Sheet, contains an overview of data required
by this notice, and point of contact for inquiries pertaining to the reregistration of zinc salts.
This attachment is to be used in conjunction with (1) the Generic Data Call-In Notice, (2) the
Generic Data Call-In Response  Form  (Attachment B),  (3)  the Requirements Status  and
Registrant's Form (Attachment C), (4) a list of registrants receiving this DCI (Attachment D),
(5) the EPA Acceptance Criteria (Attachment E), and (6) the Cost Share and Data Compensation
Forms in replying to this Zinc Salts Generic  Data Call-In (Attachment F).  Instructions and
guidance accompany each form.
DATA REQUIRED BY THIS NOTICE

       The additional data requirements needed to complete the generic database for zinc salts
are contained in the Requirements Status andJRegistrant's Response. Attachment C. The Agency
has concluded that additional product chemistry data on zinc chloride, zinc sulfate and zinc oxide
are needed.  These data are needed to fully complete the reregistration of all eligible zinc salts
products.
INQUIRIES AND RESPONSES TO THIS NOTICE

       If you  have  any questions regarding  the generic data  requirements and procedures
established by  this Notice, please contact Mark Wilhite at (703) 308-8586.

       All responses to this Notice for the generic data requirements should be submitted to:

             Mark Wilhite, Chemical Review Manager
             Accelerated Reregistration Branch
             Special Review and Registration Division (H7508W)
             Office of Pesticide Programs
             U.S. Environmental Protection Agency
             Washington, D.C.  20460

             RE: ZINC SALTS

-------
              ATTACHMENT B
GENERIC DATA CALL-IN RESPONSE FORMS (Form A)
            PLUS INSTRUCTIONS

-------
                    SPECIFIC INSTRUCTIONS FOR
                  THE  DATA  CALL-IN RESPONSE FORM
     This form is designed to be used to respond to call-ins for
generic and product specific data for the purpose of
reregistering pesticides under the Federal Insecticide Fungicide
and Rodenticide Act.  Fill out this form each time you are
responding to a data call-in for which EPA has sent you the form
entitled "Requirements Status and Registrant's Response.11

     Items 1 -4 will have been preprinted on the form. Items 5
through 7 must be completed by the registrant as appropriate.
Items 8 through 11 must be completed by the registrant before
submitting a response to the Agency.

     Public reporting burden for this collection of information
is estimated to average 15 minutes per response, including time
for reviewing instructions, searching existing data sources,
gathering and maintaining the data needed, and completing and
reviewing the collection of information.  Send comments regarding
the burden estimate or any other aspect of this collection of
information, including suggesting for reducing this burden, to
Chief, Information Policy Branch, PM-223, U.S. Environmental
Protection Agency, 401 M St., S.W., Washington, O.C. 20460; and
to the Office of Management and Budget, Paperwork Reduction
Project 2070-0107, Washington, D.C. 20503.
INSTRUCTIONS

Item 1.   This item identifies your company name, number and
          address.

Item 2.   This item identifies the case number, case name, EPA
          chemical number and chemical name.

Item 3.   This item identifies the date and type of data call-in.

Item 4.   This item identifies the EPA product registrations
          relevant to the data call-in.  Please note that you are
          also responsible for informing the Agency of your
          response regarding any product that you believe may be
          covered by this data call-in but that is not listed by
          the Agency in Item 4.  You must bring any such apparent
          omission to the Agency's attention within the period
          required for submission of this response form.

Item 5,   Check this item for each product registration you wish
          to cancel voluntarily.  If a registration number is
          listed for a product for which you previously requested
          voluntary cancellation, indicate in Item 5 the date of
          that request.  You do not need to complete any item on

-------
          the RequirementsStatus and Registrant's Response Form
          for any product that is voluntarily cancelled.

Item 6a.  Check this item if this data call-in is for generic
          data as indicated in Item 3 and if you are eligible for
          a Generic Data Exemption for the chemical listed in
          Item 2 and used in the subject product.  By electing
          this exemption, you agree to the terms and conditions
          of a Generic Data Exemption as explained in the Data
          Call-In Notice.

          If you are eligible for or claim a Generic Data
          Exemption, enter the EPA registration Number of each
          registered source of that active ingredient that you
          use in your product.

          Typically, if you purchase an EPA-registered product
          from one or more other producers (who, with respect to
          the incorporated product, are in compliance with this
          and any other outstanding Data Call-in Notice), and
          incorporate that product into all your products, you
          may complete this item for all products listed on this
          form.  If, however, you produce the active ingredient
          yourself, or use any unregistered product (regardless
          of the fact that some of your sources are registered),
          you may not claim a Generic Data Exemption and you may
          not select this item.

Item 6b.  Check this Item if the data call-in is a generic data
          call-in as indicated in Item 3 and if you are agreeing
          to satisfy the generic data requirements of this data
          call-in.  Attach the Requirements Status and
          Registrant's Response Form that indicates how you will
          satisfy those requirements.

Item 7a.  Check this item if this call-in is a data call-in as
          indicated in Item 3 for a manufacturing use product
          (MUP), and if your product is a manufacturing use
          product for which you agree to supply product-specific
          data.  Attach the Requirements Status and Registrants'
          Response Form that indicates how you will satisfy those
          requirements.

Item 7b.  Check this item if this call-in is a data call-in for
          an end use product (EUP) as indicated in Item 3 and if
          your product is a end use product for which you agree
          to supply product-specific data.  Attach the
          Requirements Status and Reoiistrant's Response Form that
          indicates how you will satisfy those requirements.

Item 8.   This certification statement must be signed by an
          authorized representative of your company and the

-------
          person signing must include his/her title.   Additional
          pages used in your response must be initialled and
          dated in the space provided for the certification.

Item 9.   Enter the date of signature.

Item 10.  Enter the name of the person EPA should contact with
          questions regarding your response.

Item 11.  Enter the phone number of your company contact.

-------
_
o

z


o
n
8
1

n
I
t»
o
"*






























-
5
i

i
-j





vj o — — »

5 01 O
3 Q- n n o
a o T *> ra
f— • "ft
•* —
| ll? S
5. -t a 01 rt
rt **«
-H D rt O
!T ~
now
2, £.3 S
•— rt
n i» jr n
S C -• rt
3 • 3 W
X U>

Q.
C 3*
3- »§
O 1*
O 3-
a (A
2."
JEP W o
•3 «^ 3
1 l§
1 »„
0) in —
*-t *t ^
< <-» B
S a-
3 B
rt S-
1 i
If*
|S
3 rt
cn C
?."
SB
"S
*5
^k **
?
•1 o
-•I
w-8
|s
n <>








•
B
n








U1

00
Ul
o
ID
1

















































30 -t-
r> •
IO
— m
t» 5
rt >
s ^
i|
**




rt rt'D O Ul •
a -> -i a •
— - e » ""
x" 5 ' o •- c
rt S"
O i? — • ^
«~ y
I*1 a ** C

* 9 S

f|H|-
* 8 i a rt"?
sjtrt 3 o d
3O 5"(0 » C
2*0*2
«' 36 oT —
1 A y<
a c * ^fi
5 ~ a ?
"1 rt C
"'IS1

^

P
i
o'
!
V










^
1
Tl
g"
rt
f
o'
«
*











g M D Oj

: vo CD <|
D u > a^
iw 2B>S
«3 • M • a,
OMS^i

^ ^ ^* rf
«* »-• w f S
*> W t-3 n
o a w "
n S M
J> W M 3
n »-3 n 13
k 1-3 O
"S
^5 ^"3 Ah
H MW|
> °
(-4 VO









(M
I'f Of
S S **
»* i
i«!
1?
o
oo cn
00 Q)
m M
0 ft
to w









w
•
O »
1 -
o
"*
o
o





V Vt

^ n
rf, ~*
I" I
5 (A
*" ^
3- ™
S S

«*
•^ 5
_."§
g °
n "O
J T^
n 9
T
"* a'

I

^

.
o

H
n
a
5,
c
X*
f
01
iched instructions
1
1

3
31
?
1
i'
3
|
i
s
§
m
?
a





















G
3
p-
rt
(D
a

cn
ft
0)
ft
_, (D
5 » m
^^ *^ ^^
^ M "^
_ 3 H-
*™ iO llf
^ rt o
7 ? i
S ?S
al Protect!
.C. 20460
RESPONSE
O
(D
3
O












| 1 §
S o »
* * 5?
moo
X ^1 <
"S, . 1.
* 2
w
«!*


















































13
fi)
Q
(D
h»
0
Ml


-------
o
z
1
1
0
"*l
I
3
^
o
§
*"*
*
^t




























_^
"^


*
c
fr
?p
"*








at o — •— oo
(a on
3 cf n * n
01 o fr -\ it
rf »* 3 ^ ^
c 2 1^ C.
n c >-•< •*
32^ —
3 m S" 3- ai
i T » a «
-H n> »» S
— B =• " 5
« -e » 3-
— f-r* It
n 01 IA

rs (9 K* g

•1 *5 '"
~ ^"9
Q.
•y ST S
O (0
2. 05
O^ 3
9D I/I O
(» •- T
•o S3
S 9i|
3 3d
^ 0
Q> (B *-
** ft *—
_. At
< ™ B
4 ® «*»
a ^t
IS B
3 O
»» 3-
1 3
•< ^*
An
re true, accurate,
punishable by fine
" 9
a'
•8 o
M ^

n S
2 •







•o

•
<»












•
01
tn
o
o
i






















































30 «-
IO
— . m
(A 19
ft >
0> T>
i'|






§lil-
•5" S' S 2- K
r* S'
§ 3 2", ^
§rs


ft •% Q O P«
?J5.»!1
o » 3 m
SSuji
-i o •* 3 3

i» •« n
S.-I 2 w o
n T » (0
F"i ^'

6b. 1 agree t
Data requiren
on the attach
"Requirements
Registrant's
3O IJ » Q
it v> as
U> <•» r» «•
"8 !» ? " «
| s 1 s y
•s S 3 =••<
— . —. S
— S s
s-is-
XI  -K -1 - -M
S m S /^ * « x
ffi B X "O
»ri



„-*-. -3
iijtji
3P Jo" » C
3*o~~
S' 30 S' -•
S? ft ^r^ **
2 ^5 S B
3 -• B J3
t?i S* c
*ri

»
n'
o
B
B













^
'
•o
8
r*
I
^
o
•
«













_
CO M So1
W *P^ ftl ^
> !-• CO »
r1 w o|
ra N> M
s: o 5s|
> 0 1-3 &•
- i^ MS

00 CO S3 |
*. CO
Cft t*0 t*5
O CO
^S3
CJ ^
i«) C5
-4 °





!-
^1 i2
O O ^Q ^^
B ^^ ^
*0 ^fc ™
fr^ ™
O
O
00 Q)
O3 Q)
0 ft
to D)











04
0 |
§s

hfl §
JO °-
H ^
o
n






f z
It I/I
B 3D

s Q
II
01 ~-
3* n

• n
Q (n
ix

* *
1 .1
s -.
i s
9 e*
1

Please r
1
n
B
-1
2,
c_
^~
*»
31
attached instructi
2
M
B
3.
s
^
^
f
5'
?
i
r»
i*
1
01
rt
i
s

7
W
t_
O
5
9





















G
3
H"
rt
(D

Cft
rt
o>
rt
O w w
Si •y 3
I"" <
o ^ t*
? 0 °
7 § I
>ntal Protec
D.C. 20460
IN RESPONSE
rt
H-
0
3
>
vQ
(D
n















IM
!!f
2* «
(V -fc
cn o
-. **"*
t*t
t

t
i
i




















1
























to
Q
to

I-P*

O

M

-------
a
1
o
r>
8
I

n
S
f+
V
n
r+





















^
7*
I
1
*









«• -j it
1 Ji£- 5
3 S * "* ^
si QL QL ^* ^*
3 n 
Q. 1 <» 01 rt
-« B rt O
rt •§ ' 5
n u in
O Bl 3 rt
-» O"-< 81
^ rt
n <» w j

4? to w
f l|
? S
— O 3"
S. a"
"• s.*
1 11
S &t
s s3-
s »?-
F* r» ^
_*. HI
§r* fit
n **
3 rt
5 a

i!"
** w
S"B
re true, accurate, and
punishable by fine, i
|n
W u
X rt
^»






«o
•
e
B
J











U1
o
o
H
U)
1
H












r^
































TO *-
s-
-. m
in ^
•i
01 TJ
rt T
O
**





oi -i T a •
--5 8.S -
X O 0 •— C
aas*
— (O Bl rt
i 1

rt rt» O O O*
5 3 rt S ?
.• rt 3 a o>
8?=5?»
2 "51s
B g  — a
ft T O O —
T n rt 3 3
T.n,JH
in T» n
i*3So
(TiS 3 * §
!^ S>* 2» "* T
S '3 n
• rt
6b. I agree to s
Data requirement
on the attached
"Requirements St
Registrant's Res
•n a -»» a>
5 rt O rt
3 C T B -•
ti> u 3 til in
t rt*
5s|

IS'
JB V) -K-l — -M
3 a °2 a *
l!ipl
'•asI5i
n n u> u> f
i*s»*
rt J rt 5. S'
is.'rtS
!ri"" Pi
385'
rt 3--DB
"2. g.

*Mrt,-) -.,,
2 0? §.2 « •
ls5;-3^
(A 394

3O 5"« » C
s^sRrt
?25-?S
?t *1 B J"

1 S 5
*^ 5T Tl fl|
"2. 1
_
. Generic
rt












•
1
rt
!
x'
n
o
B











-
03 CD Q ?
50 O >|
0 X 3|
MO B
z en Si
O «> • 0

O H|

* i*
•0 SS
M
01 o
U1
o
o
M
vo





?*
ffl*
.82 «> *
is'
03 W
oo at
Ul M
o rt
M 01








w
0 f
§ :
W j£
H^
?7
o ^
o
^
o
o





fz
C/l
ii
i *"
•~ _
|s
* U)

» rt

* 0
* T3
5 1
** 5'
^
I
n
3.
n
a
A
£.
5"

<*
attached instructions
i
w
1

3-
3'
o*
S""

«
1
s
rt
2
«T
o




















G
^*
rt
(D
a
w
rt
Q)
rt
o oF m
> ?• |
-. 3 LJ.
O 4Q JI
? 0 °
C* § 3

sntal Protect j
D.C. 20460
IN RESPONSE
j—
O
3

ua
(D
3
n









» Q -n
f * 1
< 5 >
B « 2
m S S
1 i a
_, •*<
M
M
s





































T3
Q)
Q
m
M
o

M


-------
o
I
i
s
o
n
S
I
Contact

























_,
•*
?
i
S
Q








in O — — o>
£ J*8 «
a a jf -i ra
rt rt 3 rt ^
C 3" S — • rt
3 c 5-x* 2*
3 II? S
O. I It 91 rt
-< a rt O
— 3J 3- rt 3
2. fsy
o o> »
O 01 3 rt
"» <£>< B
o it ff n
! •*« f
oT £ 5
a.
J> HK ^
& —
^< Q 3T
8. 3 *'
» ?o
A ft ft*

I *1
d) w «-
^ rt tt
** d **
S
»J
?*
5.?
s-i
s--
•8
^3
-fcrt
—^l»
- »
3'
ij
1 n
3 n







•o
*
o
1*










O
00
M
00












































Im
w" -o

D -a



rt rt'o n wi
0 T T tt .
-T 01 o 5
— rt i ft —
"* S rt 5.
J rt •«
§ 3 2! y
§ « s
1 1
rt -»0 00
rt 1 • S '_
Srt 3' m
sr x B
<• rt 5 I
C (n (» •fl n_
S i o o' —
i o rt S g
IV •*' *" •
^> m IS 73
rt > — . tt »
a. T a S o
(9 ~t to 9
m-l
i'| n

I»S|?
• 5 » 2 S
sjsls
W rt O rt
i» 1/1 a. 3
tf> rt rt 01
^3 B rt« IA 01
5 rt O rt
3 c 5 a —
o> 91 3 IB w
f»i|K
rt n j5
Jrt ->
*-as-

5S?"1"?
II i is ^
?sil|s|
1.^8 1-
01 JQ W ^«
Oi C 11 ft
||s?l
I S! ?
rt S-fl 01
-a i

?rt?2-a'
(i e> 3 JS • •
35 -"3
35338^
"S-l-'
s S.rt jog
*™ rt p>
»  •NJ j»3
3! 0 X§
g("rt
w »|
^*9 S
W W C|0
"> n s»i
- 3! 3
M n is
2 z °
*•> 'Xl
0 50 >
M W Z_
> Kg
e* S
o
M3
CD






(M
M n .^ £?
— ^ H
3 A O £
"= KO
S 2 «>*
"ij
' 1 3
3 0
o
oa n
00 P>
0 ft
M 01











•
O ?
i :
w S
50 =•
s!
o
o






s |
L c
ll
TI
f S
•* 
(D
0
*•<











! ! s
moo
^* ' Q>
"1 C3
^ 0
IV
w
s

1
1















4
1

















J
1
(0

M
O
Ml

fcm*

-------
O
i
o

o
1
1
S
§
r+
1

























_
7*
-o
a
i
i.
fli
-i






 o — — CD
3V n n n
own n
\ 5| S 2
01 Q. CL •"» f*
QL •> « 0> n
•H I> «• O
— TJ »«•» 3
T 4 01 7
O a in
o n> 3 T
"*» {XX M
o n >r g
•5 ' S w
> yl
c» ^ Q
o n
— O 3-
S "* »'
a. a
form and all atta
lisleading stateme
1 Representative 	
rt dr
|I
J*
i!
•5
*s
^ ^»
..


fl n


S !T
a ^
n n





•o

I
A










00 CO
0 O
N> N)
1 1
Ui en
ui o
U> 00













































?f.
— m
VI V
^ l*
o *o
O Q»
S



rt r*^ rt U1
o> T i e •
X o o <— c
ll*$
_«J « ?
i S' °
2 W
1 1


rt ^,0 O PS
a. 1 en claiming i
ata Exemption beci
btain the active
rom the source EP/
ration number I is'
FT ^ •• W V
B-3 3 * 3
ri"ff

• »,gs°g
»" i"! o

in ft rt V>
^3 O ^i M O
Q ** O f*
3 e 3 o —
« S a w «
<» -«.
's 3 3 3'
— . S: ^
»• o a
^ 0 Ji

1*
{fsiji
jo «"» » C*
3d. at o
- »S 5 "
S f r. IiS'
• e_ i» »
"* ^' * ^ x
"1*5
Sl §.


7b. Hy product
1 agree to sati
requirements on
form entitled "
Status and Regi
Response.11
M JO M —
2-i f"^»
y ^H rt 3
•» n » »
" 3 2 * e

n*l

o^
o
o
at
S















7. Product
I
5
o"
g
»










_.
E
TJ -J Oo
O -J X|
50 w > S

2 S i
' * *
O " H|

- M tr1 ^
IT1 K3
«> IT" 8
-J M O
M 3S O
M Ci •
00 CO
Q O
30 o
H o
p* oo
O
N


M
l| |§
rt rt irt "
? D a
a! o *
5 M-
1 3
s 0
O
CO 01
-j at
00 M
o rt
»- w









5^
n I
35 m
Cfl §
M r«
- a
H






S S
(STRUCT 10
ie additi
§«•
— "
in ~
II
^
*'
o
\ TJ
1 I
X ^'
a
5|
^
*

m
D
.
o
3

>
^Q
fl)
3
O










1 1 i
m 8 S
i ? 1
"9 O
3 o
^i
ru
w
»








































01
fl
m

H



I-"

-------
_
o
z
B
5
i
o
r>
|
o
§
rt

2






















r
1









in O — — O>
10 on
3 OT> i» n
0 5 3T-1 O

C J O — rt

I li-s s
Q. 1 !« 0 rt
rt — •
-1 B rt O
— TJ 3-rt 3
rt -0 4) 3"
^"* "™" rt (D
o at w»
O U 3 rt
•* 
r> <» w a
fi _ g g
! -£P
V) ^C a
> -.§•
rt » o
f Srt
^. o y
S M
3D S'?
rm and all att<
leading statem
epresentative_
j!
•D 3
true, accurate, i
jn ishable by fine
2

f«
-1
CA-Q
S «"
3 rt
i *
rt








•
e










00
o
ro


Ul
\o
M










































3D *-
?.m
W'T>
rt >
•i
B T!
rt "I
il
n




B ? -1 B •
-I B O 3
•• rt & O ••
•<" 5' J 2- c_
** rt »'
aa«rt
s » °
» i
rt -*O O ^
"i T CT • t*
• a ?c-
1 am claiming
» Exemption bee
tin the active
n the source EP
Cion mnfcer lis
rt > -. B B
jF"s s-
rt

6b. 1 agree ti
Data requirem
on the attachi
"Requirements
Registrant's 1
a en a. 3
B) rt rt 10
•g B -»io B
A rt.
••aaij
^< ^M n
rt O 3
— • X

*• 9 ^"
•V o

*U>^-, --M
2 rt O 9 B
"8 c -•" *
? sllrt^
'3 a. ^ 3 o 3
^ _a ?•.•»
T* _5 ^ S _ .
(n *• w •*•
rt ^ • 7
'IK
a. a.
l^rtf^
't a. « 3 o a
 &
3.
"
n
o
B











^
"
T>
T
1
rt

.
S'
S










•
T3 -4 Og


to LJ i* w
H-JCn^

« • • I
o^t^i
so w t^ s
^^ Z^> "^
n w *
-J H O"
W 25 0
H O •
oo en
§ 0
» °
>5 2
nc *
o
N


rv>
~ 3 **S
a'i Ss
«» o in *
£ i • '
J a *
^S.O

* -J 0)
NJ h^
o rt
O V)









w
t
._ O
O B
n *
H -•
o
rt*
O
ft







e" -

3
O









f ! i
! ? f
moo
"2. ?!
n S
m o
y
u
S



*
M
•
^














(
















5^
Q
ffl
IB**
O
l-h
_^
•"^

-------
                   ATTACHMENT C

GENERIC REQUIREMENT STATUS AND REGISTRANT'S RESPONSE
           FORMS (Form B) PLUS INSTRUCTIONS

-------
              SPECIFIC INSTRUCTIONS FOR COMPLETING
      THE REQUIREMENTS  STATUS  AND REGISTRANT'S RESPONSE FORM

                           Generic  Data
     This form is designed to be used for registrants to respond
to call-ins for generic and product-specific data as part of
EPA's reregistration program under the Federal Insecticide
Fungicide and Rodenticide Act.  Although the fora is the same for
both product specific and generic data, instructions for
completing the forms differ slightly.  Specifically, options for
satisfying product specific data requirements do not include (l)
deletion of uses or (2) request for a low volume/minor use
waiver.  These instructions are for completion of generic data
requirements.

     EPA has developed this form individually for each data call-
in addressed to each registrant, and has preprinted this form
with a number of items.  DO NOT use this form for any other
active ingredient.

     Items 1 through 8 (inclusive) will have been preprinted on
the form.  You must complete all other, items on this form by
typing or printing legibly.

     Public reporting burden for this collection of information
is estimated to average 30 minutes per response, including time
for reviewing instructions, searching existing data sources,
gathering and maintaining the data needed, and completing and
reviewing the collection of information.  Send comments regarding
the burden estimate or any other aspect of this collection of
information, including suggesting for reducing this burden, to
Chief, Information Policy Branch, PM-223, U.S. Environmental
Protection Agency, 401 M St., S.W., Washington, D.C. 20460; and
to the Office of Management and Budget, Paperwork Reduction
Project 2070-0107, Washington, D.C. 20503.

-------
INSTRUCTIONS

Item i.   This item identifies your company name,  number,  and
          address.

Item 2.   This item identifies the case number,  case name, EPA
          chemical number and chemical name.

Item 3.   This item identifies the date and type of data call-in.

Item 4.   This item identifies the guideline reference numbers of
          studies required to support the product(s) being
          reregistered.  These guidelines, in addition to
          requirements specified in the Data Call-In Notice,
          govern the conduct of the required studies.

Item 5.   This item identifies the study title associated with
          the guideline reference number and whether protocols
          and 1, 2, or 3-year progress reports are required to be
          submitted in connection with the study.   As noted in
          Section III of the Data Call-in Notice,  90-day progress
          reports are required for all studies.

          If an asterisk appears in Item 5, EPA has attached
          information relevant to this guideline reference number
          to the Requirements Status and Registrant's Response
          Form.

Item 6.   This item identifies the code associated with the use
          pattern of the pesticide.  A brief description of each
          code follows:

          A              Terrestrial food
          B              Terrestrial feed
          C              Terrestrial non-food
          D              Aquatic food
          E              Aquatic non-food outdoor
          F              Aquatic non-food industrial
          G              Aquatic non-food residential
          H              Greenhouse food
          I              Greenhouse non-food crop
          J              Forestry
          K              Residential
          L              Indoor food
          M              Indoor non-food
          N              Indoor medical
          O              Indoor residential

-------
Item 7.   This item identifies the code assigned to the substance
          that must be used for testing.   A brief description of
          each code follows:
          EP
          MP
          MP/TGAI

          PAI
          PAI/M
          PAI/PAIRA

          PA IRA
          PAIRA/M

          PAIRA/PM

          TEP
          TEP  	%

          TEP/MET
          TEP/PAI/M

          TGAI
          TGAI/PAI

          TGAI/PAIRA

          TGAI/TEP

          MET
          IMP
          DEGR
          *
End-Use Product
Manufacturing-Use Product
Manufacturing-Use Product and Technical
Grade Active Ingredient
Pure Active Ingredient
Pure Active Ingredient and Metabolites
Pure Active Ingredient or Pure Active
Ingredient Radiolabelled
Pure Active Ingredient Radiolabelled
Pure Active Ingredient Radiolabelled and
Metabolites
Pure Active Ingredient Radiolabelled and
Plant Metabolites
Typical End-Use Product
Typical End-Use Product, Percent Active
Ingredient Specified
Typical End-Use Product and Metabolites
Typical End-Use Product or Pure Active
Ingredient and Metabolites
Technical Grade Active Ingredient
Technical Grade Active Ingredient or
Pure Active Ingredient
Technical Grade Active Ingredient or
Pure Active Ingredient Radiolabelled
Technical Grade Active Ingredient or
Typical End-Use Product
Metabolites
Impurities
Degradates
See: guideline comment
Item 8.   This item identifies the time frame allowed for
          submission of the study or protocol identified in
          item 2.  The time frame runs from the date of your
          receipt of the Data Call-In Notice.

Item 9.   Enter the appropriate Response Code or Codes to show
          how you intend to comply with each data requirement.
          Brief descriptions of each code follow.  The Data Call-
          in Notice contains a fuller description of each of
          these options.

          1.   (Developing Data) I will conduct a new study and
               submit it within the time frames specified in item
               8 above.  By indicating that I have chosen this
               option, I certify that I will comply with all the

-------
     requirements pertaining to the conditions for
     submittal of this study as outlined in the Data
     Call-in Notice and that I will provide the
     protocols and progress reports required in item 5
     above.

2.   (Agreement to Cost Share) I have entered into an
     agreement with one or more registrants to develop
     data jointly.  By indicating that I have chosen
     this option, I certify that I will comply with all
     the requirements pertaining to sharing in the cost
     of developing data as outlined in the Data Call-in
     Notice.

3.   (Offer to Cost Share) I have made an offer to
     enter into an agreement with one or more
     registrants to develop data jointly.  I am
     submitting a copy of the form "Certification of
     Offer to Cost Share in the Development of Data"
     that describes this offer/agreement.  By
     indicating that I have chosen this option, I
     certify that I will comply with all the
     requirements pertaining to making an offer to
     share in the cost of developing data as outlined
     in the Data Call-In Notice.

4.   (Submitting Existing Data) I am submitting an
     existing study that has never before been
     submitted to EPA.  By indicating that I have
     chosen this option, I certify that this study
     meets all the requirements pertaining to the
     conditions for submittal of existing data outlined
     in the Data Call-in Notice and I have attached the
     needed supporting information along with this
     response.

5.   (Upgrading a Study) I am submitting or citing data
     to upgrade a study that EPA has classified as
     partially acceptable and potentially upgradeable.
     By indicating that I have chosen this option, I
     certify that I have met all the requirements
     pertaining to the conditions for submitting or
     citing existing data to upgrade a study described
     in the Data Call-In Notice.  I am indicating on
     attached correspondence the Master Record
     Identification Number (MRID) that EPA has assigned
     to the data that I am citing as well as the MRID
     of the study I am attempting to upgrade.

6.   (Citing a Study) I am citing an existing study
     that has been previously classified by EPA as
     acceptable, core, core minimum, or a study that

-------
               has not yet been reviewed by the Agency.   I am
               providing the Agency's classification of  the
               study.

          7.   (Deleting Uses) I an attaching an application for
               amendment to my registration deleting the uses for
               which the data are required.

          8.   (Low Volume/Minor Use Waiver Request) I have read
               the statements concerning low volume-minor use
               data waivers in the Data Call-in Notice and I
               request a low-volume minor use waiver of the data
               requirement.  I am attaching a detailed
               justification to support this waiver request
               including, among other things, all information
               required to support the request.  I understand
               that, unless modified by the Agency in writing,
               the data requirement as stated in the Notice
               governs.

          9.   (Request for Waiver of Data) I have read the
               statements concerning data waivers other than low-
               volume minor-use data waivers in the Data Call-in
               Notice and I request a waiver of the data
               requirement.  I am attaching an identification of
               the basis for this waiver and a detailed
               justification to support this waiver request.  The
               justification includes, among other things, all
               information required to support the request.  I
               understand that, unless modified by the Agency in
               writing, the data requirement as stated in the
               Notice governs.

Item 10.  This item must be signed by an authorized
          representative of your company.  The person signing
          must include his/her title, and must initial and date
          all other pages of this form.

Item 11.  Enter the date of signature.

Item 12.  Enter the name of the person EPA should contact with
          questions regarding your response.

Item 13.  Enter the phone number of your company contact.

-------
ru
as
i
n
o
«*»
r»
8
|


o
|
r>






























?
5
i
I
Tl







-. ? """ "" 3
f» o *
CT O fl>
O ^ T O
C zr o —' "i
"1 C -*» «*
m c ^x ^
3 (0 CO 3T O
a. H a » »
-H fl> r» — -
— *D y *+ o
~ 15 ffl ST 3
fmm fmm ^ f£
O — •

S, §•" *
n n> ^ ft
1(5 V j; 3
1 c ^'1
5 ' iw
in x"l
> -kS"
C 0)
rt •— o
? S3
T rt
— O »
N -1 —
a i.l
30 «'?
•3 gi
rr» Q.o>
v* —.3
i «!
OJ W —
••• Ql
* IS

^ 2"
Ji-
ff
?:
i:
2. C
1-
•— B
^S
r!
a
•3 n
ll
S J







r
o
B
rt









ocftmoxc*<*ovcn<*ch*CT><*Chm
i i l i i l i t i i i i l i l
H •voos-viOUiJ^wrowtoi-'totoi— '
'cr'Sr





f2. I||«|?35'SS
»— ** *i in o (•„ ^ j,,,,, f| _.g
^ 1 1 x ? 5 » II ' i 1 1 -
c 5" 5" S ? S > ° i. 1
« |o8^§£.
si!?**
— • ** rt TJ
« 88













££M£MMMMMM£M£MM







seeeseseeeseees



MNJCOCOtOtOMMtOMlOeOMtOlSj

999999999933399
ooooooooooooooo








<»f
II. g
T -» _>.
-?





ui

I
!T









Ul )O- JU>W U


- W
rt n
in
CM
B •
S5F
3"






i-"*
9 ^
ft CA
J?"
o
7?
i "
3


» >O
*D 3D
1*
11 *
i



_
CO M CD o
S ^ >l
a o x §
5 w » i
H 1
M M C-l B


Q 0 g
> > Jh S
3 5
W H O S
 » >
g^
f



o
o
u
o

CD




(VI
?l 2*
— * ^^ »
. ^* n
•t*
iff!
i:
&
O M
CO ft
CO 0)
o
M








"
O ?
M ->
0
^1
-




c ^
n M
01 »
i n
[i
*"" *o
Is
* y 3
33" <
3 H-
Mfc ^Q M
ft Q

g ? 1
» p 3-
^V .» B*
M '
5 », *o
E28
2 ft
» rt
a H-
» §
H
0 >
O (D
SB 3
a o
H»>
^»








Jl °
3
? *
ft O O

^ i
•?
1















































0)
a
m
M
0
H)

-------
                             U.S. Environmental Protection Agency
                        Response to Phase 3 Submission
 Company Nuifcer  / Name      BAXTER J H  &  COMPANY
 003098    / Address    SAN MATEO,  CA
 Chemical Number / Name
 088502    zinc  oxide
 Case Nunber    / EPA Manager              Use Pattern
 4099      Mark Wilhite        C
                                        REGISTRANT'S
GDLN #   DESCRIPTION                    COMPLIANCE/MRID   EPA DECISION
61-1     Chemical  Identity
        Comments:     This guideline appears as a data gap  for  another
                      registrant.  It does not apply to you.

61-1     Chemical  Identity             42126501         Pending
61-2(a)  Begin, mat.  &  ronfg.  proc
        Comments:     See comments for guideline 61-1.

61-2(a)  Begin, mat.  &  mnfg.  proc      42126501         Pending
61-2(b)  Discussion of  Impurities
        Comments:     See comments for guideline 61-1.

61-2(b)  Discussion of  Impurities      42126501         Pending
62-1     Preliminary  Analysis
        Comments:     You must provide analysis of five production samples
                      showing  upper, lower and nominal concentrations, in
                      accordance with PR-Notice 91-2, and the upper limits
                      of all impurities. A confidential statement of
                      formula  must also be submitted.

62-1     Preliminary  Analysis          42126502         Pending
62-2     Certification  of limits                        Data Gap
62-2     Certification  of limits       42126502         Pending
62-3     Analytical Method                              Data Gap
        Comments:     The anlytical method required must be validated and
                      sample chromatograms must be submitted.

-------
                                 U.S. Environmental Protection Agency
                            Response to Phase  3  Submission                g'
Chemical/Case Number
088502 / 4099
                           Company Nunber / Name
                           003098   BAXTER J H  &  COMPANY
                                            REGISTRANT'S
    GDLN  #    DESCRIPTION                   COMPLIANCE/MRID   EPA DECISION
     62-3      Analytical Method              42126502         Pending
     63-2      Color
             Comments:    See comments  for guideline 61-1.

     63-2      Color                          42126503         Pending
     63-3      Physical state
             Comments:    See comments  for guideline 61-1.

       -3      Physical State                 42126503         Pending
     63-4      Odor
             Comments:    see comments  for guideline 61-1.
i     63-4      Odor                           42126503         Pending
i
     63-5      Melting Point
i
             Comments:    See comments for guideline 61-1.
     63-6     Boiling Point
             Comments:    See comments for guideline 61-1.

     63-6     Boiling Point                  42126503          Pending
    .63-7     Density                                          Data Gap

-------
                             U.S. Environmental Protection Agency
                        Response to Phase 3 Submission
                                                Pg.
 Chemical/Case Number
 088502 / 4O99
 Company Nunber / Name
 003098   BAXTER J H  &  COMPANY
GDLN #   DESCRIPTION
                  REGISTRANT'S
                  COMPLIANCE/MRID
 EPA DECISION
        Comments:

63-7     Density
63-8     Solubility
        Comments:
You did not  identify the unit expressed for  bulk
density in your  submission.
                   42126503
See comments  for guideline 61-1
Pending
63-8     Solubility                     42126503
63-9     Vapor  Pressure
        Comments:     See comments for guideline 61-1.
                                    Pending
63-13    Stability
        Comments:     See comments  for  guideline 61-1,
160-5    chemical identity
171-2    Chemical identity
                   41777901
                   41777901
Pending
Pending

-------
_

z
0>
i
O
«*»
r>
S
1
o
1
0)
f>





























w
3-
I
it
IE
1











to o — — —
— T O
in v n •
3tro f»
5 i* i o
i ?1E- 1
* 5 5"* *
01 tt tt rt "*•
3 re (O 3- n
B. -» <» 0) 0
•H o ••» —
— 3 31 « O
» t) » 3- 5
— «-f» n
n'oi w
O Q» 3 **
•* o-x u
O it ^ ft
^ B) K 3
S C — •»
3 • a w
I/)" x" s
?^» (9
B
*» .— O
3> » 3
0 l»
T r*
— O 3-
N •» —•
a •»
3D WO
•8 g"i
s as
I 5.
B W —
... Q,
§ i-
s i-
ft ™
i
x S
_. w
ID tt
u

I
"8
^3
8
l.i
n fl
1 S
S ?






.-
o
tt
n














a\ONO\»mm mm»mn\

t 1 1 1 1 1 1 1 1 1 1 1 1 1 1
U .-*.«->,
5! w



"ao9o«£3o?"?2»S
01 ^j «B j. MI. p... Jj n^ p»> fi I IV V) IQ 9
r! ^ ^ •? 3 5 2 "" ?. ? S s ' 2
»' T — — n' n' 3' -• 3 2.
XOA TJ TJ BlOtSoS
in -. — . ^ — -< a.
C 33 V *S»°B.S
5 " •** s i o i H . 2
o -« — 3 3 ^
= I 1 ? "
S 8 8











.


^M^*MM*MH-MM*MMM






gggggggggeggggg



COMMMtVJNJMCsJtOfJIOMCOMN)

g 9399333933333
ooooooooooooo
(nwiooiwwtnoiwwcnwwww












Z 30 *•
C * •
He
o — c

"8



Wl
•
1
5"







uno junj u

^


S 2
w
w
S*
<• tf>





&^
S3
o

•n po
• '

I



*«
*B 3D
F
w ^
#•*
I





N

CD 08 Ci |
0 X §|
O «•<
x o\ to .,
Z CT» £ 1
Cl VO « „
w za
2 M £
7Q W 2-
^jj "i
VD u3 ^
» z
M


O
W
O
o
M
VO




IV
*
2! S *• "
S. vo "
g S vo *

«
a H- |
°- 3 S
»* •
5S
. 0)
O M
» rt
09 0)
01
o
M







•
o S

H ->

e
e
n
**








» in
fl» 3D
II
i .?
*"* T>
Crt *—
II
M rt
w 3
— T»
e
i;
» -.
Z 2
01 *»
-3'
I
•n
S
in
n
3
a

2.
c
^
"*
^
<*
a
i^
r*
?!
a


f
i

|

4
3'
o
s
3
i
a
s
M
Z!
"
i





















» G
2 3
? ff
S i
S en
8 aT
3 rt
n __ n>
*• en

H gj. M
g ?. 3
O 3 H-
M vQ M
Ml ^T "1
fr Q
y o 3

5 ** (D
w D 3
Sn *
n i_i
H *
Qw ^3
ago
5 2 »
3 ° o
OB H.
S3

a >
•0 0}
S D
OB n
H *<










1 £ i
2-3
| ? »
^ T*
rn o o
ni o
3 |
IS)

—
iS















































^d
a
a
(D
H"


Hi
M

-------
                             U.S. Environmental Protection Agency
                        Response  to  Phase 3 Submission
                                                            Pg,
 Company Nunber / Name
 050019    / Address
          JAMES W. NIELSEN
          BROOKINGS,  OR
 Chemical Number / Name
 088502    Zinc oxide
 Case Number
 4099
/ EPA Manager
 Mark Wilhite
Use Pattern
K
GDLN #   DESCRIPTION
                              REGISTRANT'S
                              COMPLIANCE/MRID
                           EPA DECISION
61-1     Chemical Identity                               Data Gap
61-2(a)  Begin,  mat. & mnfg. proc                        Data Gap
61-2(b)  Discussion of Impurities                        Data Gap
62-1     Preliminary Analysis                            Data Gap
62-2   .  Certification of limits                         Data Gap
62-3     Analytical Method                  .             Data Gap
63-2     Color
        Comments:    See comments  for guideline 61-1.
63-3     Physical State
63-4     Odor
63-5     Melting Point
63-6     Boiling Point
63-7     Density
63-8     Solubility
63-9     Vapor Pressure
63-13    Stability
                                                Data Gap
                                                Data Gap
                                                Data Gap
                                                Data Gap
                                                Data Gap
                                                Data Gap
                                                Data Gap
                                                Data Gap

-------
-

z
o
Jj
1
n
§



























5
1
t







V) 0 — — —
— T ~" O
"§ 7-88 •
u 8 *• i n
c ? o -• T
3  n a> a
-1 Q> " " - •
2 ?.£? ^
n —
nan
° E^ i
o re w fls
3 • 3 W
> ••.§"
C a
5 » §
0 !»
"1 •*
— O 3"
a a ^
2Q CA O
"3 2*^
A an
*» &
at vt —
_*• B|
1 JS
Is
33-
^> ^r
il

^
i;
^-S
7 (9
O"
«"R
^3
f-J
1i
j]





:*
*










LJU)U)U>UIUIU)U)U)tOfON;»-'h-'h-'
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
OJ ^N^.
a* o»



s|°32. illSI's;-!1!

^ I ^ "* -. ^ " & S i g1 1 "
1 "* 3' 5' J x " ^ o r £
IV l» rt 3 •»
| a s. i | s
J S 8














MMMMMMMMMMHH.MMM





sssssssssssssss


MMMMMNMMMMMMMMM
383339999939993
ooooooooooooooo
tnwcncncntocoojcnoitnoitvioiw








ae ao *•

ll
33;



vn
w>
y^
1









Ol JCJ IU •-' U
-

N«
•^ 1
U)

*"
J?
r*
-i n
3



&•"
» •<
Srt
"**?
i '
f

-o ya
A «

Ti
3




to N> a £
> H cnf
i^ w» »o 5
r1 w o §
n i
M w »
S 0 8 |
> 0 H &
•^ w £
* vo a jo ft
OS »tl it
H OT J8 S
J^ ^ W
CO M
O CO
X
H
U

o
tn
w
o
0



IM
*
2 S * g
SO l£> *
D at

8- * 3.
1 £|
a 3 I
•^ '"
1 °
* W
0)
O M
oo rt
09 0)
o





0 ?
z J
M -4

a
n
**






it 
ii
I!
*" ^,
Ii
^ 
S^3
(0
S3
0
Hi>
^^»





f f !
B i TJ
moo
i ? 1
? o
*NI
M*
tJ
1
*







































'O
&>
Q
(D
0
*•*.
i r>
i-1

-------
      U.S. Environmental Protection Agency
Response to Phase  3  Submission
Pg,
1_
company Nunber /Name WESPAC ENTERPRISES INC.
055500
/ Address SEATTLE, WA

Chemical Nuntoer / Name
088502
Case Number
4099

GDLN #
61-1
61-2 (a)
61-2(b)
62-1
62-2
62-3
63-2
63-3
63-4
63-5
63-6
63-7
63-8
63-9
63-13
Zinc oxide
/ EPA Manager Use Pattern
Mark Wilhite K
REGISTRANT'S
DESCRIPTION COMPLIANCE /MRID
Chemical Identity
Begin, mat. & mnfg. proc
Discussion of Impurities
Preliminary Analysis
Certification of limits
Analytical Method
Color
Physical State
Odor
Melting Point
Boiling Point
Density
Solubility
Vapor Pressure
Stability




EPA DECISION
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
	 __._
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap

-------
-
• "
I
o
n
S
1
ri
§
*•»
n
rt































W
i
f










« $-- o
10 01 0 •
3 D1 0 1»
oi 5 w -i n
r» r+ 3 rt O
c 3-5 — -i
T £ "* ~
t ^~"< ^
rt —
y o
o> a
_ g, „ ""* _.
— TJ 3T ft O
-» -t^M g- 3
n oi M
o a» 3 t
•*. (T-< o
ements made on '
knowingly false
e law.
Company's Authoi
T T
-. 03"
» :.:
» WO
« gi
8 5:5
S 3d
rt Ql
Q) M ^~
— . J *™
< ft £
3 rt-
i( B»


X ^
2" W
ft ft
w[c
S'!
•— *
n

V
" 3
3
4*°

2 IT
B i?
3 •





r
1











<*oi***< o o tn — r» i 5 r» —
(/I -». ^« rt -•» *< • Q.
| 3S S J8|S.^|
i; s' « ^

w n' a
en n














"MMH'F'MH'H'MHMH'MMH'













MMMMMMMMMMMMMMM
gsaaBBaaaaasgss
ooooooooooooooo
tnwwoiMWcnoJtnwtnoJcnww











Z SB *•
3 XI
II
3 ••*
S



um
V)
I
m










UH JO *_LW U

*"*

r* 3
CD
M
Z.*
?S
3








ft-"
sr *^
i»
??•
i'


T! i in
11
rt
i





_

< H O O|
5 vo ta <|
^ O ^*^» HI ^
5 w > D _
2 w a > 1
• N s: "•
» h- M ? 1
*• OT H 3
J? H Kg
DOS CO *
9V 33 M
» cn m s
"-3 O
|c1
c^

o
U1
00
Ul
o





ro

t!s*
S S «> *
S1 * 3.
1 H-|
3 *

* W
0>
O H»
00 ft
00 0)
en
o
to






Of
t*
~
H -"
o
o
—






i £
t (/)
il
Hf, S
1 1
*~ T>
||
» ft
pe or print in
if necessary
»
•
•«

S
l»
B
&
O
tt

c
^

y
"
1
i

2
s


1

e
5
~

3
3"
?
rmation reques
i
s
r*
y
?
1
V
•

















91 C
S 3-
ej rt

!5 CiO
z oT
HJ rt
^ n
•M fli
fed fA k_j
5 ET *^
^ H* s*
a 3 ^.

f* O
§2 §
3 g
* 
^s






5 i ?
| - 3

s? s i

I 1 l
M O
*?
—
•














































01
a
(0

M
O
Hi
M

-------
                            U.S. Environmental Protection Agency
                       Response to Phase 3 Submission
                                                            Pg.
Company Nuitber
058509
Chemical Number
088502
Case Nunber
4099
/ Name DAVID A. WALTZ
/ Address VANCOUVER, WA
/ Name
Zinc oxide
/ EPA Manager
Mark Wilhite

Use
K
GDLN # DESCRIPTION
IMPORTS M

Pattern
REGISTRANT'S
COMPLIANCE/MRID EPA DECISION
61-1     Chemical Identity
        Comments:    This guideline appears as  a data  gap for another
                     registrant.  It does not apply  to  you.
61-1     Chemical Identity             41672401
61-2(a)  Begin, mat. & mnfg. proc
        Comments:    See comments  for guideline  61-1.
                                                Pending
61-2(a)  Begin, mat. & mnfg. proc       41672401
61-2(b)  Discussion of Impurities
        Comments:    See comments  for guideline  61-1.
                                                Pending
61-2(b)  Discussion of Impurities       41672401          Pending
62-1     Preliminary Analysis                            Data Gap
62-2     Certification of limits                         Data Gap
62-2     Certification of limits        41672401          Pending
62-3     Analytical Method    .                           Data Gap
62-3     Analytical Method              41672401          Pending
63-2     Color
        Comments:    See comments  for  guideline  61-1.
63-2
Color
41672401
Pending

-------
                             U.S. Environmental Protection Agency
                        Response to Phase 3 Submission
                                                                      Pg,
 Chemical/Case Nunber
 088502 / 4099
                       Company Nuifcer / Name
                       058509  DAVID A. WALTZ IMPORTS
GDLN #   DESCRIPTION
                                        REGISTRANT'S
                                        COMPLIANCE/MRID
 EPA DECISION
63-3     Physical  State
        Comments:     See comments for guideline 61-1.
63-3     Physical  State                41672401
63-4     Odor
        Comments:     See comments for guideline 61-1.
                                                          Pending
63-4     Odor                           41672401
   5     Melting Point
        Comments:     See comments for guideline 61-1.
                                                          Pending
63-5     Melting Point                 41672401
63-6     Boiling Point
        Comments:     See comments for guideline  61-1.
                                                          Pending
63-6     Boiling Point                 41672401
63-7     Density                        41672401
63-8     Solubility
        Comments:     See comments for guideline  61-1.
                                                          Pending
                                                          Pending
63-8     Solubility
53-9     Vapor Pressure
                                        41672401
Pending

-------
                             U.S. Environmental Protection Agency
                        Response to Phase 3 submission
                                                              Pg.
 Chemical/Case Nuifcer
 088502 / 4099
              Company Nuitoer / Name
              058509  DAVID A. WALTZ  IMPORTS
GDLN #    DESCRIPTION
                               REGISTRANT'S
                               COMPLIANCE/MRID-
                   EPA DECISION
        Comments:    See comments for guideline  61-1.
63-9     Vapor Pressure                 41672401
63-10    Dissociation Constant         41672401
63-13    stability
        Comments:    See comments for guideline  61-1.
                                                 Pending
                                                 Pending
63-13
Stability
41672401
Pending

-------
rvj
1
o
o
oropany Contact





























?
J
S
i»
K
S
-









10. Certifies
1 certify tha
1 acknowledge
or both under
Signature and
tion
t the statements made on this f
that any knowingly false or mi
applicable lau.
Title of Conpany's Authorized
90 no
"3 m'i
fl> u, 9
o> *•* 3
I aj
9) 10 —
_. a,
* §5
9 &

** 3*
|1
(A
* *
"O tfl
3 *+
•2
i-J
n

^» rt
i'
-I
•• i
w-8
3 n
a f*
15 <*







r
B*
»»
o













U) (O N)
t 1 1
MUM
fO

•O > n
*H
rt «N
n o
a o
I:
ii

(A
















0> 0) 0)
l-i M t-1






g e s



H M K
to to to

333
O O 0
cn ro CD
• • •










4. Guideline
Requi rement
Number

I/I
VI
1
S"









Ul MJ ILJ-U U

^


ru O w
^ 3
(A
M
-oo
"T It
3






E
i*
*

-n OB
T •
a •?
8




1-
|s

9 V
S"1




ti -o o S
O -J X|
•-3 "J W x
> z =c S
me and Address
1. LILLY CO.
f.E. KILLINGSWORTH
.ND OR 97218


o
o
o
00
o
w





l\»

** ° * ffl
3* 9 ^^ *"
" i. vo *
? - *° S
i* 8.
* S K- |
1s
* 01
O I-1
09 rr

i
&
fi
B
A

C
^
5
^
B
f4
n
|


R
1
i
c
^
^
„
J
3^
?
i
s
i
i
s

3"
tt
^t
i










i I
a rt
9 1
iA w3
8 of
3 rf
" £S
*"3 JiL W
g * 3

a 3 H-
a *o n
& s§
i 3 s
O to
_ 3
99 ° rt
Sn *
O |_
M *
flB ^^
H *° »?

OB H-
S §
a >
*w ifl
O (t)
S 3
HK>
^*«










?Q -n
§ 1
?0 K


* g <
~ O
rvj
ts
(S








































M
01
Q
(6
0
f-ft
^

-------
      U.S. Environmental Protection Agency
Response to  Phase  3 Submission
Pg,
Conpany Nwber /Name CHAS H. LILLY CO.
000802
/ Address PORTLAND, OR


Chemical Number / Name
087801
Case Member
4099

GDLN #
61-1
61-2 (a)
61-2(b)
62-1
62-2
62-2
62-3
Zinc chloride


/ EPA Manager Use Pattern
Mark Wilhite CK

DESCRIPTION
Chemical Identity
Begin, mat. & mnfg. proc
Discussion of Impurities
Preliminary Analysis
'Certification of limits
Certification of limits
Analytical Method

REGISTRANT'S
COMPLIANCE/MRID
41758802
41758802
41758802
42261001

41758802
'-.


EPA DECISION
Pending
Pending
Pending
Pending
Data Gap
Pending ^^
Data Gap ^^
Comments: The material you submitted for this guideline does
not address the requirement. The analytical procedure
you described does not apply to zinc chloride.
62-3
63-2
63-3
63-4
63-5
63-6
63-7
63-8
63-9
63-10
63-12
Analytical Method
Color
Physical State
Odor
Melting Point
Boiling Point
Density
Solubility
Vapor Pressure
Dissociation Constant
PH
41758802
41758802
41758802
41758801
41758802
41758802
41758802
41758802
41758802
41758802

Pending
Pending
Pending
Pending
Pending
Pending
Pending
Pending
Pending ^P
Pending
Data Gap

-------
                              U.S. Environmental Protection Agency
                        Response to Phase 3 Submission
                                                Pg.
/Chemical/Case Nutter

 087801 / 4099
Company Nunber / Name

000802   CHAS H.  LILLY CO.
GDLN #    DESCRIPTION
                  REGISTRANT'S
                  COMPLIANCE/MRID
 EPA DECISION
         Comments:    You  reported two widely different values for  pH in
                      two  physical chemistry data  submissions. You  must
                      provide the correct value  and explain the
                      discrepancy.
63-12     pH

63-13     stability
                  41758801

                  41758801
Pending

Pending

-------
_.
M
Z
g
ft
o
n
j5
g
•3
0

1






























?
1
i
1







 o —•»--•
— T O
«o oi n •
3 Q" o ft
u 5 in o
C 3" O «•• 1

S gH 5
S g-g-5 «
5. I It B B
-t 0 ft --
H III s
J C!
n 9) i/i
o o 3 »»
*— **
ements made on t
knowingly false
e law.
Company's Author
— o »
N T -••
a aw
•< -*
50 MO
l» — -1
^ 2 3
l» Q.O
10 —3
O 3 &
S *° a
tt W •—
r» f* *—
—•, D
Srt- 0
3 **
i i

"
*< **
^
•g*
3 rt
" £
I'
"S

1;
"8 n
51!
1 5"
X <^
3 •






?
e
A










1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1— '1— '1— >kD03-vl^Ln^CJNJU>rO(-'[OFOH-'
u> to O x->^^
tr o»





S! 8 1 fc 1. E E "• ?. S 5" 2. r. e 5" i.
— 6 -*• •* 9 3 O " ^> 3 » ' 0
-. -o — -< <2  B_ B S O S _
8U) •«• ^> p* — . X • Q,
C 33 B X 0 eiT
^ ^vrv rt <93^^«OV3
w & "* •<* •§ i. •<
r*» •— (A C IO
SS' «' n '
3 (ft ~-

S S 8












^^MM^MMr^HMMM^MM^M








eeeeeeseeeeeesees




333B3 333333333333
ooooooooooooooooo
(ncnncncncntnnoitniocaucncncRcn








IE 9D *.
Hi
-1 jj — .
3 n
"8





Wl
I
5T












UA fl_l VJAI U


55
M
?S"
•» C
3S







(A -si
a -•


T •
if


i??1

H
n «T
I




T3 -s!0|

Ij4 l* kju g
^ >«i col
> 2 ac |
tZ« * * Is
O W „,
O M ^l

W f-" ft
ress
,Y CO.
LLIMGSWOR'
97218

M*



O
O
O
00
o
(0




r"
K S *• «?
3 | 0 S
* 2. VO *

2 0)
S tn M
w NJ ft
>J 0)
(0
o
o







4
O B

H -<

O
-*





7 z
B »
i S
•L r*
H
•o
7 It
S S
*• It

%^ ^
pe or print in i
if necessary

r

•o
i"
in
it

it
a
n
B
»
C
^
**
3-
B
|
a
^
1
B
a
g
^
£

1

o
i
i
a
3
n
o

















» G
g 2-
a 4
ft o
g 0 §

H * Q)
M ' ^
QB ^3
8 ° o
B °l
Q
3 3
OB >
i^ ^^
§(D
3
O








> Q -n
« 1 ?
^ a
i "i
m ^
i ? I.
i |
ro
S

U
|
1
^






















(



















0)
Q
(D
M
O
Hi
NJ

-------
      U.S. Environmental Protection Agency
Response to  Phase  3 Submission
Pg,
pbnpany Hunber /Name CHAS H. LILLY CO.
000802 / Address Portland, OR
Chemical Nunber / Name
527200 Zinc sulfate monohydrate
Case Nunber
4099
GDLN #
61-1
61-2 (a)
61-2 (b)
62-1
62-2
62-3
•3-3
63-3
63-4
63-5
- 63-6
63-7
63-8
63-9
63-10
63-12
63-13
/ EPA Manager Use Pattern
Mark Wilhite CK
REGISTRANT'S
DESCRIPTION COMPLIANCE/MRID
Chemical Identity
Begin, mat. & mnfg. proc
Discussion of Impurities
Preliminary Analysis
Certification of limits
Analytical Method
Color
Physical State
Odor
Melting Point
Boiling Point
Density
Solubility
Vapor Pressure
Dissociation Constant
pH
Stability

EPA DECISION
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap
Data Gap

-------
_
rvj
1
0
n
ss
B
.-£

1
n




























?
5
|
it
§
1







o _ „ _,
— 1 O
•"» ••• 3 ** W
C a- 5 -• -i
» «• ^ rT
* C ~"< —
3 rt) -*»
S **s o
Q. -i ™ a> o>
•H at »» — .
E Is? §


o » y i
^ 5T"NC V
J -t^l
5 'I.
i ?r
7 on 3
i *s
3D WO
1 H
§5 i
~ Q>
at  1 1 > 1 1 1 1 1 1 1
u> to o ~.s~.
CJ* W
*•"""*






O" B>8t»l^-'»Tl5o"'-t— O— 3
? 8 "* 2! « 5' 5' «' "" « i i' 5 ? i'
x -. S < oo «« 2. R 5 3 S -
O V) •*• •*• *** — • •< • CL
5 C 33 » XO O 4
, - - j i ; y * j i
5 5 -» — a 3 r»
w & X 1j •* X
3 ? S' J ^
S 38








- .



£££££££££££££££££
l-'t-'MI-'H'l-'l-'MI-'MI-'l-'MI-'HI-'H1






esgeeeeeeeeeeeeee



MMMMMMMMNMMNNMMMM

99383338988999999
ooooooooooooooooo
tntnwwwwcnwwmaiwwntnww








Z 3D «-
l!|
9 — •
"3





Ul
in
?






UH JU tJ-U U



3 (2
^s
w

•o 9.
a •
3S






fr'^
S -i
I"


T?
9 2
i



)OX>
1?
o 5T

I




n
n CD jc a
>5 X rto

3 KJ »x
(7^ Ml S
O *£J
^2.

M|
s 5
t0 On
^J . W
S "
O
to









ro
1! °l
" i. \o
C OJ ^^ M
? *t ^

!-i'*

2 »
S ui t->
* W ft
-o n
M
o
o






5"
CJ B*
M J
M -•
o
e
o






ll
" a
II
*"J
S- n
m «
r* «|
H r*
T.!
i:
8 2.
V) "y
O ^
•^ 3'
^
1
i
o
B
3,
c
—
**
f
a
S
I
— t


i
rf
i'
8
i

c
^
«
3'
I
i
i
i
s

3!
*
i


















I 1
a rt
H (C
90 a
S M

» - (0
* 0)
a «
8 •* 3
Q 3 H.
Ht ^Q h4
<^ o
g 0 3

9 0 ?t
H t_ tu
M ' ^
OB ^3

§ g o
* rt
a H-
» §
H
a >
M \Q
fefl k^










f !i
I 5i
m S 3
•8 3 |
* 1
fy
*

{
~





















i





















T3
Si)
a
R)

o
M

-------
                             U.S. Environmental Protection Agency
                       Response to Phase 3 Submission                 g'
     Nunber /Name      RETTA MFG., INC.

 010699   / Address    EUGENE,  OR
 Chemical Number / Name
 527200     Zinc sulfate monohydrate
 Case Nuraber    / EPA Manager              Use Pattern
 4099      Mark Wilhite         K
                                        REGISTRANT'S
GDLN #   DESCRIPTION                    COMPLIANCE/MRID   EPA DECISION
61-1     Chemical  Identity

        Comments:    This guideline appears as a data gap for another
                     registrant.  It does not apply to you.


61-1     Chemical  Identity             42233801         Pending

61-2 (a)  Begin, mat. &  mnfg.  proc

        Comments:    See comments for guideline 61-1.
61-2 (a)  Begin, mat.  &  mnfg.  proc      42233801         Pending

61-2 (b)  Discussion of  Impurities

        Comments:     See comments for guideline 61-1.



61-2 (b)  Discussion of  Impurities      42233801         Pending

62-1     Preliminary  Analysis                           Data  Gap

        Comments:     In the sample analysis you submitted,  you did not
                      account for the monohydrate. You must  either
                      calculate the amount of all fractions  or submit a new
                      method.


62-2     certification  of limits                        Data  Gap

        Comments:     You must submit the upper, lower and nominal
                      concentrations of zinc sulfate  monohydrate as well as
                      the upper and lower limit of each  impurity of
                      toxicological concern.



62-2     Certification  of limits       42233802         Pending

62-3     Analytical Method                              Data Gap

-------
 Chemical/Case Nimber

 527200 / 4099
      U.S. Environmental Protection Agency
 Response to Phase 3 Submission

Company Nunber / Name

010699  RETTAMFG., INC.
GDLN #   DESCRIPTION
                 REGISTRANT'S
                 COMPLIANCE/MRID
 EPA DECISION
        Comments:     In the analysis you submitted the water  content was
                      not accounted for. You must revise this  data
                      submission using another analysis or  submit a new
                      method.
62-3     Analytical  Method             42233802

63-2     color

        Comments:     See comments for guideline 61-1.
                                   Pending
63-2     Color                          42252501

63-3     Physical  State

        Comments:     See comments for guideline 61-1.
                                   Pending
63-3     Physical  state                42252501

63-4     Odor

        Comments:     See comments for guideline 61-1.
                                   Pending
63-4     Odor                           42252501

63-5     Melting Point

        Comments:     See comments for guideline 61-1.
                                   Pending
63-5     Melting Point

63-6     Boiling Point
                  42252501
Pending

-------
•=
1 "Chemical/Case Nunber
I 527200  / 4099
      U.S. Environmental Protection Agency
 Response to Phase 3 Submission
Company Nutter / Name
010699  RETTAMFG., INC.
                                                                      Pg.
 GDLN #   DESCRIPTION
                 REGISTRANT'S
                 COMPLIANCE/MRID
EPA DECISION
         Comments:    See comments for guideline  61-1.
 63-6     Boiling Point                 42252501
 63-7     Density
         Comments:    See comments for guideline  61-1.
                                   Pending
 63-7     Density                        42252501
 63-8     Solubility
         Comments:    See comments  for  guideline  61-1.  .
                                   Pending
 63-8     Solubility                     42252501
 63-91     Vapor Pressure
         Comments:    See comments  for guideline 61-1.
                                   Pending
 63-9     Vapor Pressure                 42252501
 63-10    Dissociation Constant
         Comments:    See  comments for guideline 61-1.
                                   Pending
 63-10    Dissociation Constant         42252501
 63-13    Stability
         Comments:    See  comments for guideline 61-1.
                                   Pending

-------
                              U.S. Environmental Protection Agency
                        Response to Phase  3  submission
                                                 Pg.
 Chemical/Case Nuifcer
 527200 / 4099
Company Umber / Name
010699   RETTAMFG., INC.
GDLN #    DESCRIPTION
                  REGISTRANT'S
                  COMPLIANCE/MRID'
EPA DECISION
63-13     Stability                      42252501
81-4      Primary eye irration-rabbit   42233803
81-5      Primary dermal  irritation     42233804
                                    Pending
                                    Pending
                                    Pending

-------
           ATTACHMENT D
LIST OF ALL REGISTRANT(S) SENT THIS DCI

-------
e

S
o  o  o
Wl  Ul  O
in  O  V
sn  o  O
O  -•  -O
o  -a  o>
S     S  £  5

S     3  i  3
o     >  M  m

»     «  *  Z
•      HI  "   C.

c     5  *  x
5     m  —
r-     »  m  e«
^     Tl  r-
N     »  lo  o

i     a  s  1
 g    SSI
 -     -     S
 s    '=     I

 3    I     s
      !*•     I-
          82
                    1
   On  >w
   y
00
      O  2
   2

03 1. VO  "»
                          0 -
                          ro *
                     o

                     o
                     X
                     H-
                     a
                     A
      n

      n
      o
      I—
      rt
      en
                                       n
                                       ft

                                       10
                                        (A
                                        ft
                                        i-J
                                        0)
                                        3
                                        W

                                        S
                                        V
                                        o
                                        ft
                                        (D

-------
    I
S
         00 3 o «

         -4 2. ^0 *

         oo 2 vo **
         O •"   i»
-Iff
H-| O

O * W
    tu
O   M
3*   rt
M   W
o
1^
                  en
                  ct
                   >
                  fl)

                   J
                   cn
                   (0

                   3
                   n

                   o
m
•


7*
          01


          o
                   t
                   ^*

                   o
     n

-------
 O
 cn
 VO
                  ui 3

                  31
                  to 2
                  o ~
                  o *
                       O »
                          a
                          i
 (0
 rr
 rt
 3     C
       s
 3
 n
                  o

                  en
                  C
                  01
                  ft
                  (0
                  o

                  I
                  o.
                  H
                  0)
                  rt
                  (D
0»

rt
to
                               9

                               •J*
                               n
                               t

                               11
                               9
                               WT
                               (D
to
O
en
            i
            3
                               p-
                               ^.

                               0)
                               ft
                               0>

                               r>
                               o
                               ft
                               tT
                               to
n
0
tt
A


-------
          ATTACHMENT E




COST SHARE/DATA COMPENSATION FORMS

-------
     r/EPA
                       Unlttd  States Environmental Protection Agency
                                    Washington, DC 20460

                           CERTIFICATION  WITH RESPECT TO
                        DATA  COMPENSATION REQUIREMENTS
Form

QMS N«. M70-01W

Approval Iiplrtt 13.31.11
  Public reporting burdtn for this coiitciion of information is tstimattd to avaragt 15 minutts ptr response, including
  time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and
  completing and reviewing the ooHedion of information. Send comments regarding the burden estimate or any ether
  aspect of this collection of information, including suggestions for reducing this burden, to Chief, Information Policy
  Branch, PM-223, U.S. Environmental Protection Agency, 401 M St.. S.W., Washington. DC 20460; and to the Office
  of Management and Budget. Paperwork Reduction Project (20704106). Washington. DC 20503.
Please fill in blanks below.
C*«pMf NMM
Product N«m«

EPA R«g. Mo.
 I Certify that:
1.
2.
For each study cited in support of registration or ^registration under the Federal Insecticide. Fungicide and
Rodentieide Act (FIFRA) that is ah exclusive use study. I am the original data submitter, or I have obtained the
written permission of the original data submitter to cite that study.

That for each study cited in support of registration or registration under FIFRA that is NOT an exclusive use
study. I am the original data submitter, or I have obtained the written permission of the original data submitter, or I
have notified in writing the company(ies) that submitted data I have cited and have offered to:  (a) Pay
compensation for those data in accordance with sections 3(c)(i)(D) and 3(c)(2}(0) of FIFRA: and (b) Commence
negotiation to determine which data are subject to the compensation requirement of FIFRA and the amount of
compensation due, I any. The companies I have notified art:
    U The companies who have submitted the studies fisted on the back of this form or attached
       sheets, or indicated on the attached •Requirements Status and Registrants' Response Form,'

3.  That l have previously compfied wtth section 3(c)(l)(D) of FIFRA for the studies I have died In support of
    registration or reregtstrttbn under FIFRA.
SifMtHM
1
Dm
NMM mtf Ho* (PitM* Type er PftnQ
GENERAL OFFER TO FAY: I hereby offer and agrtt to pay compensation to other persona. wXh regard to the
legislation or ^registration of my products, to the extent required by FiFRA sections 3(C)(1)(D) and 3{c)(2)(D).
Sl|Mtur«
0«t«
NMM «iX Till* (M«aM TrH er Print)
EfA («• SS7fr.11 (440}

-------
    C/EPA
                         Unlttd States Environmental  Prottetion Agency
                                     Washington,  OC  80460
                            CERTIFICATION OF OFFER  TO COST
                         SHARE IN THE  DEVELOPMENT OF DATA
f»tm

OHI No. M70-0l0f

A»»r*v»l tiplrct U-Ji.fi
  Public rtporting burden for this collection of information If •stimattd to avtragt 15 minutes per response, including
  time for reviewing instructions, searching fitting data sources, gathering and maintaining the data needed, and
  completing and reviewing the collection of information. Send comments regarding the burden estimate or any other
  aspect of this collection of information, including suggestions for reducing this burden, to Chief, information Policy
  Branch, PM-223. U.S. Environmental Protection Agency, 401 M St., S.W., Washington, OC 20460; and to the Office
  of Management and Budget. Paperwork Reduction Project (2070-0106), Washington. DC 20503.

  Pleat* fin in blanks below.
  Product  Namt
                                                                         EPA Rig.  No.
  I Certify that:

  My company is willing to develop and submit the data required by EPA under the authority of the Federal
  insecticide. Fungicide and Rodenticide Act (FiFRA), If necessary. However, my company would prefer to
  enter into an agreement with one or more registrants to develop jointly or share in the cost of developing
  data.

  My firm has offered in writing to enter into such an agreement.  That offer was irrevocable and  included an
  offer to be bound by arbitration decision under section 3(c)(2)(B)(iii) of FIFRA if final agreement on all
  terms could not be reached otherwise.  This offer was made to  the following firm(s) on the following
  date(s):
       •t Plra(i)
                                                                           Oft* «t Otter
 Ceriffieatian;

 I oirtythatl am duty authorized to represent^                                            have made on
 this term and alanactvnents therein are true, accurate, and complete.  I acknowledge that any knowingly false or
 misleading statement may be punishable by fine or imprisonment or both under applicable law.
SiSMtura •(
                      Awlliarlsatf Bapraaa*tttl»a
Oat*
 Naaw an* TJUt (Picas* Ty»a a* Mill)
If A fen* 1170.32

-------
    APPENDIX G
Product Specific Data Call-In

-------
                UNfTEO STATES ENVIRONMENTAL PROTECTION AGENCY
                           WASHINGTON, O.C. 20440
                       DATA CALL-IN NOTICE
 CERTIFIED MATT.
   OPFCfOF
KSTCCESAfO TOXIC
  •USSTANCCI
 Dear Sir or Madam:
 Th*s Notice requires you and other registrants of pesticide
 products containing the active ingredient identified in
 Attachment A of this Notice,  the Data Call-In Chemical Status
 Sheet,  to submit certain product specific data as noted herein to
 the U.S.  Environmental Protection Agency (EPA,  the Agency}*
 These data are necessary to maintain the continued registration
 of your product(s)  containing this active ingredient.   Within 90
 days after you receive this Notice you must respond as set forth
 in Section III below.   Your response must state:

      1.  How you will comply with the requirements set forth in
         this Notice and its Attachments A through G; or

      2.  Why you believe you are exempt from the requirements
         listed in this Notice and in Attachment C,
        Requirements Status and Registrant's Response Fqrm. (see
         section III-B); or

      3. Why you believe EPA should not require your submission
        of product  specific data in the manner specified by this
        Notice (see section III-D).

      If you do not  respond to this Notice,  or if  you do not
 satisfy EPA that you will comply with its requirements or should
 be exempt  or excused from doing so,  then the registration of your
 product(s)  subject  to this Notice will be subject to suspension.
 We have provided a  list of all of your products subject to this
 Notice in Attachment 8, Pata  Call-in Response Farm, as well as a
 list  of all  registrants who vers sent this Notice (Attachment F).

      The authority  for this Notice is section 3(c)(2)(B) of the
federal Insecticide,  Fungicide and Rodenticide Act as amended
 (FIFBA), 7 U.S.C. section 136a(c)(2)(B).   Collection of this
information  is  authorized under the Paperwork Reduction Act by
OMB Approval No.  2070-0107 (expiration date 12-31-92).

-------
       This Notice is divided into six sections  and  seven
 Attachments.  The Notice itself contains  information and
 instructions applicable to all Data  Call-in Notices.  The
 Attachments contain specific chemical information and
 instructions.  The six sections of the Notice are:

      Section X   - Why You Are Receiving  This Notice
      Section II  - Data Required By  This  Notice
      Section III - Compliance With Requirements Of  This
                    Notice
      Section IV  - Consequences Of Failure To Comply With
                    This Notice
      Section V   - Registrants' Obligation To Report
                    Possible Unreasonable  Adverse Effects
      Section VI  - Inquiries And Responses To This  Notice

      The Attachments to this Notice  are:

    •  A  -  Data Call-In Chemical Status Sheet
      B  -  Data Call-In Response Form
      C  -  Requirements Status and Registrant's.  Response  fgra
      D  -  EPA Grouping of End-Use Products for  Meeting Acute
           Toxicology Data Requirements for Rereoistratlqn
      E -  EPA Acceptance Crjteri.a
      P  -  List of Registrants Receiving This Nqt^ee
      6  -  Cost Share and Data Compensation Forms, and Prqdqet
           Specific Data Report Fqrm
SECTION I.  WHY YOtT ARE RECEIVING TfflS NOTICE .

     The Agency'has reviewed existing data for this active
ingredient and reevaluated the data needed*to support continued
registration of the subject active ingredient.  The Agency has
concluded that the only additional data necessary are product
specific data.  No additional generic data requirements are being
iaposed.  You have been sent this Notice because you have
product(s) containing the subject active ingredient.

SECTION II.  DATA REQUIRED BY THIS NOTICS

II-A.  DATA REQUIRED

     The product specific data required by this Notice are
specified In Attachment C, Requirements. Statue and Registrant * a
Response Forp.  Depending on the results of the studies required in
this Notice,  additional testing may be required.

-------
Ii-B.
                     SUBMISSION or DATA
      You are required to submit the data or otherwise satisfy the
 data requirements specified in Attachment C, Requirements Status
 and Registrant's Response Form, within the timeframes provided.


 II-C.  TESTING PROTOCOL

      All studies required under this Notice must be conducted in
 accordance with test standards outlined in the Pesticide Assessment
 Guidelines for those studies for which guidelines have been
 established.

      These SPA Guidelines are available from the National Technical
 Information Service (NTIS),  Attn:  Order DesX, 5285 Port Royal Road,
 Springfield, Va 22161 (tel:  703*487-4650).

      Protocols approved by the Organization for Economic
 Cooperation and Development (OECD)  are also acceptable if the OECD-
 recoaaended test standards conform to  those specified in the
 Pesticide Data Requirements regulation (40 CFR f 158.70).  When
 using the OECD protocols,  they should  be modified as appropriate so
 that the data generated by the study will satisfy the requirements
 of 40 CFR f 158.   Normally,  the Agency will not extend deadlines
 for complying with data requirements when the studies were not
 conducted in accordance with acceptable standards.  The OECD
 protocols are available from OECD,  1750 Pennsylvania Avenue N.w. ,
 Washington, D.C.  20006.

      All new studies and proposed protocols submitted in response
 to this  Data Call-in Notice aust be in accordance with Good
 Laboratory Practices [40 CFR Part 160. 3(a) (6) J.

 II-D.  REGISTRANTS RECEIVING PREVIOUS  SECTION 3feU2WBl NOTICES
       ISSUED BY  THE AGENCY

       Unless otherwise noted herein,  this Pata Call-In does not in
 anv wav  supersede or change the requirement^ of any previous Data
 Call-in (m) .  or any* other agreements entered into with the Agency
 pertaining to such prior Notice.   Registrants aust comply with the
 requirements of all Notices to avoid issuance of a Notice of Intent
 to Suspend their  affected products.
SECTION III.  COMPLIANCE WITH REQUIREMENTS OF THIS NOTICE

III-A.  SCHEDPLB TOR RESPONDING TO THE AGENCY

     The appropriate responses initially required by this Notice
for product specific data must be submitted to the Agency within  90
days after your receipt of this Notice.  Failure to adequately
respond to this Notice within 90 days of your receipt will be a
basis for issuing a Notice of Intent to Suspend  (NOIS) affecting

-------

-------
 your products. This and other bases for issuance of NOIS due to
 failure to comply with this Notice are presented in Section IV-A
 and IV-B.

 III-B.  OPTIONS FOR RESPONDING TO THE AGENCY

     The options for responding to this Notice for product specific
 data are: (a) voluntary cancellation, (b)  agree to satisfy the
 product specific data requirements imposed by this Notice or (c)
 request a data waiver(s).   ,

     A discussion of bov to respond if you choose the Voluntary
 Cancellation option is presented belov.   A discussion of the
. various options available for satisfying the product specific data
 requirements of this Notice is contained in Section III-C.  A
 discussion of options relating to requests for data waivers is
 contained in Section III-D. .

     There are two foras that accompany this Notice of which,
 depending upon your response,  one or both Bust be used in your
 response to the Agency.  These foras are the pata-Call-ln Response
 Fora,  and the Requirements Status and Registrant's Response Form.
 Attachment B and Attachment C.  The Data Call-In Response form oust
 be submitted as part of every response to this Notice.  In
 addition, one copy of the Requirements Status and Registrant's
 Response Torn,  aust be submitted for each product listed on the
 Data Call-in Response Form unless the voluntary cancellation option
 is selected or unless the product is identical to another (refer to
 the instructions for completing the pata Cal?.-In Response Fora in
 Attachment B).   Please note that the company's authorized
 representative is required to sign the first page of the Data Call-
 in Response Form and Requirements Status and Registrant's Response
 £20 (if this fora is required)  and initial any subsequent pages.
 The foras contain separate detailed instructions on the response
 options.   Do not alter the printed aaterial.  If you have questions
 or need assistance in preparing your response, call or write the
 contact person(s)  identified in Attachment A.

     1.  Voluntary Cancellation  - You nay avoid the requirements of
 this Notice by requesting voluntary cancellation of your product(s)
 containing the active ingredient that is the subject of this
 Notice.   It you wish to voluntarily cancel your product, you Bust
 submit  a  completed Data Call-In Response Fora, indicating your
 election  of this option.   Voluntary cancellation is itea number 5
 on the  Data  Ca^l-^n Response Fora. If you choose this option, this
 is the  only  fora that you are  required to complete.

     If  you choose to voluntarily cancel  your product, further sale
 and distribution of your  product after the effective date of
 cancellation aust be in accordance with  the Existing Stocks
 provisions of this Notice which are contained in Section rv-c.

-------
     2. Satisfyingthe Product Specific Data Rgguiyeagnts of this
 Notlea.  Thar* are various option* available to satisfy the product
 specific data requirements of this Notic*.   These options are
 discussed in section IIl-c of this Notice and comprise options l
 through 6 on the Requirements Status and Registrant's Response Fora
 and itea numbers 7a and 7b on.the Data call-in, Raaponae Form.
 Deletion of a use(s) and the low volume/minor use option are not
 valid options for fulfilling product specific data requirements.

     3. Hagueat for Product Specific Data Waivers.  Waivers for
 product specific data are discussed in Section III-D of this Notice
 and are covered by option 7 en the Reauireaents status and
 Rcglstjran.t'q Response Fora,.  If you choose  this option, you aust
 submit both forms as veil as any other information/data pertaining
 to the option chosen to address the data requirement.

 XXI-C  SATISFYING THE DATA REQUIREMENTS OF  THIS MOTICE

      Zf you acknowledge on the Data caii-^n Response Form that you
 agree to satisfy the product specific data  requirements  (i.e. you
 select option 7a or 7b), then you aust select one of the six
 options on the Requirements Status and Registrant's  Responae Fora
 related to data production for each data requirement.  Your option
 selection should be entered under item number 9, "Registrant
 Response."  The six options related to data production are the
 first six options discussed under item 9 in the instructions for
 completing the Requirements Status and Registrant's  Response Fora.
 These six options are listed immediately below with  information in
 parentheses to guide registrants to additional instructions
 provided in this Section.   The options are:

      (1}   X will generate and submit data within the specified
           timeframe (Developing Data)
      (2)   X have entered into an agreement  with one  or more
           registrants to develop data jointly (Cost  Sharing)
      (3)   X have aade offers to cost-share  (Offers to Cost Share)
      (4)   X am submitting an existing study that has not been
           submitted previously to the Agency by anyone (Submitting
           an Existing Study)
      (5)   X am submitting or citing data to upgrade  a study
           classified by  EPA as partially acceptable  and upgradeable
           (Upgrading a Study)
      (6)   I aa citing an existing study that EPA lias classified as
           acceptable or  an existing study that lias been submitted
           but  not reviewed by the Agency (Citing an  Existing Study)

     Option l,  Developing-  Da^a ••  If you choose to  develop the
required data  it  must be in conforaance with Agency  deadlines and
with other Agency requirements as referenced herein  and in the
attachments.  All data generated and submitted aust  comply with the
Good Laboratory Practice (CLP)  rule (40 CFR Part 160), be conducted
according to the  Pesticide Assessment Guidelines (PAG), and be in
conforaance with the requirements of PR Notice 86-5.

-------
     The time frames in the  Requirements Status and Registrant's
 Response Fom are the time  fraaes that the Agency is allowing for
 the submission of completed study reports.  The noted deadlines run
 from the date of the receipt of this Notice by the registrant,  if
 the data are not submitted  by the deadline, each registrant is
 subject to receipt of a Notice of Intent to Suspend the affected
 registration(s).

     If you cannot submit the data/reports to the Agency in the tiae
 required by this Notice and Intend to seek additional tiae to meet
 the requirements (s),  you must submit a request to the Agency which
 includes: (1)  a detailed description of the expected difficulty and
 (2) a proposed schedule including alternative dates for meeting
 such requirements on a step-by-step basis.  You must explain any
 technical or laboratory difficulties and provide documentation fron
 the laboratory performing the testing,  while EPA is considering
 your request,  the original  deadline reaains.  The Agency will
 respond to your request in  writing.  Zf EPA does not grant your
 request, the original deadline remains.  Normally, extensions can
 be requested only in eases  of extraordinary testing problems beyond
 the expectation or control  of the registrant.  Extensions will not
 be given in submitting the  90-day responses.  Extensions will not
 be considered  if the  request for extension is not made in a timely
 fashion; in no event  shall  an extension request be considered if it
 is submitted at or after the lapse of the subject deadline.

      Oction 2.  Agree  to Share in Cost to Develop Data --Registrants
 may only choose this  option for acute toxicity data and certain
 efficacy data  and only if EPA has indicated in the attached data
 tables that your product and at least one other product are similar
 for purposes of depending on the same data.  Zf this is the case,
 .data may be generated for just one of the products in the group.
 The registration nunhar of  the product for which data will be
 submitted must be noted in  the agreement to cost share by the
 registrant  selecting  this option.  Zf you choose to enter into an
 agreement to share  in the cost of producing the required data but
 will  not be submitting the  data yourself, you must provide the name
 of the registrant vho will  be submitting the data.  You must also
 provide EPA with documentary evidence that an agreement has been
 formed.   Such evidence may be your letter offering to join in an
 agreement and the other  registrant's acceptance of your offer, or a
 written statement by  the  parties that an agreement exists.  The
 agreement to produce the  data need not specify all of the terms of
 the final arrangement between the parties or the mechanism to
 resolve the  terms.  Section  3(c)(2)(B)  provides that if the parties
 cannot  resolve the terns  of the agreement they may resolve their
 differences through binding arbitration.
    Option|. Qffer to Share in^he Cost of DataDevelopment  ~
This option only applies to acute toxicity and certain efficacy
data as described in option 2 above.  Zf you have made an offer to
pay in an attempt to enter into an agreement or amend an existing
agreement to meet the requirements of this Notice and have been

-------
 unsuccessful, you may request EPA (by selecting this option) to
 exercise its discretion not to suspend your registration (s) ,
 although you do not comply with the data  submission requirements of
 this Notice.  EPA has determined that as  a general policy,  absent
 other relevant considerations, it will not suspend the registration
 of a product of a registrant who has in good  faith sought and
 continues to see* to enter into a joint data  development/cost
 sharing program, but the other registrant (s)  developing the data
 has refused to accept your offer.  To qualify for this option, you
 must submit documentation to the Agency proving that you have made
 an offer to another registrant (who has an obligation to submit
 data) to share in the burden of developing that data.  You  must
 also submit to the Agency a completed EPA Form 8570-32,
 Certification of Offer to Cost Share in the Development of  Data,
 Attachment 6.  In addition, you must demonstrate that the other
 registrant to whoa the offer was made has not accepted your offer
 to enter into a costsharing agreement by  including a copy of your
 offer .and proof of the other registrant's receipt of that offer
 (such as a certified mail receipt) .   Your offer must, in addition
 to anything else,  offer to share in the burden of producing the .
 data upon terms to be agreed or failing agreement to be bound by
 binding arbitration as provided by FIFRA  section 3 (c) (2) 
-------
    To meet the requirements  of the DCI Notice for submitting an
existing study, all of the following three criteria must be clearly
    a.  You aust certify at  the tine that the existing study is
    submitted that the raw  data and specimens from the study are
    available for audit and review and you must identify where they
    are available.   This Bust be done in accordance with
    the requirements of the Good Laboratory Practice (GLP)
    regulation, 40 CFR Part 160. As stated in 40 CFR 160. 3 (j)
    * '[rjaw data1  means any laboratory worksheets, records/
    memoranda,  notes,  or exact copies thereof, that are the result
    of  original observations and activities of a study and are
    necessary for the reconstruction and evaluation of the report
    of  that study.   In the  event that exact transcripts of raw data
   -have been prepared (e.g., tapes which have been transcribed
    verbatim,  dated,  and verified accurate by signature) , the exact
    copy or exact transcript may be substituted for the original
    source as raw data.  'Raw data1 may include photographs,
    microfilm or microfiche copies, computer printouts, magnetic
    media,  including dictated observations, and recorded data frost
    automated instruments . " The term "specimens", according to 40
    CFR 160. 3 (Jc) , means "any material derived from a test system
    for examination or analysis."

    b.  Health  and safety studies completed after May 1984 aust also
    contain all GLP-required quality assurance and quality control
    information,  pursuant to the requirements of 40 CFR Part 160.
    Registrants must  also certify at the time of submitting the
    existing study  that such GLP information is available for post-
    May 1984 studies by including an appropriate statement on or
    attached to the study signed by an authorized official or
    representative  of  the registrant.

    e.  You  aust certify that each study fulfills the acceptance
    criteria for the Guideline relevant to the study provided i
    the FIFRA Accelerated Reregistration Phase 3 Technical Guidance
    and that the study has  been conducted according to the
    Pesticide Assessment Guidelines (PAG)  or meets the purpose of
    the PAG (both available  from NTIS) .  A study not conducted
    according to the PAG may be submitted to the Agency for
    consideration if the registrant believes that the study clearly
   meets the purpose  of the PAG.  The registrant is referred to 40
   CFR 158.70 which states the Agency's policy regarding
   acceptable protocols. If you wish to submit the study, you
   aust, in addition to certifying that the purposes of .the PAG
   are met by the study, clearly articulate the rationale why you
   believe the study meets the purpose of the PAG, including
   copies of any supporting information or data.  It has been the
   Agency's experience that studies completed prior to January
   1970 rarely satisfied the purpose of the PAG and that necessary
   raw data are usually not available for such studies.

-------
     If you subait an existing study,  you Bust ctrtify that the
 study Bests all requirements of th« criteria outlinsd abovs.

     Zf you know of a study pertaining to any requirement in this
 Notice which doss not Beet tha critaria  outlinad abova but doas
 contain factual information ragarding unraasonabla advarsa af facts,
 you aust notify tha Agency of such a  study.  Zf such  study is in
 tha Agency's files, you need only cite it along vith the
 notification. Zf not in the Agency's  files, you Bust subait a
         and copies as required by PR  Notice 86*5.
     Option S.  Upgrading a S^udy -• Zf a  study has been classified
 as partially acceptable and upgradeable, you Bay subait data to
 upgrade that study.   The Agency will review the data submitted and
 determine if the requirement is satisfied.  Zf the Agency decides
 the requirement is not satisfied,  you aay still be required to
 submit new data normally without any time extension.  Deficient,
 but upgradeable studies will normally be classified as
 supplemental.   Kowever, it is important  to note that not all
 studies classified as supplemental are upgradeable.  Zf you have
 questions regarding  the classification of a study or whether a
 study aay be upgraded,  call or write the contact person listed in
 Attachment A*   Zf you submit data to upgrade an existing study you
 Bust satisfy or supply information to correct all deficiencies in
 the study identified by EPA.  You aust provide a clearly
 articulated rationale of how the deficiencies have been reaedied or
 corrected and  why the study should be rated as acceptable to EPA.
 your submission must also specify the HRZD number (s) of the study
 which you are  attempting to upgrade and  aust be in conforaanee with
 PR Notice 86-5.

     Do not submit additional data for the purpose of upgrading a
 study classified as  unacceptable and determined by the Agency as
 not capable of being upgraded.

     This  option should also be used to cite data that has been
 previously submitted to upgrade a study, but has not yet been
 reviewed  by the Agency.  You aust provide the MKZO number of the
 data submission as well as the KRZO number of the study being
 upgraded.

     The criteria for subaitting an existing study, as specified in
 option 4  above,  apply to all data  subaissions intended to upgrade
 studies.  Additionally  your submission of data intended to upgrade
 studies aust be  accompanied by a certification that you comply with
 each of those  criteria  as well  as  a certification regarding
protocol  compliance  vith Agency requirements.


     Option  6.  Citino- existing Studies — Zf you choose to cite a
study that has been  previously  submitted to EPA, that study aust
have been previously classified by EPA as acceptable or it aust be
a study which  has  not yet been  reviewed by the Agency.  Acceptable

-------
                                 10

 toxicology studies generally will  have been classified as "core-
 guideline" or "core minimus."  For all other disciplines the
 classification vould be "acceptable."  With respect to any studies
 for which you vish to select this  option you must provide the MRID
 number of the study you are citing and, if the study has been
 reviewed by the Agency,  you must provide the Agency's
 classification of the study.

     Zf you are citing a study of which you are not the original
 data submitter,  you oust submit a  completed copy of EPA Form
 8570-31, Certification with Respect to Data Compensation
   -  Registrants who  select one of the above 6 options must meet all
 of the requirements  described in the instructions for completing
 the Data  Call-in Response Form and the Requirements Status and
 Registrant's  Response  Fora, as appropriate.

 III-D  REOtJESTS FOR  DATA WAIVERS

     If you request a waiver for product specific data because you
 believe it is inappropriate, you must attach a complete
 justification for the  request, including technical reasons, data
 and references to relevant EPA regulations, guidelines or policies.
 (Note:  any supplemental data must be submitted in the format
 required  by PR Notice  86-5) .  This will be the only opportunity to
 state the reasons or provide information in support of your
 request.  If  the Agency approves your waiver request, you will not
 be required to supply  the data pursuant to section 3(c)(2)(B) of
 FIFRA.  If the Agency  denies your waiver request, you must choose
 an option for meeting  the data requirements of this Notice within
 30 days of the receipt of the Agency's decision.  You must indicate
 and submit the option  chosen on the Requirements Status and
 Registrant's  Response  Form.  Product specific data requirements for
 product chemistry, acute toxicity and efficacy (where appropriate)
 are required  for all products and the Agency will grant a waiver
 only under extraordinary circumstances.  You should also be aware
 that submitting a waiver request will apjfe automatically extend the
 due date  for  the study in question.  Waiver requests submitted
 without adequate supporting rationale will be denied and the
 original  due  date will remain in force.

 IV.  CONSgQDEKCES OF FAILURE TO COMPLY WITH THIS NOTICE

 IV-A flOWCE OF INTENT TO SPSPENP

    The Agency Bay issue a Notice of Intent to Suspend products
 subject to this Notice due to failure by a registrant to comply
with the requirements of this Data Call-In Notice, pursuant to
FIFRA section 3(c)(2)(B).  Events which may be the basis for
 issuance of a Notice of Intent to Suspend include, but are not
limited to,  the following:

-------
                                 11

     1.  Failure to respond as required by this Notice within 90
     days of your receipt of this Notice.

     2.  Failure to submit on the required schedule an acceptable
     proposed or final protocol if such is required to be submitted
     to the Agency for review.

     3.  Failure to subait on the required schedule an adequate
     progress report on a study if required by this Notice.

     4.  Failure to submit on the required schedule acceptable
     data as required by this Notice.

     5.  Failure to take a required action or submit adequate
    . information pertaining to any option  chosen to address the data
     requirements (e.g., any required  action  or information
     pertaining to submission or citation  of  existing studies or
     offers,  arrangements, or arbitration  on  the sharing of costs  or
     the formation of Task Forces,  failure to comply with the terns
     of an agreement or arbitration concerning joint data
     development or failure to comply  with any terms of a data
     waiver) .

     6.  Failure to submit supportable certifications as to the
     conditions of submitted studies,  as required by Section III-C
     of this Notice.

     7. withdrawal of an offer to share in the cost of developing
     required  data.

     8. Failure of the registrant to whom  you have tendered an offer
     to share  in the  cost of developing data  and provided proof of
     the registrant's receipt of such  offer either to:

     a.  Inform EPA of intent to develop and  submit the data
     required by this Notice on a  Data Call -In Response Fora and  a
     Requirements Status and Registrant's Response Form;

     b.  Fulfill the  commitment to  develop and submit the data as
     required by this Notice;  or

  •   c. otherwise take appropriate  steps to meet the requirements
     stated in this Notice,  unless  you commit to subait and do
     subait the required data in the specified time fraae.

     9.  Failure to take any required  or appropriate steps, not
     mentioned  above,  at any time following the issuance of this
     Notice.

ZV-B.  BASIS FOR PeTEHMTWATTOK THAT SUBMITTED STUDY IS
    The Agency may determine that a study  (even if submitted within
the required time) is unacceptable and constitutes a basis for

-------
                                 12

 issuance of a Notice of Intent to  Suspend.  The  grounds  for
 suspension include,  but are not limited  to, failure to meet any of
 the following:

     1.  EPA requirements specified in the Data Call-In Notice  or
     other documents  incorporated by reference  (including, as
     applicable,  EPA  Pesticide  Assessment Guidelines, Data Reporting
     Guidelines,  and  GeneTox Health Effects Test  Guidelines)
     regarding the design,  conduct,  and reporting of required
     studies.  Such requirements include, but are not liaited to,
    . those relating to test material, test procedures, selection of
     species, number  of animals,  sex and  distribution of  animals,
     dose and effect  levels to  be tested  or attained, duration  of
 .  .  test, and, as applicable,  Good Laboratory Practices.

  ..  2.  EPA requirements regarding the submission of protocols (if
   •  applicable),  including the incorporation of  any changes
     required by  the  Agency following review.

     3.  SPA requirements regarding the reporting of data, including
     the manner of reporting, the completeness of results, and  the
     adequacy of  any  required supporting  (or raw) data, including,
     but not limited  to,  requirements referenced  or included in this
     Notice or contained in PR  86-5.  All studies must be submitted
     in the fora  of a final  report;  a preliminary report  will not be
     considered to fulfill  the  submission requirement.

 IV-C  EXISTING STOCKS OF SUSPENDED  OR CANCELLED  PRODUCTS

     EPA has statutory authority  to  permit continued sale,
 distribution and  use of existing stocks of a pesticide product
 which  has been suspended or cancelled if doing so would  be
 consistent with the  purposes of  the Act.

     The Agency has determined  that  such disposition by registrants
 of existing stocks for a suspended  registration  when a section
 3(c)(2)(B)  data request is  outstanding would generally not  be
 consistent with the Act's purposes.  Accordingly, the Agency
 anticipates granting registrants permission to sell, distribute, or
 use  existing stocks  of  suspended product(s) only in exceptional
 circumstances.  If you  believe such disposition  of existing stocks
 of your product(s) which may be suspended for failure to comply
 with this Notice should be permitted,  you have the burden of
 clearly demonstrating to EPA that granting such  permission  would be
 consistent with the Act. You must also explain why an "existing
 stocks* provision is necessary, including a statement of the
 quantity of existing stocks and your estimate of the time required
 for their sale, distribution, and use.  Unless you meet  this burden
the Agency will not consider any request pertaining to the
continued sale, distribution, or use of your existing stocks after
suspension.

    If you request a  voluntary cancellation of your product (s) *
-------
                                  13

 all Agency requirements, you will have, under aost circumstances,
 on* year from the date your 90 day response to this notice is due,
 to sell/ distribute, or use existing stocks.  Normally,  the Agency
 vill allow persons other than the registrant such as  independent
 distributors, retailers and end users to sell, distribute or use
 such existing stocks until the stocks are exhausted.   Any sale,
 distribution or use of stocks of voluntarily cancelled products
 containing an active ingredient for vhich the Agency  has particular
 risk concerns vill be determined on a case-by-case basis.

     Requests for voluntary cancellation received after the 90 day
 response period required by .this Notice vill not result  in the
 Agency granting any additional tiae to sell, distribute, or use
 existing stocks beyond a year froa the date the 90 day response was
 due unless you deaonstrate to the Agency that you are in full
 coapliance with all Agency requirements, including the requirements
 of this Notice.  For example,  if you decide to voluntarily cancel
 your registration six months before a 3 year study is scheduled to
 be submitted, all progress reports and other information necessary
 to establish that you have been conducting the study  in  an
 acceptable and good faith Banner aust have been submitted to the
 Agency,  before EPA vill consider granting an existing stocks
 provision.
 SECTION V.   REGISTRANTS'  OBLIGATION TO REPORT
             UNREASONABLE ADVERSE EFFECTS

     Registrants are reminded that FIFRA section 6(a) (2)  states that
 if at any tiae after a pesticide is registered a registrant has
 additional factual  information regarding unreasonable adverse
 effects on the environment by the pesticide,  the registrant shall
 submit the information to the Agency.   Registrants aust  notify the
 Agency of any factual information they have,  froa whatever source,
 including but not liaited to interia or preliainary results of
 studies,  regarding  unreasonable adverse effects on aan or the
 environment.   This  requirement continues as long as the  products
 are registered by the Agency.
SECTION VI.  INQUIRIES AND RESPONSES TO THIS NOTICE

    Zf you nave any questions regarding the requlreaents  and
procedures established by  this Notice, call the contact person (s)
listed in Attachment A, the Data Call-in  Chemical Statpa  Afreet.

    All responses to this  Notice (other than voluntary cancellation
requests) oust include a coapleted Data Call-in Response  Form and a
coapleted Requirements Status and Reiatrant'a Reaonae Form
(Attachment B and Attachment C) and any ether documents  required by
this Notice, and should be subaitted to the contact person (s)
identified in Attachment A. Zf the voluntary cancellation option is
chosen, only the Pata Call -In Reapenae Form need be submitted.

-------
                                14
    The Office of Compliance Monitoring (OCM)  of the Office of
Pesticides and Toxic Substances (OPTS),  EPA, will be aonitoring the
data being generated in response to this Notice.
                             Sincerely yours,
    A
    B
    C
    D

    £
    F
    G
                   .Daaiel M. Barolo, Director
                  .'•• Special Review and
                      Reregistration Division

               Attachments

Data Call-In Chemical Status Sheet
Data Call-in Response Forp
Requirements Status and Registrant's Response Term
EPA Grouping of End-Use Products for Meeting Acute
Toxicology Data Requirements for Rereoistration
EPA Acceptance Criteria
List of Registrants Receiving This Notice
Cost Share and Pat? Compensation Forms, and Product
Specific Data Report Form

-------
                                 ATTACHMENT A

             ZINC SALTS: DATA CALL-IN CHEMICAL STATUS SHEET
INTRODUCTION

       You  have been sent this Product Specific  Data Call-In Notice because you have
product(s) containing zinc salts.

       This Product Specific Data Jail-In Chemical Status Sheet, contains an overview of data
required by this notice, and point of contact for inquiries pertaining to the re registration of zinc
salts.  This attachment is to be used in conjunction with (1) the Product Specific Data Call-In
Notice, (2)  the Product  Specific Data Call-In  Response  Form  (Attachment B), (3)  the
Requirements Status and Registrant's Form (Attachment C), (4) EPA's Grouping of End-Use
Products  for Meeting Acute  Toxicology  Data  Requirement (Attachment D), (5) the EPA
Acceptance Criteria (Attachment E), (6) a list of registrants receiving this DCI (Attachment F)
and (7) the Cost Share and Data Compensation Forms in replying to this zinc salts Product
Specific Data Call-In (Attachment G).  Instructions and guidance accompany each form.
DATA REQUIRED BY THIS NOTICE

       The additional data requirements needed to complete the database for zinc salts  are
contained in the Requirements Status and Registrant's Response. Attachment C. The Agency
has concluded that additional data on zinc salts are needed for specific products. These data are
required to be submitted to the Agency within the timeframe listed.  These data are needed to
fully complete the reregistration of all eligible zinc salts products.
INQUIRIES AND RESPONSES TO THIS NOTICE

       If you have any questions regarding the generic database of zinc  salts, please contact
Mark Wilhite at (703) 308-8086.

       If you have  any questions regarding the product specific data requirements and
procedures established by this Notice, please contact Joanne Miller (703) 305-7830.

-------
      All responses to this Notice for the  Product Specific data requirements  should  be
submitted to:

             Joanne Miller, Product Manager Team 23
             Herbicide/Fungicide Branch
             Registration Division (H7505C)
             Office of Pesticide Programs
             U.S. Environmental Protection Agency
             Washington, D.C.  20460

             RE: ZINC SALTS

-------
                  ATTACHMENT B

PRODUCT SPECIFIC DATA CALL-IN RESPONSE FORMS (Form A)
                 PLUS INSTRUCTIONS

-------
              SPECIFIC INSTRUCTIONS FOR COMPLETING
                 THE  DATA CALL-IN RESPONSE FORM

                      Product Specific Data


     This form is designed to be used to respond to call-ins for
generic and product specific data for the purpose of
reregistering pesticides under the Federal Insecticide Fungicide
and Rodenticide Act.  Fill out this form each time you are
responding to a data call-in for which EPA has sent you the form
entitled "Requirements Status and Registrant's Response."

     Items 1-4 will have been preprinted on the form.  Items 5
through 7 must be completed by the registrant as appropriate.
Items 8 through 11 must be completed by the registrant before
submitting a response to the Agency.

     Public reporting burden for this collection of information
is estimated to average 15 minutes per response, including time
for reviewing instructions,  searching existing data sources,
gathering and maintaining the data needed, and completing and
reviewing the collection of information.  Send comments regarding
the burden estimate or any other aspect of this collection of
information, including suggesting for reducing this burden, to
Chief, Information Policy Branch, PM-223, U.S. Environmental
Protection Agency,  401 M .St., S.W., Washington, D.C. 20460; and
to the Office of Management and Budget, Paperwork Reduction
Project 2070-0107,  Washington, D.C. 20503.

-------
INSTRUCTIONS FOR COMPLETING THE "DATA CALL-IN RESPONSE" FORM FOR
PRODUCT SPECIFIC DATA

Item 1-4. Already completed by EPA.

Item 5.   If you wish to voluntarily cancel.your product, answer
          "yes."  If you choose this option,  you will not have to
          provide the data required by the Data Call-in Notice
          and you will not have to complete any other forms.
          Further sale and distribution of your product after the
          effective date of cancellation must be in accordance
          with the Existing Stocks provision of the Data Call-in
          Notice (Section IV-C).

Item 6.   Not applicable since this form calls in product
          specific data only.  However, if your product is
          identical to another product and you qualify for a data
          exemption, you must respond with "yes" to Item 7a (MP)
          or 7b (EP) on this form, provide the EPA registration
          numbers of your source(s) and complete and submit the
          "Generic Data Exemption" form; you would not complete
          the "Requirements Status and Registrant's Response"
          form.  Examples of such products include repackaged
          products and Special Local Needs (Section 24c) products
          which are identical to federally registered products.

Item 7a.  For each manufacturing use product (MP) for which you
          wish to maintain registration, you must agree to
          satisfy the data requirements by responding "yes."

Item 7b.  For each end use product (EP) for which you wish to
          maintain registration, you must agree to satisfy the
          data requirements by responding "yes."  If you are
          requesting a data waiver, answer "yes" here; in
          addition, on the "Requirements Status and Registrant's
          Response" form under Item 9, you must respond with
          Option 7  (Waiver Request) for each study for which you
          are requesting a waiver.  See Item 6 with regard to
          identical products and data exemptions.

Items 8-11.  Self-explanatory.

NOTE:     You may provide additional information that does not
          fit on this form in a signed letter that accompanies
          this form.  For example, you may wish to report that
          your product has already been transferred to another
          company or that you have already voluntarily cancelled
          this product.  For these cases, please supply all
          relevant details so that EPA can ensure that its
          records are correct.

-------
              SPECIFIC INSTRUCTIONS FOR COMPLETING
      THE REQUIREMENTS  STATUS  AND REGISTRANT'S RESPONSE FORM

                      Product Specific Data
     This form is designed to be used for registrants to respond
to call-ins for generic and product-specific data as part of
EPA's reregistration program under the Federal Insecticide
Fungicide and Rodenticide Act.  Although the form is the same for
both product specific and generic data, instructions for
completing the forms differ slightly.  Specifically, options for
satisfying product specific data requirements do not include (1)
deletion of uses or (2) request for a low volume/minor use
waiver.  These instructions are for completion of product
specific data requirements.

     EPA has developed this form individually for each data call-
in addressed to each registrant, and has preprinted this form
with a number of items.  DO NOT use this form for any other
active ingredient.

     Items 1 through 8 (inclusive) will have been preprinted on
the form.  You must complete all other- items on this form by
typing or printing legibly.

     Public reporting burden for this collection of information
is estimated to average 30 minutes per response, including time
for reviewing instructions, searching existing data sources,
gathering and maintaining the data needed, and completing and
reviewing the collection of information.  Send comments regarding
the burden estimate or any other aspect of this collection of
information, including suggesting for reducing this burden, to
Chief, Information Policy Branch, PM-223, U.S. Environmental
Protection Agency, 401 M St., S.W., Washington, D.C. 20460; and
to the Office of Management and Budget, Paperwork Reduction
Project 2070-0107, Washington, D.C. 20503.

-------
.
a
B
O
n
fi
8
I
8




















.*
?
1
!









at o — — oo
*^» ™i •

9 & & W O
3 (T ff » •
a. T it a ft
-t » m n o'
J» ? » 5-
» Iii
n  "* s.
I •;
a- » 3
e »
2. o S
M ^ — .
JO S'?
•8 ™ 3
| i!
3 3
r* ft
• 5 "
i' |s
9 B
3 ft
if
!?
•ue, accurate, and con
shable by fine, inpri
S
a *"
"'"


o

*












O
VO
V0
t











Z
•
^
•




Z
•



















» f-

»' J
• TJ
li
"



•» «t T) ft \i\
". a i * -
* g**«
• * " _ £•
w n
*™ a VI ^
' '

r» "* O O O>
3-1 er B s
O r* r* •
«•» 9 • B
3 ' » 3 * a
3 j, J^ o
S o *» ~~
!i T 8 3 "5,
Is? -
isisi

tf T ff J
5" 2 9
ft — • Q. •"• if
i"| S

6b. 1 agree to satis
Data requirements as
on the attached forn
"Requirements Status
Registrant's Respons
** ^ ^»
'• a. || «
ill
|![|||
'» fi. J? 3 So
|l55l
• a « **

** I * *"8
"ll^.

_
H?i*
» 3 «••• M ** *i
• a 2, J ° fi
0 O ^ f*
W JO S" ^
T IS^" *
t 5" * * n
• i S e
5I%S

;
|
f>

?
•








I
f
O'
?











_^

M DB S3 o
G O W|
Z M > ,
W w i
0 3 1
Q 0\ l"fj
* *^
VO |
s s'
w •













rj
*• S?
o |
VO ^
-i
H- a
3 3
Q
01
B)
rt
W






TJo
§1
li
tti
On
H
*•)
W




c —
0> m
A I/I
il
l-f/ turn
0 S
i 5?
*™ ^
(A *-
il
e
li
g 3
^ 3-
3
r
2
§
n
n
g.
n
|
C
1
a
i
I
1
*t
|

c
1
S
1
a
£
i
!
fl
e
1

















G
3
H-
ft
a
en
rt
ta
ft
(D
a ^ w

H n n
> 3-3
H-<
ess-
?ft 0
§i
H^ A
10
Z 3
al Protection
. C. 20460
RESPONSE

S
(D






* o >
5
m S 3
5^ » 96
2 °
3 |
;3
M
S

































fil



H>
o
Ml
M

-------
I
o
o
i
•3
|
r*

*+




























I
1






if, S -- P
(D fll O
3 y f> fll O
5 5 ir -i «
*» ** p ** i
iifff
Z | f 5 3
jf z ** *
8> &• 5 «
»— r*
n 
r> >
"I
•» -1
i|
r*




r* rv Tt fl W
i 3 i 5 1
•<" S' n — x
' 3 " ^ S"
fPs

1 1

^^ 0_.
a o »• •» •
i* 2." —
2 0» «fl O
|i » j.»
Pfl-
yS ^* |
S" * 5' ""
I 3 o'

I|EI^
il-i*
5 3 •» C 1
3 " I
Itt 7 3 i^
3D I* * O
it 01 a. 3
1 1 f 8 i
?1i!I«
^ S S
1r» T
lo



||3|«^
*iM-^
*flssl
m o ** ^
;• » 3 « -
jit?:
-111!
S| 1
|!Hfi
?-^ilsl
9B n m » c
iS*-
«l W M^
II f^S
™ T" • 5 "
*l|«!
^
i
^
i















i
1
(A
1
S"
O







gg5||
isfsj
M" M' a
"»^NS
S H>>9
>HMCH5
i^ CO ^^  I
VO
VO »
i
^r
o

W
0)
ft
W










*
§S
&
•o S.
H ~
H
0


INSTRUCT
Use addi
ft «"*
0 i
g!?
""" "W
W •—
fll 0
(ft (ff
<"* (ft
(A *•*

^ ||
"* 0
ll
i ^
x 2*

I
|
^
i
careful
x
«
9
rt
f^
i
a
s
— 4
I
i
I
*<
3
A
3

I
•*«
3
3
|
3
3
1















G
H*
ft
A
a
Cft
rt
0)
ft
(D
O S W
H W W
* H<
O 3 H-
E ^ °
1 33
8 a!
50 * W
w o M
i Ls
W 0 ft
n ^ ffl
o\ o
o ft
M-
O
3
X
A
0
*<









1 1 §
1 ? 1
5 S 2
? 2
i 5
ISI
*






































TJ
ID

1-1
o
H»
M

-------
p
I
o

o
ompany Contact
























r
|
s
1







(» o _ _ p»
3 CT O <• O
5 Q *• i i»
<» «•» a t n
c » 9 — »»
T 1 •* —
S J"* »
S n* a 7 S
2JL "i i • ^
ion
t the statements made on '
that any knowingly false
applicable law.
Title of Company's Authoi
s SZ
a s."
30 (To*
1 ii
* ""* 3
r+ 9
a CB —
C. ? ""
* Is
3
* I?
i!
a-
n ft
c
i.?
S-S
-i
9
x ^
3'.*
8

Ii
1 ?






o
i









U1
CD
VO
|
H






Z
*








5g
•
*





















3D *•
|S
*•» "1
S a.
X

rt « "O 0 W
a ~> T 9 •
— * 8- n -

X* t.0 O »
33SU?
•-» 3 « «
S' ft 5' m
?.|i
Is "fa
Mis I;
«* 5 o
n * 3* * *
di-l
o > 5 -••
• ' 3 **

» > a a  -3
z a 3
W W M S
me and Address
AN ROOFING PROD
ALISH RD
1 WA 98250
a






fu
*
Ss
vO *
*i

8'
0

0)
ft








w
s*% ^
§1
*>rt ^L
W „
•a 3,
n o
On
M
Ht
O


si
§
2r» —

,,
Please type or print in
I sheet(s) if necessary.
^
3
(1
i
n
|

S
3-
*
a
g.
1
g
n
S
f4

1
i
«>
|
^

?
1
rt
i'
\
i
3
s
5











G
3
.H-
ft
(t)
a
en
ft
0)
rt
 D)
H M W
> 3-3
H-<

P ft O
e< o 3
133
H - 0
9! 3
S * M
M O
W ^
91 MO
W 0 ft
n » (D
Ot O
o rt
H-
O
«o
A
3
O








! - !

S o >
m 8 i
i 3 |
i i
OJ
M



































*0
01
A
^-
O
M)

-------
s
K
I
i

a

n
fi
1
r>
§


































_.
i
1





W> O — "- OB
«.» n •
ftt n
n* n » n
O ^ ^ ft

«| ]T -*, —
ft C *-'<-»'

o» uL OL. ^ n
2 « 
a. T ft Q) #•»
™« fl> *•• Q
— 53-^ 3
« -O 0 3"
JJT *™ ** t>
fi Q} W
° !H i
» < l
> ^g.
^ ^i it
« — o
3" W 3
0 0
™> ••»
^. o j
A en
3. 3 ^
5 — °
13 i.
i 3 ^~
5 " o
D yj *••
ft t!
3 fi

il
in
^ D
•g it
5 "
tn c
1;
• s
11
— < ft
ft *
I'1
li
1 2
I'






•o
D
B
*»
It






U1
(Jl
o
o

1
















z
>









z
^
,



















n -
to
«*. m
ai "O
F. >
» TJ

*"* Q

3 S



O T -1 01 •
-1 01 O 3
7 1 5 ~ E.
r^ V)

O It —•
~* to ^n »*
So
VI



r ? ft.P 2-
3 S SS?
- " 2 * _
* •* a a

So •» —
1 5 S o 5.
-i n " 3 3
- < B- i'
— • m it It (2
IB T> r>

*• 3 I 1 \
?!• i-l

? S "


_
(O ft ** *
«' c ? * «
~ — ft 1
T *n ft to
3 A ft ft lA
^ i - S. 3
» 3 31 •?' i»
en «^ n n
» n 3 o
it CA a 3
» ~ X in
in in 3 «> M^
Sl§|«
f-^
alo


It » O It 0)
•gsils,
ft 0* ^ 3 ^
>s a H 3 3 I
?awss
UQ O y* r*
— • s 3 —

! ;• ! 3 «
• n " it e
"1 Sa'
2S-1§
in 9 a.
7b. Hy product i
1 agree to satis
requirements on
form entitled "R
Status and Regis
Response."
? S 5-? "
5l--S
F* T • »
in 1 S ^ c
2 3- % B

9^
n
2
n
O
0)
fl)



















-g
•o
&
(A
!

o'
0
a
0?






-
W W S ?
w •* m •§
*£} I— I ^ Q)

^3 v* T3 ^r

r co n 1
w s
(o W „
s o z S
> o 1-3 a
H W |
vo *o 3
oo en » S
M i-3 M
* M
ff> CD PI
O M
X
M
£* Z
0"! O
Ul
(^J
•o







«J

f»* n
o S
VD
«l
H1- 0)
3 I
f)

V)
Q)
rt
01










LJ
•0 o
§!
d Type of DCI
JCT SPECIPI
O



I I

fr C
«. «*

-. o

g J?
*"* ij
(A •—
II
tfl *+
ri
~* o
si
2 2
o ••*
. 5'

3-

•D
|
^
It
8.
n
QI
it

£
•T
3-

a

Cfl
ft
Ol
rt
ro
o £ en
> 0)
*3 M M
> 3- 3
H- <

y ia HI
F rt 0
T 3 i
(H - (D
Z 3
D ft
M At
50 * *
S* *Q
i
Z W 0
W 0 rt
FTI i& A
O\ O
O rt
O
' 3
J2
ID
3
0









5 i ?
* - 3
i " f
moo
•* o
2 o
S
M
«
















































Q)
vO
ro
P— >
o
i-h
«

-------
f
a
n
£
r*



























J
!
i





M o _ _ pa
f 7*8 o
S S M- 1 l»
| ?1| 5.
It C *-X •*
a a 8. •» o'
a if if z •
T l» • »J(
* iis
«-" «4
O f» JPT j*

1 f af
" "1
I *;
? ss
T ^
N ^ — .
•
I ^S
! if

- 3
3 « i
i |»
1
*< ^*

e
t!
• s

X T
•**
3'«*
^
" 9
3"
2-1
|£
3 *




>0







LJ
O
09
M
00










z

•





5g
•
j»
•


















f|
D -D
i'l


nil:!
<" 5" n 2- C
H5*


rr •« o o p»
i -i H- • *
*i«L

9 J"3 —
h*li
T n ^ 3 3
W ••• 2'
f?as:
? -. S.-3
P*| S'

» X O O ft
230 3 « fr
A ^ •
? S" ** J2 M
a A 9 2 a
3s S — • A
Cft 5 n 5
CD 7 3 f*

« JT3
ST f* T
in
• c« ^> -i — -g
"||||l
l|f::-
Ipa

7b. Ky product i
I agree to satis
requirements on
fort* entitled »R
Status and Regis
Response."
? a ?•?*
n T"» 5
• 1 2 fi
-I§SJ

•
!
T
n
0

















•
f
JT
o
:






•
0 H|
3 n 9
> W » §
W W t4 a
^ a: *•
S|^|
-SS2
A O S
* tJ
o » >
Npl









rv>
*
||
VD »
Ml

3'

0

0)
0)
ft
0)








M
§3
d Type of DCI
JCT SPECIFI
O



? =
n * Ml*
0 i
1 !f
Please typ
sheet(s)
:*o
n T>
i i'
F

"O
1


1
g
1
•?
?
attached 1
g

T

^.
§
8
|
|
—

?
i
i
«6
a
s
3
«T
1










G
3
H-
ft
 0)
H cn n
S vi H"
H rt O
H rt **
[p O 3
133
H - (0
Z 3
Q t-J
SB M o
W 0 ft
n * (6
OA n
0 ft
H-
0

M

-------
o
X
S
o
n
i
r+
n
rv



























—
^
|
|
1




„ o -- «
2 8" Sr ? S?
i? Sr 2 !!T "*
5 5*^5
1 II|S
-1 M 5.** 8
1 '"*
»!ig
S n j s
! f !•
1 h
N T —
1 .»
9D » O
^ |3
8 — -S

•« a
i' So
It A r*
II
||
%l
i:
•8
A
$ T
^» S
3'^*
J{
* s
S"
f 1
i «
1 ?







«
o







03
O
N
1
Ul
vo
H








5g
A4





55
•
^
•























» «-
2*
^' W
w -v
ft >
* TJ


•» « -D r» 1/1
t||l;
< i ?S-
ffs«

»» •» o o o>
ssls?
r* 9 • »
? rt 5 5

c «i a 1J n
S- 2 a ~ 5"
i| "i n o —<
T 0 rt 3 3_
|s|.|!
y?.i-l
2- 7 3 rt
<» « 1 5 °
« rt rt »
"8 rt 3"" "
Ig38£

** **" A
J ** T
lo
„
A rt* O 9 9
l!3f*i
'• & rt 3 O O
f assf
li8;--.

ii."^rt •
5ili'


?CA ofc "1 <••> ^
Jsl*?
1 Sfif
• 3 ^* n i% ^
• Irt 3 O O
^ rt Q
f 1"SR
* .82"
fll 3D 0 ^**
rt T* S
« n rt « m
"l?s*
p-
^

o
a


















«
^
In
j

IT-
e






-
*d -J o S
O -J X|
5 ss x i
on .
O " H ^~
» x f g
H r &
r 5s
«> F S
<0 H O
MZ 0
M O •
00 CO
1






ro
.&, n
°i
vo
*i
j«3
^* 8
3 1
Q

n
01
rt
01










w
S*k ^
Si
Type of DCI
rr SPECIF]
o


S «
^
9 9
§• i
:TIONS:
iitional
Please ty]
i sheet (s)
— U
\\
a »»
I
f
O

1
o
5
^
3-
It
rt
i
3

T

_.
I
8
i

?.

I
I
O
rt
i'
1
*
i
s
•'
1











c
H-
ft
(D
a
w
ft
0)
ft

o S w
> 0)
Ni n M
ft S'H-
S ft O
Til
H - fO
SB 03
OJ O
o ^
SB WO
W 0 ft
n * 
(D
3
S










in
ill
i i

1







































fi)
(D
M
o
H"

-------
O
I
S
s.
o
i
8
I
8



























7*
!
1







(A O — — CD
1 1 I ?• §
«5 jj[ «•. MM
* § f "* ™
3 IS-? 8
& •? (» 9 !*
-i « ~ " a
?!**
rt or w
*— *•»
i H
i s?
N T «••
I I1
1 a1
•* O)
B) <» •—
a «•*
S 9
i n

<|
!T«
i;
as
Is
2
2;JJ
$
* 5
Is
o ^-
1?

























X *-
2-
— • m
HI "O
S Tl
l|


ft r* ^ O Ml
3. S j. 8 -
x S'S 2.,
• 3 r» —
S3 "
2. 3 »'
• "


« -* a. o o>
-i -i 9 o) 0
D) O ft r* '
H * S. * _
e »> (i fl o

-t 2 n 8 a'
<• ^« -*•



2. 2 S
y^i-f
a" 3 s-

JO I 0 O Jt
a 9 ™ •
— ji •» •
* -•? " ~

22^sf 3L
93 4
^ n  CA
il

II
I?
9 °
(4 w
it *
M /*
:S
if!
II
"? ?
I
1*
!S
&
s
-1
l»
-«t
e_
•<"
r»
n
a

i
1"
r+
fi
M

i
9S
1

1

information
|

i
s
•
!














C
^
p>.
ft
S-
to
ft
0)
ft
(D

H W PJ



y iis M
P 0 3
1 33
* Oft
S * M
OT O
^5 ^t
w o ft
H * 0
0)
vO
A

O
HI
H

-------
o
1
o
-*»
1
o
1
*
rt






























-
5

»
1







8. Certificat
1 certify thai
1 acknowledge
or both under
Signature and
H- 1 2 s s
- ?::
O V 5 rt

1 ^1!

i ll

O It
w o 3
A "" S'
a a
f ^f
^ 0
$ 9^3
3 2
« »i
i' |s
i j.
i
II


c
5.?

Is
2
*< ^
S
In
-•j
|;
















00
o
N;
Ul
O
(R















25
^
•








Z

•


















!J
rt 3">
CD Tl
rt "I



rt rt "O 0 IH
• ^ Tl • •
T a ej 3
• 3 rt ^ -••
< n sr 3"
||« s
1 1


rt ^» O O Oh
*i?.s:_
fl' •* 3* m
? * s

B- e B — s~
it T O Q —
T o ft 5 3
•- * -• I"
m ™ o
4*35*
ffi-i* f
o ? A 2.
• ' ?» **


23V 3 ft fr
A r* •
*» -*• Ct T
* 9 * -fl ™
<• »» O 3
» A S O
a»&I.
| SJ'R
|SiS£
** **" A
^is-
K
* i 5 e 8.
» i» « • C
i .52"
ai JO oT —
1 5 s yi

"ll*i

JB U» -» -^ -" •>
3 § it T it <
A 9 r» 1 V
• 3 — 9 •» ->
I fi. r* 5 O O
-JJ "I
a a. B n
-. . S 2. "*
s ' " « S ;•

si'-s
•• ^ » w
"'I5l

o>
e»
3
^
jr*
e
a















i
"
|
o"
g

s








1. Conpany nai
CHAS H
7737 N
PORTIA
S-L,
O H ^

^Ps!
5 HOS
w 55 O
M O .
00 CO
§
M0
^3
a










N
"
ji, n
°!
vO n
*i

H* II
n
Q)
H1
ft
(fl








•
Is
VN« K
9i
w -
a*
8s
H
"3
H
O


INSTRUCTIONS:
Use additiona
if
i s
A
W •»
s*
1 °
3 ^.
W 3*
$ J

3*
.





i
•
5
-t«
C_
^
rt
4


I
i"

|
I
i
I
|
information
T
|
JS
a
s

3
n*
^t













G
3
tl'
ft
(D
a

CO
rt
01
ft
(D
p s w
5 Q>
h3 W W
> 3*3
H- <
n 3 H-
E ?1
133
H - ro
SB 3
0 ft
5g • fi)
| P^
Q r^
X to O
W O rt
W * ffl
0> O
0 rt
O
3
£
»
3









?! ?
g
m S 3
T" o
3 5
IM
M
S
(D

-------
e
1
o
n
|
n
*•»
"

























?
3
§
I






at o — — os
S 5 x- -i IB
•» *» a »» ->
•1 B ^* -*•
** § jr** 2",
i Ufa
S i ll 5
,-. ^ d
9 ••«
•*» V *< 9
^ *»
J»ff
* /jp a
i
g? Jjf
1 ss
s -1
1 a *
S ^a
| ||

3 3
S s =
< " B
a 13
1 •
f 0
II
?:
(9 V
^
i:
"> C
1*
•5
*S
-»
s*
-i
1 8
i *



?
•
*







Ul
to
W
Ul
*•













Z








?

















» *•
5 T»
r* >
<"t ™*
rt


<-»••» TJ O U1
ft -i -i a .
= * 1 3 -
X 0 S i C
• s " « »

»— 2 5* *»
5? °


r* -* e O O>
-•?!•!"
? •» 5 8
E « if'Ji o
?s 5s|
^ <° ir i'
»' ^ rt
i» * a' c *
|a|«f
S" " J ~ -•
• - 2

?.| - s •
» e. -y —
** --• ID T
S 3 « 2 S
M STS
fl> y 9 **
3D n S o
g "3.3 ™
islss;
• • 4 — •<"
'asa.-
s1 0*3
• * *
as-
j^i"-
'» a. j» 3 o «
? JO •" —
•* 2 • Jl
"1 |ij
sa
» «> -*-« — 2
ifH^
»sM8*
B & ^ !) O O
«8 g * H
~" S 3 ~'
"| |x "
§ ? a 5 '
"• J ^* O JJ
«I52

O>
3
$
~
|













:-
I
A
JT
J
•







-
S^Sa
> o o J
W 0 ZJ

Z *« Z §
cl35 ° 3
Z W O *
t-3 0 S
o » • |
n w 3
3 ?
K>-
o
0 Z
o •
ui S!
*
CA
G
n

(_>
o
o




IW
*
II
p

0)
01
rt
n





^
§1
W1
•0 S.
Ho
O f*
H ""
o



Ii
||
-. 3
s *
2 S?
*~ •«
ii
r* ff
«•%
W rfr
if
«•«*
M "*
»i 3*
9 •*
"•* 3"
&

|
!{
n
8.
a
n

x"
5
**
S
A
S
I
i'
f*
8
^
§
i
i
n
3
H
i
i
s
a
n
S














G
3
H-
rt
(D
a

w
rt
01
rt
A
D £ n
> 0)
H w w
> 3-3
M * *C
Q 3 H-

V 3 i
H - (D
Z 3
O ft
S Ml
e.
w o
s • s
Z to 0
W O ft
W •* ffl
o» o
0 ft
H-
0
 1
«•» «*K ^^
3 i
rvi
M
t




































01
03
(D
I-1
O
HI
H

-------
O
1
o
I
8
ft




























i
f
|










en o — — m
fir n it n
S *••?<»
rt ft 3 rt "¥
i If* !
ion
t the statement)
that any knowii
applicable law,
Title of Compai
* i.
w •< i
> -»l
* • *
3- ST 5
o it
— o sr
9 T
1 a
' lr
» a. a
S 3'J
• <« «—
rt rt r-
* II
i!

|I
T
i:
M C
?-
|l
j}
ft
3 it
1 ?






•0
rt











Ul
O
O
H
VO
H











55
>








?






















30 *•
*5. in
in "V
• ?
rt ^
O

•f ••» IB 0 Ul
1 £ 8. 3 L
x" 5 ' o 2- c
rt 9t
^ ^ y y
•-2 ?«*
s s- °
i t

^^ 0
III!"
3 t» ?fl n
* o « S a!
"mi yi
S > -. a •
a. ^ a w n
yaj*!
5. 5' y " *
2" ' S' -.
w A


? 3O 8 O? &
^c 5 "•
li.li
10 7 9 r+
0 r* rt Cd
5 ft O f*
|ii8£
2 • 9

In
9B M 4i ^ *• «4

•S 5 itS '
'•jfjSi
rt tt rt f •
Si *«"
:illf
•I
ilH^
n > S 9 ^
" 2 "*" 5 **
i Q, rt 3 e fi
3^-0 5s
II?I"
8 •• * V
*^ «Bi «5
** S ** * S
|p.
^
•
n'
o
a
















•9
i
1
I
-*t
|











_,
O X 3j
X W W 3
HA fi
me and Address
W. HIELSE
69
NGS OR 9
-4 SS
«^
H
Ul











r*
o §
vo
vo *
1
M- flF

0)
01
M
ft
n







n,o
11
w *
•02,
M o
0«
H
H
O




c —
St M
• 3D
is
ii
I-
•D
|§
<• •»
rt -D
8 «••
(B 3
8 **
• a'

F
!
n
i
A
i
g

•<
•
a
ft
?
id instruct
^
1
1

f
3
e
i
r»
S
i
s
I
















G
3
H-
ft
(D
a
en
ft
a
rt
(D
O *! w
Ni W W
> 3- 3
fl 3* N-
> v£J hj
H ft O
t< O 3
H *• <0
58 3
Oft
90 * ui
W '""'
O ' ^1
SB NO
W 0 ft
H Aw
* o
0 ft
H-
0
I
3
O








f § §
S o >
* " 5
^ M ^
€ 1 I
! i
*N
N*
U«
t




































*i3
0)
vQ
A
M

O
HI
h-

-------
                       ATTACHMENT C

PRODUCT SPECIFIC REQUIREMENT STATUS AND REGISTRANT'S RESPONSE
               FORMS (Form B) PLUS INSTRUCTIONS
                            AND
                       PR NOTICE 86-5

-------
              SPECIFIC INSTRUCTIONS FOR COMPLETING
     THE REQUIREMENTS  STATUS AND REGISTRANT'S RESPONSE FORM

                      Product Specific Data
     This form is designed to be used for registrants to respond
to call-ins for generic and product-specific data as part of
EPA's reregistration program under the Federal Insecticide
Fungicide and Rodenticide Act.  Although the form is the same for
both product specific and generic data, instructions for
completing the forms differ slightly.  Specifically, options for
satisfying product specific data requirements do not include (1)
deletion of uses or (2) request for a low volume/minor use
waiver.  These instructions are for completion of product
specific data requirements.

     EPA has developed this form individually for each data call-
in addressed to each registrant, and has preprinted this form
with a number of items.  DO NOT use this form for any other
active ingredient.

     Items 1 through 8 (inclusive) will have been preprinted on
the form.  You roust complete all other items on this form by
typing or printing legibly.

     Public reporting burden for this collection of information
is estimated to average 30 minutes per response, including time
for reviewing instructions, searching existing data sources,
gathering and maintaining the data needed, and completing and
reviewing the collection of information.  Send comments regarding
the burden estimate or any other aspect of this collection of
information, including suggesting for reducing this burden, to
Chief, Information Policy Branch, PM-223, U.S. Environmental
Protection Agency, 401 M St., S.W., Washington, D.C. 20460; and
to the Office of Management and Budget, Paperwork Reduction
Project 2070-0107, Washington, D.C. 20503.

-------
  a o
?&5 n
382 ?
o

o
f §
53
  •5
Autho
•ade on thi
ly false or
 Ij
 I!
       i>
       f+
       *
           CJUUWUJUtOMN)
            i  I I  t  i  i i  i  i
i
10
I I
(O H
                .
           2.   5  s   2.2i.
       £



       |


       8
       rt
       i'
                  ^   o
                           2 3
                      in1'-

                      Hi
   IM
     *» ft

   ? !^
   O •*• __
                                 9 2. 2
                                 3 » «
           o o o o o o o o o
           MMMWrtWMWto
           ooooooooo  o
                              n n
                              11
                              oo
           w w. w             ,

                              w w
       !!!lgg§?S
       CO Q (Q'ttO) A. Ok 01 CD
           * * •'.: •  *.,
                                    W
; aa «*

if

 if

 -3
                 VI
                 4


                 VI
                                             rt2
                                             « *
                                             li
                                             0 »
W W C|
»o>.
ox SB
o  w-
X W CO
M O\
Z 0> £
O vO •
                                                      H S
                                                      E2l
                                                      M
                                                      55
                                                  (J1
                                                  w
                          E
                                                  z
                                                  o
                                              U1
                                              0
                                              o
                                                      vo
                                                  N B


                                                  f

                                                  0)
                         fr
                         
                                 ft
                                 »

                             CO  01
                             H  W M

                             S  H-<
                             3  3*H-
                             co  «a H

                             *  ?§
                                3 3
                                                               O  "
                                  3

                                  fit
                                     .  »o
                                       *1
                                     M O
                                     O ft
                                     *. n>
                                     « o
                                     O ft
                                       H-
                                       O
                                       3
                                                                 1  o
                                                                    1
                                                               3  2
                                                               3  e
                                                                      (fi
                                                                      (D
                                                                   O
                                                                   ct>
                                                                       M

-------
a

M O


* i
n -•
it
— o

IS
o*
3 o
33

*'


1
  8
  3
                    00 09  03 00    00 09
                    H H  H H    H H
                     I  I  I  I     II
                                                0V Gft Cft 0^ 0*t ON (Jl

                                                I  I   I  I  I  I   I
                                                M ts> H )-» H M H
                                                M O <0 00 -4 0^ Ul
                       •o  -o  >    >  >
                       2.  2.  g „ g  g
3                          a  J» o •*  ••
                          S  » * a  9
                    2. 3  * m 4  *  »
                    « S  — ~ »     o

                    g  11 i' I    I
                    5. ^  s I c     s

                    «*fU     1
                       r*  3 n       »
                       -.  r. -.       vf
                                  »  ^
                                  ro ui
                                  »  O*
                                  M »
                                               i
                                  O
                    te 3^ ^ *
                    OD CD GO t
                    O O O (

                    H M M M    M t4

                    O O O Ci    O O
                    as a a s    a a
                    W M H M    MM

                    »« « «    x*
                    o o
03 CD QD 00 CO 00 GD
O O 00 O O O
o a o a a o o
M M M M M M
                                                aaaaa aa
                                                M M M M M M M
                                                o o oo o o o
                       w w w    MM
                                                M X X X X X X


                                                   M M W W M M
                    00 00 00 00    00 00
                                  to IB
                    n n
                                                   o  o o o o  o
                                                   w  ot ID ot ot  ra
                                                                          p *•
                                                                           o

                                                                           I

                                                                          '?
                           vn

                           u»
                                                                         S3

                                                                         1"
                                 DO ^^

                                 O X
                                 o

                                 M O*
                                 Z Ot
                                 O.VO
                                                                                 0
                                                                                 »
                                                                                 •si:.
                                                                                 *»
                                                                                 !-•
                                                                                 Ul
                                                                                      z
                                                                                      M
                                                                                      M
                                                                                         _
                                                                                         I
                                                                                         8l
                                                                                      M
                                                                                 M
                                                                                 5
                                                                                      O
                                                                                      to
                                                                                 (Jl
                                                                                 0
                                                                                 o
M
H

O

(0
&)

ft
ta
                                                                                        fl
                                                                                         ?
                                                                                         I*
                                    ® Q -«

                                    2   f
                                    VO OT *

                                       §M a
                                       O 2

                                    (O *Q
                                    U M
                                    -a o
                                    vr>
                                                                                             o i
                                                                                             I y

                                                                                             !?
                                                                                             S 2
                                                                                             S3
                                                                                                i
                                                                                                !


                                                                                                ^>
                                                                                                9
United
                                                             D)
                                                             ft
                                                             (D
                                                          s: n
                                                          Qi
                                                          01  M
               W

               i
               a  ^-<
                                                                                                         vO i-«
                                                                                                          rt o
                                                                                                          O ft
                                                                                                          .  Q)

                                                                                                          o
W O
O ft

o* a
o rt
   H-
   O
                                                             3
                                                             O
                                                                                                     2   2
                                                                                                     8
                                                                                                                 N>


                                                                                                                 O

-------
       •:  I
               i *» M fv» -• e •
  jo jo o * *  it
     ~     H
           8
           2,

           "
      •« •» "
   i 3 3 8 a
  3 r i" ** *
  * * »i i I
  * r» !r S 8 5>
  4« i SJ 8
  8" 3 — - -
  3 2. Z 2. i
  I 5" ~ *~ *~
 il',?§'
 %» n  n — i
n Ji IT R « 2!
»» -i j» o g.
H*  V
2 •• i  -
 i"  i
°s-=  ?
  ia  3
J'  !
**  »  **
3  5  ?
*  i  ?
 y i  ••


 1 1  \
 9 "  -S
•ft. r»  3
 ? «  |
 "» "   O
   *   f9

 I?  I

 I I  f
 3 -  S"
 I «  «
 * S.  -
 i
      2.
1  S  3
                                          r
                                 i3n
              Ar+rtf+f4*4c^jCi*^bC04Bg  B 3 •»
                       jj *• g to  O     *•» ^ Q, 3
              *O ""•• ••* "•* o o w  o it ** 33^3 (^ j—**  ^"
              ^MGsnOO^^^   3
              O     33li5'*T3OS'^CtL'3Qi  :  :  5*«
                        "  ?*  *  8  ?»S2
                        5  • S  S  i  ZS S:
                        f  %ff  t  2-  3 = 3
                           < 5  3-  a,  -* 3 ~
                           it   rr  (T  o a «
                            -  s
                                  I  Si*
                           S8  S  ?  8-=
                            i*     f §15
                            I'  I  I I  r
                                i
                                [-.
                                n  — a —
                                                 ... 5

                                                 si?"
                                                 fig I
                                                 3 o " a
                                ?  I

                                I

                                t
                                3

                                !
                                3
                                                   • *
                                              —  3 « •
                                               !
                                    «
                                S

                                i
                                                   !!
                                                        I ^ r
                                                        felt
                                                         35.
                                               CO

                                               s
                                               O  '  ' '
                                               I  lit
                                                   s
                                                                      C


                                                                      M-
                                                                      ft
                                                                      (D
                                                        W
                                                        rt

                                                        rt
                                                      £ (D
                                                      at n
                                                      n
                                                      cr M
                                                                     ft *t
                                                                     O O
                                                                    as
                                                                    •  rt
                                                      O O
                                                      *» ft
                                                      A (D
                                                      o n
                                                        ft
                                                        H-
                                                        O
                                                       • 3
                                                                         o
                                                                         H>

-------
M i_i
3
i sit a
5}«» §
D a <* sr X-
0 0 ° < «
° 2, -. « jg
" - 1 Q. »
M 2T ** (T
TZ » s- 1 *-*
8 m * 1 fl
!*• K 5?
~. ^ ~. ft ft
-» o •* M
li*i £
sill "
n e> i* >*
33f I
-5 2.
»i 2.
• n
^ » •»
gi o
2 _. 9
s: 1
a •» n
n «>
n «
?s -
n? £
si 5
l* IP n
n (A
• 3 3*
?l :
-^ ?
II -
— O 0)
Rf Ti
— 5 >*
s? i
o a •
^» ^
»» f
•g »» a
rt -T «'
— 7 «
•: §
-> l» rt
? S •
" 1
t> o — •
•o 5. a.
2." °
1* £
— 2 **
s' « c
si i
SI 1
5! i
r- 1
-^ o
^* X
^ 3"
• A ••»
^ o
-^ O T
r£ *
! I
* -8
•*» 9
o 3
"» 3
! J
- "S
a s
8 |

S*
.
§ ^
^ 1
S?
8-
^ •••
= i
i 9







3
|
i «
n *^

I! S""
1^ \V
rt 5 a
» o m
Sw rt
Q 0)
^k ^ ** fli
^V ^ IV
_ » m
o> 2 in
3 S 31 W
O, g H- 3
SB 2 «S H-
SS rt h<
300
H 3 3
.. 2 - a
*, 5 0§
^^ ^^ »rf
5w * f
3 o»
* g OM
N 9 Mh
H. S o o
3 S ^ rt
O S Ov (D
Hoo
Stj <*
^^ * •
5 H-
H S 0
ft W 3
m . .
P? *^
S 
-------
                   f
                            —
  —  1
?$  -•
                      i
                      —«  B  rt *  •***
                      ?  S??3

    HI
    •  *"
      \>(v>(sJ
 1   1  1  1   1  1  1  1   >
M(-*^J^WeOWN>H
A to
                                                                        MH
                                                                        II
                                                                        W
                                    o-a
                                    MX

                                    &
                                    N*
                                    s-
                                    r>ti
                   HI a
                   «r ?   .   .
                   B 5  » o    »»
                                                       9. *     ™
                                                       t       Q    D
                                                       w       3    rt
                           —.    — »
                           9    • i
                                                                o    o  i if
                                                                •+*    3  — —.
o  ^
                                    ooof>ooooo
                                    DODOOOOOO
                           >

                           n
                           D
                           W
                                       ^9 ^9 ^9 ^fl ^fl ^5 ^v' ^y.    ^y
                                       oonooooo    o

                                                          H    H
                                                          t|.    C4
H H H H HI H H
L| t, C| Q CL( C4 '

W
                                    ooooooooo    o
                                            O
                                            P)
                                            H H
                                            C4 t<
                                    oo

                                          W 9 n (D
                                          •  «.:-.•  •>;:.."•  -•:.:•
                                    tQ CO
                                                           9E JO


                                                           K
  >
                                                      UI


                                                      CA
It
                                                                                         S3
                                                    «i

        > O O-

        £°g5.
        H M >
        SB ^ Z
                                                                                                z w o

                                                                                                n w
                                                                     o
                                                                     0 Z
                                                                     o •
                                                                     en S
                                                                                                   (0
                                                                                                   C
                                                                                                   H
                                                                                                   O
                                                                                                   o
                                                            M    *» ff
                                                            1^    O 0)
                                                            >    vo *
                                                            5
                                                                           O)
                                                                           10
                                                                           *k


                                                                           LJ
                                                                           (J)
                                                                           «k
N *
K-B

^

W
0)

ft
v>
?
                                                                          O 5




                                                                          ml


                                                                          H o
                                                                          O §
                                                                                                   U)


                                                                                                   •s) H
                                                                                                      O
INSTRUC
Use add
                    8

                    S*
                    ?  3"

                       I

                       •n
                                                                           i
                      G
                      3
                      H-
                      ft
                      0>
                      a

                      w
                      rt
                        sra
               H  H- <

               01  tfi  >1
                   ft O

               433
               a  -  9
H  o
W  *  *Q
       n
    to o
    O ft
    •f. (D
    » O
    O ft
W     H-
       o
»     3
                                                                                                                        o   -n
                                                                                    IS}


                                                                                I   i
                                        T3
                                        Q)
                                        A
                                        n
                                                                                                                                o
                                                                                                                                HI
                                                                                                                                M

-------
~j
m
I to indicate cert
text of certificat
ification as to infornation on th
ion is on page one).
a
1





-

0
a
 »» IS onxc «•*
3 — — C »» C C » <» n <• a O T) •
a g 3 *# o *» *» r ^ "i o n i »~ a
j s s <» s[ » • U R 8 ? 8 * 2. 8 — X • — -•
3 IT x • x B *•• i n •» •••——•
a a * — ft |i _ a *< t "• "
~-a* • T »» P* 1  r\ivi IMI» ^* »rf s^ w*
%* " ?





oooo oo oononoo
W W W M W W W t1^ W W W P3 W
^w ^5 ^9 ^^ ^fl ^fl ^fl ^N ^fl ^^ ^3 ^fl ^fl
o o n n on onooooo
aaaa aa aaaaaaa
c^dtiQ ci ci C4 ti t( t< CH CH C(
OOOO OO OOOOOOO
W W W W .••• HH: W W W W W W

•• ••
a a B a as B a a a a a a
000000 OOOOOOO
noon (BO- onncootottn


z so *•
H-
.?
"» -1 —
-i
Wl
Ul
I
•*


i-OCX»-««r,
-
~ I'
1?

}f


K
S3

-n 9
T a
f

30  O 2
-J M
O
si
s ?
CT10MS: Please typ
Iditional sheetCs)
i a
x 5'
i
i
n
5
?
?


i
g
1
i
f
5
3"
i
H
3
a
•T
i






United States Ei
Wasl
REQUIREMENTS STJ
,»• ^ _i
s H. <
a 3 H-
ft O
Z 3 3
O * (0
id o rt
H n
CO • *0
3 to o

* 0 ft
O
W >
CO O
Hk>




1 I 1
m S 1
T" o
i i
s
















•c
01
^^
to
0
to

-------
      -, -,  8
• -i -i S « n  2.

~2.&3i!i  "
«t    ** M. „•„  i

S S 3 : 5 5
  • 5*18
  a, _ 2 +? ff
                  B » » g  «
                 *""" *"T ^' ""*• 3 _r "
n x o • o a
a 3 o r B S.
a 5 e  »rx

£JI  fi
-if  ;s

It'  S?
T: a. -i  TJ
-*• «
             *~  " ° 2
             n  3 n —•


             ^.  ^* n 0
             n  o> t r>
             «  K — —



             J  '"[I*



             i  *J{
             •t  -. • 4
                                 *  5.1
                          •i   a

                          M   s-
                          i!   i ^  i
                          ? S   2 -
                                 5
                               3  I  3*!
                               &  f  ^c*

                               8  I  irs
                               •»  a  ui M n
                               •  3  «v >*
                                       3  A
                                       «"*  a
                         iv S  -i 8

                         S £|s:|
                                              ^-  i ^ •*
                                              ^*   O *»

                                              *  i 52.

-------
•^
f-tV
=!?
o' 3' "*
« a •*
f» o
0 O
2^3
far **
«R
1 * *
5' — <*
0 _ §.
n w' A
i!
5 "*
0 «
f s
A
r> S"
*» A
IV B
1 »
A 3

O i—
T X
= 1
— o
O f*
!a
o
»r
1 "
rt f>
5"?
iZ
22
ll
3" «
*• 3
°™
n l
2l

• »
X 0
n
r*
JT
<-t
8
rt
O
§

"^
rt
?
-*
i
T1
1 1
f !
< ip
* n
1 §
^
^
0
£
1
x"

5.
S
**
^
It
<
I
•
I
»
«
1
§•
rt
5
A
i
1
r
!
1
|.
•
•
a.
1
rt
gr
a
8-
1








|
o
M
W


» o
01
ft m
«
4fc
DEFINAT]
and mam
?. g
* w
S a
vo S
so
N §
[DELIHE
nc salt
O M
0
N
i
1




















G
3
H-
ft
A
a
n
ft
Q)
rt
C (T>
s Enviro
ashingto
3 3
* 3
(D
0 3
• rt
&>
O I-
*
to i-i
0 O
tection
460
• p,
A
O












































•0
Q)
ifl


M

O
H»
to

-------
o _ _ _

""
I
   >
 32; ?
r -•
    ••
   7 n
   » »
y ^ *•» *t
  n* » <»
3. S;35







111
horized Repr
on this form
alse or nisle
 I
    -1
   <*
   *
         0^ O^ 0^ 0t O^^O^O^^
         UUU)UWWN>MIO

         1  1 1 1  1  t 1  1  1

         H(->*-lJ>U>MbJM»-»
         4k N)
                      0V01
       OOO

                   OO O
fc J »T» » • *•-* M^W »-» »T*


Illllll


H M H M H H H
     ^^ ^J ^J ^J

       X » «
                          o
          ooooooo
       ntQHHtdHMtrQtd  w


         00 00 00 <

         §§g§§
         CD CB W IB, 0)
               09' 09 Ok '
                             , QQ-v'
                  9 BO  W
                      gg
                      OH D
IF
X

it
 "3
                                       90 T?

                                      II
                                       • i
                                       3
                                       s
                                         S3
                                      S-j o
                                      -j a
                                    50 w >
                                           5??
                                           D W
                                      F K s
                                    * r  i
                                    -JN o
                                    W Z O
                                    H« O •
                                    03 CA



                                      1
                                      S
                                             n
                                             £
                                           o
      CO
      o

       I
      ut
      o
      03
                                              vo
                                              o|
                                              m *
                                                  i

                                                  !
                                        N
                                        H-
                                        3
                                        O


                                        (0
                                        0>
                                        (-•
                                        ft
                                        0)
                                               fi 2



                                               H
                                               O
i:
« «.


ii
«-» Mi
O i
a m
                                            (A <—
                                            f 2

                                            Is
                                            0 •»
                                                   J;
                                                   l!
  §

  |


  i
                                                     &
                                                     s
                                                        W

                                                       _,  N

                                                       N
                                                       S
                          •d
                          a>

                          


-------
c 2,
I to indicate
text of eerti
fic
on
on as to informa
on page one).
00 00 03 00   00 03
H M H H   H H
 I  I  I  I    II
<3> U! *• U(   MM
            (JV Qhi Cft 0^ O\ 0^ O^
            W W Cai W W W CJ
            I  I  I   I  I  I   I
            (O (O H M M M M
            H O V0 00  i
                                                                     O W
                                                                        •
                                                                     O
co.
LINGS WORTH
97218
                                                    n
                                                    £
                                                    »
                                                    (D
                                               r»


                                             ^8
                                             vo «
                                                i
                   OJ
                   »
              03   1-
              o   rt
              N»   01
               1
              w»
              o
              09
oo§|
o g *


»«1
C/ T3 •%
                                                                        W H
                                                                        *• "fl
                                                                        M H
                                                                           O
        ii
        ft *"

        [i
           •«
        S- i»
        S S
        ft «t
        *^
        * 5
        rf

        i!
        M »
        S 3
        ^3"
                                                      1

                                                      I
                                                     •<

                                                      %

                                                      I

                                                      i

                                                      3
                                                      ^
                                                                                        W
                                                                                           3 H-
                                                                                           3 3
                                                                                           D ft
                                                                                          Q   •"
                                                                                •0
                                                                                SO
                                                                                tfl
                                                                                (D
                                                                                                 O
                                                                                                 Ml

-------
  >o » o • «  ni
  - - it o e  ™
S s 9 9 8 »  n
C 1 Q» & ** **  SF




i*iM?  *
S- i 2. -. • »
2 & S 3 . -
3 «t -. « n
         S'>« o a n
           : -» »• O
           , . -. t n
I!
O
"I



fir *;
.«.' T a.  3':
          S o
          ^
.8  3 ?


 Mi

 U{
 I  s- *
*  '  8-
o  a  f
T  »  O

»  i  «
I  I  5
£  S  if
=:  R  2.

i  i  ^



!l!
> !
M *X
I ?

1 I
          .
                                            T


                                            9
                                            •
                                       3 .,,
                                       O • • i
                                       ft »»^

                                       a S  '
                                               a
                                              "
                                                     S- 2. ? 2.
                                                       ^sa
                      — — . — . n n
                       S -?•*
                       (»'»'53o>»O>— —
                        vaooarsigna
                                                *
                                                o
                    n i c •
                 -OQ.Q.-- — «

                  xs"-^a'~r
                  ^*01^»fl'MQ
                  a -5 o IS  S
                      !
                     f!
                                       -8.
                        •^  Q>  TI *N -* **
                       ||  I  i Jy


                    Hi  i  f lit
                           3  O * ™ w
                    ^  i! i  i
                       . ~ t  c

                       ^8
    s.  i  = |?a

? 'l  I  I Us
  a 3  c  "*   n S

  ?2  §  S ?£f
  112  -9  — -»S S
  a. —  A  •* »* —
  3 *  3    *• 2 °
                               §« g  • *  -> • a

                               & ••  S n  3 ** fl

                               ?"  * ft  *3-
                               A   tr If  a a m

                               5"S  '  -
                      H  I 1  \ll
                      "  i»S"
                                   3 £  5 ? 3
                                 S  a -  ~3-S

                                   2 §  ¥j:
                               II  I 1  i2|

                               i!  I I  if?
                               5   • 3  8 S!»



                                   Z S  3" S
                       a- 9 -e

                       it I i
                        • rt •

                       I' £ I
                                                r*  I-
                                              o i-o .

                                              ^«1 S

                                              5JS-"
                                              «  • TJ
                                                ^ v> ^
                                                Reno
                                                2 a. a
                                              « ft  C
                                              -. 3"O R

                                              $»^-
                                         II?  3i£
                                       If





                                       -*>  " f» r»
                                                    ?

                                                   1.8
a
                                       •    c
                                       s  I
                                       - 3 e "  -oS
                                       n SB—  > <4
                                       w. 3 it •  =
                                                    i
*:i3
32 X*
"all


?i;l

IIP
•t.* •»•*

ir-|
s-o1
-.? °?
2 *li 1
53^5.
4-3 S
S f*
5 £ ~* *
•o S g ?
> ft ft. J!
5 o S «



«i«
".sl:
                                                ,fn
                      o 5    -   g •     »i...  43

                      Is  *  "  8*3     S -oj.  3S
                      99  0-3  *>4*_     S 3 2 -B  <*•
                      3ZiT&2.2.g-     S 8-25  »&
                      	Q  __  -* * ~     ^?i«  ST
                                        !  ^si
                                        s  s|i
                          n A T ^
                          «JS —

                          mi
                          llH
                          l*il

                          III!
                                                    n  ^ —•
                                       "  J
                                       S  *
                           i—»»-«
                          -.1-3
                          2. — ?•
                          £ 3" 5 »


                          I*:*
                          ?-«I s-

                          'H?
                           3:2.
                                       e
                                         O *• <"
                                         lit
                                         r 5 S




                                         i!i'

                                         ! i
                                                i&g

                                                "i»
                                                2*1
                                                ii^
                                                8-
                                                i^
                                                » 3* *•


                                                111
                                                         "?

                                                           o
                                                             n
                                                             A
                                                          G


                                                          N'

                                                          ft
                                                          (D

                                                          O.


                                                          cn
                                                          rt

                                                          0)
                                                                  0> D)

                                                                  0)

                                                                  3" W
                                                                  H-3

                                                                  3 <
                                                       H  ?

                                                       a-s
                                                       Cn
                                                     O

                                                     VO

                                                     VO
                                                          (D
                                                         a 3
                                                         • ft
                                                          01
                                                             ft
                                                             n
                                                         o o
                                                         ** ft
                                                         a* ft
                                                         o n
                                                           ft
                                                           H-
                                                           O
                                                                   §
                                                                   o
                                                       S
                                                                      
-------
l*« I
t) in — . — . fr
= «S3- g
So SS" m
" * ! 1 w
1 m f I "H"
«ai £ 3
Q^ «•» 0 ^> ^T
•-• 5 "* i *
3' 0* S 9 ***
g 8 £ **
O tfl O ^*
-n w n
9O 1 • 3
rC -. ^
-* A ^
gl o
Sf 1
*: i
?» -
o- •
n If -»
T S "*
• | g1
y 2 <
— o w
|! I
— 3' f*
s3 1
5" rt 7
!: 2
•S3. a.

5| §
3' 2 *
sl' ?
n a ft
3l ?

* ** H
^ o
^* O "1
rs *
A «
•» (
• ]'
i *
i ^
a s
- fi
! 1
A
I i
} |
! I
5 I
£











3
s
i i
* ft
A 5 ^
» o M
CD p- ft
9 ft
* "• * ft
s Environmen
ashington, D
DEFINATIONS
and Name: 4
o •* • rt
tc 3 o>
* i pv
A T3
N 2 to M
H* S O O
g H ^ ft
O B O> (D
n E ° ft
o, H £.
5? « 3
a S jp,
*2C fO
2 |

1
w




















































Qi
»

O
Hs
W

-------
    ~-
    tp n •
    n it
    in 0
    3 «* I)
    s — -i
    *  " "
i
— a »*» s
? Isr s
   Si
   • S
   n
^!
il
i?
      uuwwuutotoro
      1 1  1  1 1 1  1  1 1
      HM*Ji(*UtOUli4H
0V O\
H H
I  I
(O H
             o      a
        • "* '        --
                         8 & 1
                    *»  5
                    3- o 5

                    '
      i
      8
S. -  S | I
0   -» n X
i   I £ ».

3   rt rf fl
*   Si!

~    •:!'
         S8S&B88SS   s
                    M
         HHHMHMHHH
         L|C|C^QIL,C4L|C^(L|

         ~* •
                                        \"
                                            I
                                            I
                     TJ
                     0
  «J O
                                            > Z BC
                                            *2j •  •
                                            o n

                                            o '  ""*
vo e«
*4 H O
w z o
M o •
oo en
                                                w  *•
                                                *O  ^5
                                               i
                                                   vo
                                            Z  O
                                            o
                                                D)
                                                0)
                                            O  t->
                                            O  ft
                                            (O  0)
                                             I
                                            OI
                                            Ul
  I  ^

  ?il
  (o r> 2
  W H

  W H
    O
SS

p
fi
                              :
                             n ^
                             si'
                               I
                               i
                                                                 (D
                  en
                  rt
                  at
                  rt
                  (D
                S 
                                                                    to

-------
ion as to information on
on page one).
CD CD 00 CD    09 CD
t-» M H H    HI-'
 I  I   I   I      II
0» U1 » U>    N) «-<
{^ CTi ^ CA  0) ^ ^h
u> u> u u>  u u u>
 I   I   I  I  1  I   I
IS) tS> H H  M H M
t-J O VO CO  ^J O> Ol
          •
«• "i  "i  o     no
§ i n  i s  %
   •<•<-•  0  O.  0

Flanmbility
Explodability
Storage stability
Viscosity
Niscibili
Corrosion
Dielectri
e Toxi
— • -     <    ,     r
S S i S  5     f
   S S  n  -     3
   — .  .  —       «t

   8
 «» -• ru to    -• -«
 ^rf »  %^ %*    •»   *
   IM          M W
ui    *»  w

o o o a    oo
   W

o o o o
M rt W W
      o o
      W W
                             ac a s aa ac a
                             M M M M M M H
                             ^^ ^J ^J ^J ^^ tj C*J
                                9^ X ?*? W W
O O O O
O O O O O O  O
•§ ^ ^ «5  ^ N? ^

W M W M-   M W
                              W 36 OK 3C S
   W W W W PI W
flD 09 40 00   • 09 09

01 CD m W    ID 9
   0
   O
   n
9898
O  O O  O
tn  ot to  n
                ig
                                                        u
Subs
9. Registrant
Response
                                                                n
                                                                •«
                                                                o
CO
o

 I
Ul
Ul
w
« *
   5

jfl
VI
01
(-•
ft
CO
                                                                         M

                                                                   H *Q o
                                                                   to
                                                                    i n

                                                                   U H

                                                                   N> H
                                                                      n
                                       P
                                       |i
                                       §•?
                                       it  &
                                       rt  <•
                                       ^H
                                       •>  >v
                                       :i
                                                a  ••
                                                ii
                                                                                 f
                                                                                          O ft
                                                       m   S
                                  5
                                 05
                                  (D
                                                                     to

                                                                     O



                                                                     M

-------
5 *• w
A e — — i T
si-tag.
sx aiiis o
• S " 8-1 i i
" 1 " 3 5 S O


8"* — 5 ^ — —
- » " X-" "
  i S.R8 •
  ' « -• 1 *9  o o o
                   » 3   f* H.
                   T»»  n c f
                   '  •
                             *"*  X! 55
                             i»  > -
            f!
                             2 ,.«••


                          Sirf
                          S  8 ? 5*.
                          •D  M X - 3
                          8  x » 8!

                             • f?^
                    ?  It s  I pi
                       " •  1 !ss
 2  •*  * ^45"
 2.  —  -9 wt a
 *  •  g ?S2



 "  »  « o I *
 C      it ft <»
 £  Q.  g T n

»» •  &  •- n" i


•i  2.  fi oi^

S  I  I =|l


 •  -  "" ~5"y

                                i
                       El
                       13
                       ? s
                       55.
                             s  s£?
                             I
                             8  ?g
                                  I
                I

                I
                a
                *«
                q
                ?
                                       5      <
                                       S i- n OB it
                 &
                 J
                 8

                 f
 •» > 5
' ' ' ff
SO > "H f*
8f ?!
— s -i a
| ± 8 i
I°?a
i|ftf
O O *"*• •"
** CL O
030

"li
 §<* >* n
 •» •

JT o 5' c
•_ 5 A 5.
 ** »» o
TO  e
IS 32.
*« *3
S.2-?^
 r» T S
 •«5
                                         jfl
                                         ill
 ^
 if
 li
 ?i
                 s
                                           : n
                                          III
                                       H
                   SB?
                     1
                                       5 i
                                       $
                                       a
                                          I
                                            1
                                       ID  • — i
                                       S
                                       g
                                       g
                                         — n >  S «
                                         3 2 -O  a.
                                         rl •  3 *'
                                         8 i •»  35
a.5*
1*8"
— -i o
liSfi
•;s^§
*i'l
"ll^
•8l|.T
-i n n
«,« "•=?
   •H A
Si"l

fjis
-S! s?
5"TJ3
a 3 3 5.
9-. "35
   U-?
- *-2 *
T,«|?
> *» 8 T
ssf*



«i!
si^a

*lii
3l5f
5 S3 2.
i-.4;-
3*^1
« 3 o —
                                                 «r
fi:
li^
 i«  !
«—<-»-»
l!?i
• 3 •» •
«-i
a*-ai
  fl-
                                                  i
                                       o  ' '
                                       1  as
                                            !
                   5'i
                   ^•  3
                   *  i
                   r»  &

                   '»
      "I "
      •a B. (l


      «f
      88
      Ui
      MI
      ^ i*
      8." s
      R-S
                                                     i
                                                           G
                                                           3
                                                           H-
                                                           ft
                                                           A
                                                           en
                                                           rt
                                                           a
                                                           rt
                                                         £ A
                                                         o> tn
                                                         w
                                                         tr w

              5 ft ^
              H Sg
              i -  i
              S   (0
                                                     B
                                                     Q>
                                                     a
                                                           0)
                                                          fl M
                                                          to h(
                                                          O O
                                                          * ft
                                                          Ot 
-------
" n?
isll 1
— • 2 . 3 & "'
n 3 O
a 
A
O






















































T3
D)
•£1
A
to
O
Mj
fO

-------
r
2.
c  ** 2 2 *

i
   *
     'I
&
!
made on this for* and
l false or Misleading
         n
       i!
       l!
    li
    ft
         *

                •sj •(* U> N> U> M M   M     N» H
              a   5    8   222.
              \
                                 o    3  «.
                                 *    t-ffi

                                          '
              8


              3


              S S
                                      8 2. 2.
                                        fl» *•»

                                        -:l
              CD Off CD 09 G9 09 CD Ov 00   CD'
              OOOflOoOOO   O
              t3 C? C3 C? C7 C? ^3 C? C3   ?3
              MWWWPJWMMW   td
                                        »
                                        uv CO
                                        OO
                                          W
              ooooooo
                                        ^5 ^Q
                                        oo

                                        MM
                                        oo
                 j M M H W M W M
                                        W M
                                        W
              03 0 00 00 00 OB 00 OB 00::l|:: OOs-'-sl   OB 09
                                           CD Q
              B is n. to
, M «•"

'!»

 n

 "3
                                                      !«
                                                     'r
S
                                                                  o
                                                              O-M
CO.
INGSWO
7218
                                                              n
       00
       o

        I
       Ul
       vo
            3*1
            o

            u
            0>
                                                                ?w «
                                                                •oS.
                                                                Wo
                                                              M O 2
                                                              ij L^ *™

                                                              Ul H
                                                                O
II
p

II
» 2
li
f<•
**
a r»
rf

ii
«> 3
B A
            i*
            I

            |

            1
            M

            I

            I
                                                                        i
                                                                        3
                       I  "

                       ^  3

                       I  i
                          •o
                          0)
                         vQ
                          (0

-------
~-
--.
I to indicate cert
text of certificat
ification as to infornation on th
ion is on page one).
i







f*
i*






00 00 09 00 03 00
1 1 1 1 II

? Z Z 8 ~ 8 £
{[ i 3 J 8 J •
m "* x a 2. fr °
i§um
iiLfjt |
»» *
rs» ** N v*





o o o o o a
n n n n MM
So o n ci ci
a a a aa
H M M H .H H

O O O O O O
W M W W .--•• M W

,.•:,
8888 §3
01 CD ^B OB ''•- 0) Ok



1 1 1 1 1 1 1
H O VO 00 -s) O> Ul
Flanmbility
Explodability
Storage stability
Viscosity
Niscibility
Corrosion characteristics
Dielectric breakdoun voltage
Acute Tonic - Reoutar Chearical
ui *• w rx» -»





G0 CD GD 00 09 OB 00
o n o o o o o
a o o a o a o
W W W W W W M
o o c> n o o o
a a aa aaa

o o o o o o o
n s x x :< z z.
: .•• . M W M W K M


• ' O 0 O 0 O O O
;- -'• m CD COl 091 01 01 01


X 30 **
H'
.1?
-1 -1 — .
11
UI
ut
r*
5"


| Q| |Q IQJU 1
-
"H
T »i
5*
•^ A
3


7. Test
Substance

i-
'r

9. Registrant
Response
-
§381
131!
o w * .
O " H *
ess
K CO.
LLINGSWORTH
97218

ru
n *> 2
*rt o 5
^ Vk
99 9
0 1
vQ N -
• H- *
51
01
0)
00 M
0 ft
to 01
UI
VO



w
H HJ o
«§i
III
M O 2
%J *l|
UI H
O
es
X ?
ICTIONS: Please tyf
iditional sheet(s)
« or print in ink. Please read ci
if necessary.
ireful ly
n

1
ft

8
1
I
f

1
lion requested
3
H
1






United States El
Wast
REQUIREHENTS STJ
1^ r* -1
Jj H- <
ft O
a! a a
O » (D
3
O *-•
H O
W • TJ
3 to o
> 0 ft
* 0 ft
en H-
3 §
i 1
i ^
n *s



! * f
« 8 I
S 2

-------
$ *• M  IV


    o x ; n
      -» ff
                joaoanx o jo r» — e J» » O.'O so
                j»2«K—a«v-*3S 3—^4  Q
                4).g.g-i>-'*.gi» n a S e> o 4  f
                etcx—oc  r» o •- « a. e  a
           TTTII-l-l-OWO-IXdSa^o
a             949444 •» C 3 8 »» 3 3 — «» •*
             aaaaaaaL:J;oa.3ijiio-.
                   « *M>I r^ ^ *» (B ^ •*> *" ^ Q»
                      -
a*;;
                      o.          „
            «•* <••• «#» *»» ••»» -"»« "••«  *M>I r^ ^ *» (B ^ •*> *" ^ Q» -««l  W
            -«.^>-fc^,^,^.^,,-r>3-o f» n   T "  «
            9V17T>'OT>'*9'  it»3-owa.3-»r»  i—
            3S»!»S»S Q*


                   ^  ?s  * ™ -s-RS
                   l -.
                                      (D  «* " ** 9
                                      Mt  •*  "I •
                                      n  — a -.

                                      ••  •!'$
                                      r»  g g ^> it
                                             *2.
                                             •* 3
< s:&
•» 030

rt«
3  1

1 :?:

5 Mi
3 § 23
* o a "
| a|t

1  ^1
*  3 *
I  li
                         SS3|
                         "~ rf rt O
                         " f ° i
                         X S S ^

                         im

                         *!h
                         jpi
                         ?S"S? 5
                         5 5 8."
                         aaS!5
                         « • •»
                  S  **
Mir
  2!"
  sis*
hil
.1 5-" g
,!?**
23.^
•hi
iJH
» « --0
> c » I
55 . S:
< 5 -a
In8?
3aS2
 15 «i S.
 ft 9 a

li:!
                                      s
   n 5
   «!
    i
                                      Ifl  X — O

                                      3  ' ' '
                                      >  — o
                                        — o > n
                                        2 2 -S o-

                                        ?3 • I*
                                        8 4 ft i
                  i f
                                      in  •— 3 r>
                                      vt

                                      S
                                      MH
                                        s3i
                                        i i
                                        £ !
—  IT n
 5r» • y
 °« S
" 3 a *
•«?3*5
l&S-

"*;
5j*i

ali*

3!!!

asal

i"«S
rlas
-, 38s-
• — ft -*
3:1^2
a-?8
• 3 rt •

fa"i

    &
                                            IF;
                          •. ^ *
                          III
                          31.
                          "S*
                          a^f
                          |S|

                          i?i
                          |ti
                       i   ;u
                       1   H;
                                                   *

                                                   N  Q

                                                   "

                                                   B
                                                        C

                                                        h"
                                                        ft
                                                        ft
                                                        a

                                                        en
                                                        rt
                                                        0)
                                                        ft
                                                       £ 
-------
IM ^^
•^ ^
f-H "D S O
8 is rr
— •» o n S
-•-••" g
S* Sf ft
* «• 2- a
o J R 1 "5
S ' o S P
-• a S i g
i-o * ft
— 5 "*" 1 *
3' r- <• _ "^
** ' fi *"
•" « 9
»5 • 1
IS c 5*
ru — S-
gi o
^f 1
Z" i

7 •
— T A
r* It A
il -
•I f
o 1 <

— o" m
3^ 9
9 3
3- 30
1" 2
S - s-
• » g
^ _5
9 g «
i'? |

±1 I
II |
II 1
n |
X O T
r^ 1
tl
! *
H
s 1
rt •
I \
5 '
1 *
i










PM
Q
i
§ G
W H.
W ft
(^ ro
S? o n
s « sr
1 S s^
_ ft 01
a J3 H-B
x B 5 H-
P 5 ft h|
i a o o
ffl g 3 3
" 1 ' *
* W 0 3

vfl gj O H-

N Q M I?
h*« S O O
a g *k ft
Q H oo
8 H £
5 s ^
i «
H
i













































*o
01
A
NJ
O
NJ

-------
3 *£?«
* "• *" 5,
— 5 5»» 5'
•» t} • » a
5" S " *

* MI
O » W A
    f A

     8
    « *~r

    If

    ^1


    !5
    if
    r
          UUUUWUiNJWW

           1  1  i  1  1  1  1  1 1
3

          •»

s.s?±s   c.
                                    « g
                                    •~ S.


          WWWWWWMMW   M



          XXXXXXXXX   X
          MMMMHHMMH   M
              C| C4 0| Cl C| Q C4 .
          OOOOOOO
              8S
              00
              w w

              ii
              H H
              C< C-l
              OO
          H H M H M M H H H :.'.•• M
              W W
                             S.  .'..';,
          •HH
          in oi; n w w
4. Guide
Requirem
Nunter
                                                 'i

                               CO
                               n M
                                                     vo « O
                                                     *• O S
                                                     *•  T)
                                                     o » >
                                                     w n z
                               n
                                   o

                                   VO
»    a
A    !
iQ  N K

'   51
35  O
O
    to
    01

O  ft
vo  n
00
 I
                                 o o _,


                                 ?w^

                                 O W o
                                  • O 2

                                 Ul **)
                                 -J H
                                 oa n
         Is
         ii
         fi
         I *
         \i
         S 3
         3 ?
                                          i
                                          n

                                          3
3
!
i
i
i
               ri

               w



               09
         c

         H-
         ft
         a
         a

         en
         ft
         (D

       0)
       01 n

       H-<
       3 H-
                                              O  "
                                                                    d
                                                                    «
  3
O ft
.  (a


O
.  »o
  n
N O
o rt
•^ ffl
                                                                         1
                                                                   I  i
                                                                            to

-------
e -

*" •
it
** o

H
— n
33
i ±
k
si
1s
  :
nfr QQ Qj QQ   Qp 05

t-> H1 H M   H H
till   II
Ot Ul *• U>   K> M
                                  OA OA 0^ O1* 0^ O^ W
                                  w u u w w u w
                                  I I I I I I  I
                                  M M H» M »-» M H
                                  H O \0 00 «J 0> W
                ff
                ii»
                •< 3 ~
                      A a. o
                          -
                          s
                          a
                          n
                    2 ? S 1 S 5? 2
                    S. 3 S 8 S £
                    a s ? s s i
                      3      =
                      o      •*
              SfffS
                r* 3 n
                s if
                  » £
                                  W«   *•
                        " 3
              ssss   ss
              DODO   O O
              w w w w   M n
              o o o n.  no
              a a: x a   as
              M M H M   M H
              O O O O
                    Q9 03 00 00 03 00 00
                    OOOOOOO
                    a D o o o o o
                    M M W W W M W
                    ci o «•> n o n C5
                    aaaasss
                    H H H M H H H
                    f* ^^ ^J ^J C«J ^J ^>J
                    OOOOOO
              *H ^3 wi ^n
                    Mxaxagsx

                      W M M W W W
              09 09 09
              a a fit n   n
                    at o> to to D in in
-I
 I
                                                    •o ».
                                                    5*
                                                      S
en H OB
> ^ >
35 O X
  O H
2   M


M M C4


O O
188
COMPAN
NO RE
9446
2
Y
AL
                                                         w  *
                                                         S  o
                                                         >  \o
                                                          as.   o
                                                          o
                                                              0)
                                                              0)
                                                          CJ   M
                                                          O   ft
                                                          O   0)
                                                          09
                                                               i
                                                              '•i
                                                            x] M

                                                            03 O
M
11
«•» mm
II

l!
r print in ink
necessary
                3

                |

                I

                i
                        c

                        H-
                        ft
                        (D
                        a

                        en
                                                               ft
                                                               (D
                                                             £ (fl
                                                             Bl
                                                             cn n
                                                          S  H-<
                                                          3  3 H-
                                                          W  *Q h
                                                             ft O

                                                          233

                                                          a  o ft
                                                          n  •  °*
                                                             o
                  N) O
                  O ft
                  *• n
                  0^ O
                  O ft
                    H-
                    O
                                                                             (D
                                                                             3
                                                                             O
                                                                       f  If
                                                         i  2
                                                         8  o
                                                                                to
                                                                                (O


                                                                                O
                                                                                H>

-------
i" ? ? S 2 3  I
-aasll  rt

Ilifi!  i
                               S »
            -»->->->-)-)-i-«.<»OTX<»$i»,-t3B

            aaaaaias-s.Sijtilo2.~
                 T»
               : i

               i \
    *t
    i»
         a
     «• «•  "i
         0
Sag-4""  J

.•gSftll  1.
 &.  3 .•»<•»  n
S « 9 • * *  •
C O. O • ^ ^  •"

     --
              <*<»«'
                     3;iTii?sa383  8
                     » T  S S.^wj|   ^
                             --
     ^
   Sf
     8
i
             '
                    :          a  -«
                    SS-I-S^*  S  J2-.
                    !lEr&i:  1  »i|
                           DO
                           —  •*  • •
s;


<»


IS
II J»
              X
»» n  • n

* »  n C
                                »j — r»

                                !*s
                           s       .

                           i I  li!
                       2.3
                       *S
                           —  5  i 2. g-


                       H I  |  |i|


                           n  =M
                         _ *»  ^fc  «« «* ^»
                         r A  c  ** c 3
                         5 a  =  " a*
                         •a  S  *  ~



                        o a  2  ^  • S 2
                        " s.  2  o  a • =•
                       ^S
                              s  sis
                         » *  a 8.8
                        ra  t
                           —••»">
                           _  5  o 01

                                "*
                           -

                           £
                            o «•»> > S


                            11! if
                            ft | - s a
                            rt> anna
                            m 2 a 2 *
                            5 »|»
                     n«
                                         rt  I- O CO
                                         n
                                         0  III


                                         i  ||;


                                         '  »h

                                           82 -
                                           t|*
                                             -«
                                         a    i
                                         i   !?
                                           O «- i
                                   to

                                   °
                                                       tt
                                                       I
                                                       S
                                                       M

                                                       N g
                                                       3 S
                                                       o S
                                                       I
 G
 3
 h"
 ft
 A
 a

 w
 ft


 rt
£ (0
0) (0
01
vn
                                       «a H-
                                       ft H
                                       o o


                                       ?1

                                       °s
                                       • ft
                                         ft>
                                       O i-
                                       t
                                         •o
                                       to i^
                                       o o
                                       <» ft
                                       ff> A
                                       O O
                                         ft
                                         H'
                                         O
                                         3
                                                               0)
                                                               to

-------
" o
« ~"T3 C 0
1815". rt
•— n o O 3
S a * f (?
3 "** 3" * (Q
"S * ? I ••*>
H mS | 0
= ' fi S 0
z a- ' 2 s
8.-o S rt
- s * a •
3 — B» <*->
*• S C • "
0 1. a"?
n n' n' •*
aJ -
IM -. .—
§~ I
w •*. S.
w — S
O ** n
"" 0 S
58 x
* rr »
JT 9
1 -*

 "1
^ n
8^ O
^h
i ^
5 S
f |
M •
o
S *
* 1
« 1
i I
a




















pj
n
(D
4k
ft
I
1
**
0
ve
VO
N
H-
f)

S
V
I-"
























O
i
S
m
K
W
**M
B

a
H
g
X
kJ
[NATIONS
i
§
H
S
M
£4
SB

i
^2
M
§





















G
3
H-
rt
(0
a

u
ft

rt
£ to
ft 01
tn
sr w
H- 3
vironmen
ngton, D
• rt
0)
0 H-
*
•o
W h<
0 0
*. ft
ON (D
o a
ft
^*m
O
3
(D
3
O
^















































»d

-------
jjt
r°
1
o
o
I
1
o
s
5


































w
5
s

5
9
s
T















<« o — — g
IO 8B O *
§ ?I 1 I
oi a. S. •» — •
3 n » It
B> n •—
F* r* ^
_• a
| 5
3 n


X *+

* 9j
•O <9
• ^
— ^

S-'
•5
9
— 9
is "

a
•0 n
if







r
0>





















ff*0>ON(J><3NO\  0>
UJWLJWUiLOfOPJW M MH
1 1 1 1 1 1 1 1 1 1 II
"9 "oT



1?
— * 3 O **C ^ w ^ W «"•* W "O "O (fl O t
a (fl-iwo— r* — 30-s -infi. In
-. — — ~1 •< - — *S C O O -r C^ Sf
M *» n «-t-*3cwsnS.— . o jn
-». •< Q> — . ^. —. -i gQ g 13 H» ||
3 >"" o n 3 ••'-«* n i
gi ••^•r<-)fl«r3 ••* ^v Q. I
O ** -•'-*< IB OH) W
3 • s |8^S2. =s§ b
(1 7Qm^* -i ,1* !•»
r 15" ^e-^*
33 f) ^+ C n 3
••• -^' *•"• 3 o n
• e o S J 1
Sin 3 r» >* fl 5.
— IB S n
ft 2. § 2 £ SL
S "* S' ft ""
? i'

\+ \ft ** LM PJ














>>>>>>>>> > > >
CD CD CD CD 03 CD 09 CD CD CD CD 00
ooooooooo o oo
OOOOOODOO O OO
MMWMRJMWMW M KM
ZXZXSSSXS S S DC

sssssssss s ss
2 2 2 2 2 S 2 2 2* 2 2 2
ooooooooo o oo
333333333 3 33
^o^o^o^a^ij^o^jjTO^j -TJ ^o^o
MPJMWPJWWWM K PI W








00 Q9  -*J
§"'-«
1?






-n GO
01
i -.
'i





J 5*
 ITJ jj
> <-• M 5
•4 tn TJ -3
-3 > 3
f cn o |
w S
W W m
s o z S
> o -3 a
•^ P3 ?
. M ^.^ ^
^0 ^j it
00 M » S
•£» C/l
O> CD P)
O W
X
M
J^ Z
o^ O
w
w
•o










IS)
*
W -N J
•B o S
> vo «
V0 t
50 w
m i
«•« ^" X
J 4
z o
o
en
Ol
tn rt
Ln (A
o
o
1
M









' "
1— 1 *O o
0 » S
ifc O »
a »
m c 5
mo

o cn^
t T3 a
?8 W o
O O «


N> *t}
U M
oo O
O




c -
V X
t ut
T RUCTIONS:
additions
•o
S-*
% 1
»« £
n
>r prin1
necessi
Dl *^
F
•^
2
(fl
n>
•I
S.

s
?
—
^

3-
Q
0
^
S
J
s.
I
-1
c
n
— .
§
(fl
01
(fl
t
n
3
e
I

i'
1
I
%
^

a>
^
o
T
3
















i






tQ 3
G rt-*
M (0
jo a
9 en
§ ST
i"3 r»
w 
s: w
en cu
i-3 W W
> 3" 3
G 3 H-
M vQ M
rt 0
2P O 3
233
O * (0
3
53 o rt
w • £
A I—1
M n
W • ^3
S o rt
2 *^ ft
3 ON o
* o rt
M >-•
O
» 3
W >
S*«Q
z 3
8 3















1 I f

1 ? 1
- -s, 1
moo
M -3 <
?. ° i
10
S 3
"*l
IV
|L
"7*
ISJ























































(D


»-i

O
t-h

N>

-------
t
^3
— -.
1 to indicate cert
text of certificat
ification as to information on th
ion is on page one).
•g
1?





.

5
It






COCO W 0= 00 00
1 1 1 1 II

O T> 15 > > »
it i -t n no
3 i' f 5 S 5 5
& 5 & n x rt t
5" Z 5. §" S. S"
s" 1 II J 1
•» 3 n o
s i?
Is
r\J f\J trf
«M* » ^





OB CO CD CO 00 CD
noon on
DODO D CJ
W M W W M W
o ci tn o o o
X X X X XX
c-i t_i Cj CH d ci
o o o o o o
X 3 3 3 33
W W W W MM


3333 33
O O 0 0 00
co w en en w tn



i i t i i i i
H O VO OS xl (Ti (Jl
f larmability I
Explodability (
Storage stability
Viscosity (
Niscibility <
Corrosion characteristics
Dielectric breakdown voltage <
Acute Toxic - Regular Chaiical
K/I ** l*j r\j ^
.^ ^ ^ «^ ^^





03 ^^ ty Q0 QJ pn Q3
O O O O O O O
o o o o o a a
W W fd M W W W
O O ffi O Cl O O
X X X X X X X
NP* NP* M NP* M kvl Ivl
O O O O O 0 O
R 3 3 3 3 3 3
H0 ^0 T3 ^D T3 T3 ^3
W W W W W W


3333333
O O O O 0 O O
to co (0 w en en co


Zl*
K-c
del ine
cment
in
I


i-Ono-0»-<
'-
"• is
-• n
u V <*
*** W
6. Use
Pattern


7. Test
Substance

-n 09
i L,
*I

9. Registrant
Response
.-
to to £ £
** r*j ji
> M co 8
•-3 tn -0 3
"3 > 3
f W O I
w 1
w m o,
£ 0 Z S
> 0 H a
-3 W g
X 50 |
VO TJ i?
oo en 30 g
M -3 M
*> CO
(Ti 03 PI
O CO
X
M
*• Z
01 o
u
-J

M
M ** £
tJ O S

I? • 1
vfl (S c
• H- »
. 81
n
salts
>. 55500-1



M "0 o
Its O ?
O 0
W G i
0 T?
0 W „
1 T3 2.
DO?
1 H
NJ T!
UI M
00 O
O
c —
gio
r-
ICTIONS: Please typ
Iditional sheet (s)

B
.T
a
fi
i
I
3-
3|
?
i
tion requested
5'
-4k
O
i






United States Er
Wash
REQUIREMEifTS STJ
*z ~ ~
>-3 M- <
G 3 H-
Cfl iQ 1
n- o
§ § 1
D » (1>
3
50 D ft
H O
W • T3
Jfl tsJ O
£ 0 rt
* Or*
M H-
O
» 3
n
w >
303
tD
Z 3
M 0
^



fo •»
I I
1 ? *
~ -8
moo
2 °
" 0
fy
















Q)
^Q
(D
ro
0
H)

-------
1  7*3 '
•  o T -i n
*»  a 3 •» i»

s  E 15 5.

•  01 CL ** "••
   ip f a- n
B.  -t 

                                             w en H
                                                      > M
                                                        wso
                                                        9C
                                                        os 5o T] <•
                                                        N> a H g
                                                        01  SB*
                                                        OL  O
DUCTS
                                             M

                                             5
                                                        Ol
                                                        03

                                                        vo
                                                  SJ
                                                  a

                                                  (0
                                                  o>
                                                  M
                                                  ft
                                                  m
                                                              i
                                                         I H
                                                        M 1)
                                                        W H
                                                        0» O
INSTRUCT
Use addi
                                                                  ii
                                                                    i
                                                                  i
                                                                 r
                                              G
                                              3
                                              H-
                                              rt

                                              8.

                                              en
                                              rt
                                              a>
                                              ft
                                              (0
                                            * si
                                            a
                                            01 M

                                            tt
                                            3 H-

                                            ft O

                                            §i
                                                                           to o
                                                                           o ft

                                                                           on o
                                                                           O ft
                                                                             H-
                                                                             O
                                                                      A
                                                                              O
                                                                              I-H
                                                                                  f

-------
t
         »» o

         11
         ** <"T
         -• r»
         83
on as to inf
on page one)
00 03 00 00
H H H H
I  I  I  I
O\ Ol *. U
00 03
H H
I I
(O H
0^ OA 0^ 0^ 0^ 0^ 0^
U) U) U) LJ U) CJ U
I I  I I  I  I  I
N) (O H K-* H> H )->
M O «9 00 *J Ot Ot
                        •  ^ T l»   O O
                        i  > § 5 ? 5 S
                        £ * a n a^ i» «




                        llU}1!
                            5T Q O"   •••
                          - -r * «   2.

                        S  | i | S   "?
                     o n • < w m ^i
                *    • 5 S 8 ? i I
                ?    *>s*i||
                &    s-s=4?52: =
y
charac
t
it
ab
                          8 If
stics
volt
age
                                                *• mi
                                            09 CD 09 CD CO 0» O
                                            o o n n o oo
                                            O D D D O D O
                                            W W W W W W M
                                            H H M H M H M
                                            c< r_, (4 CH «4 t| ti
                                                  « »x»
                        o o o o   o o
                       o oo
                        at as a a


                        W M W W.
                        - •
          as ae


          : W W
            •"•-••
          M a
        sax
               W W W W
                        tt Oft QB Oft \ . Oft OB
                            Cft fltt •
           (ft
           s a &a u s a
           o o o o o o o
           tit W n o> ot o n
(f
  g

il
-*?'
                                                            •OOO-
                                       ^*

                                       H
                   rf 9


                     '
                                                                     CD W O
CTS
                                                                     W
                                                 O

                                                 \o
                                             s    I
                                             iQ  N «
58
salts
                                                                       M HJ o
                                                                       2§5
                                                                         w
                                                                       eo *4
                                                                       U H
                                                                       09 O
Is
11
II
                                            r.f

                                              ^
                                              r*
                                              i
                                              ^


                                              I

                                              i
                                              M
                                                 •o
                                                 fll

                                                 
-------
tit*!!  i
 "
  1 I
  a  n
  s*  —

            i f
                               "9 ?

                               I I
                       *. ft 9 O ^
           5.8-
                        *  S  "iP
                        a  o  _ & o
            g>

            9*
            , O




            a




           2- 5


           Is.
        So  T sr

        2  -H- S

* '   ^  S  ^ll
if w'g    TJ  —43

J :l  s  i  i3.«
^ ?
n S
        2

                   * --s.  s  s  a a;
                   o TJ5"  ~  •*  "21*"
                     3 a  c  —  <•« o B
                    T •*

                   I «3  ^  '  5if
                   * r*.  Tj  5;  ^ 29
                   —•  if

                   ' ' ' 5
                          n I
                          "
                  ••  5. s i s

                  «  00 •*,"?,
                  3  I
                  a
                  ^»
                  o_


                  2

                  I'


                  |


                  •



                  i
                        13*1
                         *» r» ft
                         t?° S

                         !*i
                        *:?s
                        a » o  no
                    HI b
    Hi;
    1^*3

    iiil
    —  s «


    ?fjl

    s-h
    »°«s
    "I o *
    Tf^*?

    sll;-
    " 5.
    SJ'I

    dii


    Jl|f

    IfriS
                    |i?
                    aii


                     a
                     n

                     «
       8-a "^
       o^l
        J3n«


       ~??3
       a*,*

       •Si 5

        |i3
        3
                  m  o «- "t
                  ^i  iii


                  Mi!
                    s •• —
                     _3 o

                    1^1
                          «u

                          liT
                          1^

                          *'l
                          If!
                          s-rs.
• s
« *<
             I
 G
 3
 H-
 ft


 &


 CO
 ft

 0)
 ft

* A
0) 01
n
tr M
  si<
  2*0^-
                                                      ft ei

                                                      O O

                                                    r~i

                                                    i
    to h
    o o

    0» (D
    o n
      rt
      H-

      §



     f
      o
     s;
                                      o
                                      Hi

-------
•



















1

















1
k
•
w





3 J
t-1"? S. 0
812 rt
-. 2 S S- 3
sal* 2.
* 3 « ft
o o < n
-!-•>—•<* SS
0) 3 Ol
1 * ? 1 ~
2. ™ 5. 1 °
3! 5' *» 0
— a is 2 3
a = : . a 3-
c •» * •
a ± « * i.
*. 8 c "
° I. S:1?
r> 5" 5' •»
^i 0 n
JD -1 . 3
^a ?.
si 2.
-3 «
yd. e
i: 1
«: 5
35 <
» - ^
oft
S'3 If
? 8 "
•1 1
^* cr
o *~ <
H I
-. o «
"i" '
— s f>
•i »
^» **
|5 I
rt ^* 91
-•7 --»
-: ?
^ « «
O to •
2»» y
« S

si' i
n • <••
sl ?
«! 5
*» a B
'** 4
•« *
^* o
*H O -I
— 1 A
r? 1
3 *
: f
^ 1
8 &
**
2. T[
n o
ft r*
S §
s •
s I
1 I
* z
i 1
** <"»
5 1
A
2.










1
I c
w 2-
w rt
•M A
> a
£ o M
n - rt
« | ft
» K S (!)
_ So W
6> s tn
3 S n* w
a J5 H-3
« s 3£
e S ft *i
i s §§
M 8 " 8
* M 0 3
O M ' ft
* 2 °
« g OM
8*c
W 1^
^- ^ 0 0
S H * rt
0 S os n
H o o
SC ft
3 H.
•-1 3 o
J? 3
m
50 **t
S *fi
?Q (D
S «
§ ^
c
3
^3
CO


















































*0
&
irt
**4
A
N)
0
Hi
N)

-------
   O — •- —

        P

        r,
r 5 ?s 5
*t ^ a a* 3
WWUWWUtONJfO   M

 1  1  1  1  1  1  1  1  1    1
 II
N)M
— «•
01
                     .
                    _      12
              -  -    1 s.
                    23
                                  *
                                  o
            S 5
ooooooaoD   D
MWWWMWMWW   n

nonnooono   o
aaaaaaaaa   s
MMMHMMMMM   M
d

 nn
 •o >o
§g§§§
a tn a  n a
                         00 Oft 00
                       BB
                       O
             000
           09 n n n
§
0)
Bl
n w
. Guideline
equi rement
Nunter
                                                   ooo-oa
                                          i1
                                                w
                                                5
                                                            o
                                                                o
                                                                U>
                                                                VD
                                                                  I
                                                                I'
                                                                0)
                                                 O
                                                                    O ft
                                                                      H-
                                                                      o
                                                                                  A
                                                                                  3
                                                               1  1
                                                                2  S
                                                                          a>
                                                                         vQ
                                                                          ft
                                                                                     0
                                                                                     i-h
                                                    t

-------
    4
    X r+
    " O
    o —

    :i
    It O
    -i a
    M »*
    — a

    n
    * *»

    3 5
ion as to in
on page one
il
^
                    09 09 09 09   09 00

                    M »-• H M   M H
                    I  I I  I    II
                    0\    M H*
W CJ W U> W U W


tO N> M H M H M
h* O VO 03 »J 0> UI
                    *• -• M
                    ^^ »  ^*
                      M
                    8888
                        W W
   O O O O O O
   W W W W W W

(T) O CS O O O O
XXSB xxa s
H M H M M M M
C| t| t| d t| C| Cj
   i^i ^S ^S i^S ^% i^
                    OO 00   OO
                      as x
                        w w
w a at sc ar x a
   W W W W W H
                    09 09 09 00   09 49
 09 09 09 00 09 03 00
                    01 (0 CD 0)   0 (R
 (D 01
(B 01 W
                                                             3s
                                                             ?s
                                                               s
9. Registr
Response
                           ^wi-33
                           ^   Ng
                         VOXW
                         00  XM
                         o>wwx
                         «HMg


                             3C^
                             H«

                             >
                             r
                          I   1^
                              ^0 %
                          V     9
                           •»
                           :?

                           j'
                           82
                             rt
                             i
                             I
                             i

                             I
                                                                                   O '
                                      (D


                                      W
                                      ft
                                      ft!
                                      rt

                                    £ 0)

                                    n m

                                    H- <
                                    3 H-

                                    rt O

                                    3 1
                                    O ft
                                                                                      O
                                                                                      . T3
                                                                                        >1
                                                                                      w O
                                                                                      O ft
                                                                                      *>• n
                                                                                      o\ o
                                                                                      O ft
                                                                                        H-
                                                                                        o
                                                                                        3
                                                                                         (t>

                                                                                         O
                                                                                      i  o
                                                                                  m   S

                                                                                  •S   3


                                                                                  S   2
                                                                                  M   O
                                                                                   S
                                                   A


                                                   fo

                                                   O




                                                   tu

-------
 jo jo o z JJE  a
1 * 5 S. o o
* A 42  « »»  -<
n e e TJ     e
-._._. 5 -,-,  5
a i -t rf n it  ...
*" 8 9 9 * -8  "
r»      -

Ef^-ii  |
«•• 9 "      IQ

S a ?5 55  i.
-3-D * ..«  ?
      s?  s
§ 3 1. S. 8.'
2 I ft ? . .
3  » -• o> «


il'fl!
s§

5JS:
  S r»
    .»  an
    o »» —
    ^» o »
    •  »
S.** 1
3 •• g -
& n n i»
,j
o c — <»•>
 S  8  S
 I  !  i
 -  S  8

                     • >B  « -i  n  g   ao
                     a     t» —  «  a.  -» •
                     4  -.  05  -.  F  o-*
                     3  3  • *  S  "  •» *
                                     Sff •"
                                     ao o
                                     • 3
                                 —  TS
                              .  ^  3
                              3  8  a

                          -    I  S  I
                          Z"  H  "  •*
                                     1
                                     -
                                     s-
                                     •- s
                                     » fi.
                          TJ   •  £  S1 fr ±
                          S3  c  2  -SS
                          =:-,  IS  S  ft is.
                          2.5  ,,  .  1^8
                          *«  ?  -  .*Tfio
                          w 5  S.  5    s -
                          _      |O  •  ••» A

                       p  ;i  i  i  s»l
                          < w  7  O.  . "> 3 «
                          S   «  IT  o a (o
                          " ""  n  **  5 S" •»
                          SS  5
                          •iS.e  oi^

                          2|  |  I  j|f

                              3  t  SS5"
                          "I •  ^-    ^^39^
                          •<   38  R,  *







                          x" S  2  5"  3 iv 8
                          f   *  3  01 v «*

                          s a  s-  5  s" i"
                          — ••  •  a.  e • j»

                          83  I  5  ?S"
                          ft   •  *   3 »4 e>
                           V  C  II   ^  •
                          • «C  ff  *l   O •» ^
                          3. *  "  5"   3 ° «!

                          i*  I  !   I  ?
                                             ~j
                                            8
                                            rt
                                            0
                                            ft
                                                   S
                                                •"»»
                                                  • n
                                                 -,&
                                            I*
                                            ?

                                            s
                                            i'

                                            **
                                            n
                                            (•
        g!*{

        :i;«
        »»-»•>
        « n « «
        S-"" -a
        S" o 5" i
        • a * j>
        * *» *» r»
        s y° s
        •2«5
        *!*!
        o 2,-a^
        ">-S 8
        » 7 n o


        •Hi
        — 3"^ I!
        *!]-
        —• ft C m
          5n •»
         • «»
                                               f B -i
                                            3  *J8

                                               i§i
                                            n   s ?
                                            I   f!
                                                -•*
                                            g   '*
        hit
        .T5-"g
        •oS5*
        = i-l
        . d-o a.
         « ™ 6

          ?• 3 «
S  ^

m o «- rn

^ i?f
— g»»
  "" ~ JT

  ri
  i  i
  £  g
     A
     I
;;£!


i***l
•CO.**
353^
 s"?.
  RT A O
  » T •»
" a  —•

I'la s

ill!
T •• T «
a-a|

i'f^I
r!»?
  ••• 6 ^
^ +.H
m —• f» ^»
ft 9  a

£3"* •



fell
  11 •»
  s&?

  EU
                                                      :i
                                                      ii
                                                       ?
                                                       5S
  I58

  *n
  fl*
  s?3
                                                              w
                                                            si
        Di

        §.
                                                              H
                                                              O
                                                              3
                                                                  ft
                                                                  ID
  rt
  0)
  ft
£ fl>
o> (n
en
y w
H-3
3 <

ft M.
O O


'31
O 3
•  ft
  0)
                                                            Pi
                                                            H
                                                            ft
                                                            n
                  _   H3
                  2 W hj

                  g 28-

                  Son
                  Fj   ft
                                                                     T3
                                                                     0)
                                                                     vfl
                                                                     (D
                                                                     a
                                                                     Ml
                                                                          I
                                                                          t

-------
w
^^ • -* tJ
m s s -•
w =2.?
n 3
D 2 rt
So"
"!«•«•*»•
* « 2.
<• » •»
?:•
.,.
-•as
1-0
c S,
^* (f
3 - U>
fill
n 0 ii
•» »
30 -\ .
si
IM -.
3*
A —
S*
0 «
?!
y !.
oir
« 3
n v
f M
5" 3
1
?z
"
5-3
I M. r*
L -Co
i f
^
K
£ *
s |
2S
» o
1 •*
" ?
5§.
!i
3 -»
si
91
*I
* r*
•"rt
I?
^
<-> n
•* i
• rt
•*
?
5
<*
•>
«
1 ^
V ?
f
;
%
n
<»
-i
*•*
*•»
i
' j?
^ §
* rt
& §
1 s
n fn
0)
8 "^
! o
f §
rt ft
a ^

• 17
TJ
S
1
y
*"
*t
o
1
T
s
^

s.
jt
r*
^
^
»
<
I

r+
i
a
»"
*+
T
1
»
«
1
a
c_
rt
C
rt
7
rt
|
•?
->
8-
S
rt
O
«*
| .
g
•
I
8
**
•jf
|
o
%.












s?
2
1
3
w
IM
o B
V o
SM
y
n
,„
g i
&
[NATIONS
, Name: 4
S 3
* 8
GUIDELINE
Zinc salt
W M
e
H
1
1
























G
3
H-
ft
(D
a
M
ft
fit
ft
S ID
0) (A
(n
D1 W
H-3
vironmen
ngton, D
• rt
0
O t-
•
Protection
20460
>
v5
(D
O
»<

















































•3
&)
tfl
(D

ro
O
>i)
to

-------
fw
i
>* •• 3 •» i»
| » Si' 3



I III f
-t a •»   —
— a »•• a
•» -o « 3- S
     Hi
       i:
       «> o
    I1
       a
UUUUUUtOtON)   M     H H

I  I  I  1  I  I  I  I  I    I      II
H>t-*^JiD>UrOU)N)l-'   N)     N> M
*> (O                  *•*.-».

                     er     ex

                   n
                   **


                   i*
                                 . 2.
                            • S rt O

                                *
                         M O —


                         3-1
                         •. ? 2:
                                              U

                                              I
                                              l
                                               *
             8

             5 5
                                o    o -> »
                                *   s y z

                                      SI
                            M »•   W
             »»»>»
           000000000
           WPJWWPJWWPJW
           *rj *4 *1 *q — •	•" —
                                  §

             *^ ^^ ^^ ^"^ ^^ ^^ "^ m ••

             HMHWHHMMM

              >
                                 M "
                                   o X
                                 o ON ia
                                                           <£
                                                           o
                                                           tsj
                                                            58 g
                                                            o
                                                           n
                                                           •o
                                                           »
                                                           n
                                                        z
                                                        o
                                                           vf)
                                                           VO

                                                           i
                                                               \o
                                                               I
                                     V

                                     m
                                     »

                                     ft
                                     ca
                                                           M TJ o

                                                           So 5
0\ ^i
VO   x
vo w *
 i »o 2.
» W o
a o 2

to *q
U) H
                                  SS


                                  P
                                  si
                                                                    I*
                                                                    is
                                                                    f a
                                    I
                                    2.

                                    i


                                    |


                                    I


                                    i



                                    f
                                                                              3 3
f  1

I  ?


i  1

S  I
•0



(D
                                                                                         t
                                                                                   M

-------
L? =
= :
1 to indicate cert
text of certificot
k
ification as to infoi
ion is on page one).
I
i'
s
y
»>
•i
ID
a


^
1
F



e
»
4^
l»



|
i
|
GO 03 09 00 GO 00
iiit ii
 > >
*t -i -i rt on
§—"«»« c ^ c c
_ i i j §. ; s
~ •< -3 =• 5! a- a
S|i!-:!5-
E i ? ?. i - i
8 - 2. 8 i ff
*» •* *» «t ••••
8 S a 2. S -;
C. ? 2. R
8 i-5
1 5
« !t
•> ^ l\> M — -*
** • ** ^^ • m
ru i\> M
«?
cf S3






» » »
CD OD QJ 00 pp HJ
O O O O O f5
O 0 O O 0 O
W M M W MM
Cl O C5 O O cS
ac a a a a a

« « ^ 3s ~ 5?
O O O O O O
X 2 Z 3B 3Z
W M W M MM
*0 *O *O *0 *0 *O
w

B8K8.8S
W W 0* (A W CO


^ (^ 0^ 0^ O Ch Ch
1 1 1 1 1 1 1
H O VO 09 -si • ^
• 2.58S?-2.a
1 IliMti
«• s- s -•* s = =
; 5r !?-
E w o •»
| | J X
Q * 5'
| i?
3> ^» w
=- *
^ ** W ftj ^
^^ *•* ^i* *^ ^






>>>»>>
sssssss
o o a o o o o
M M M M W W M
C) n o n o n o
a a a K x a a

?s ?s 5^ ^ ?? 5*5 ?s
O O O O O O O
MS z xzxac
W W W M M W
T3 ^0 ^3 n3 ^3 TJ


s g s a s s s
o o o o o o o
o tn 01 01 w w n


X » X-
H-
,vl
1*
-*i"
Ul
in
!
-»
«*
<•




''OOO^OMi
dA
"11
"» 4
u, -3
yr
x$
3*


g'"
Stf
9 w
3 r»

-n a
-» •
I ^
*l

JD -O
•n »
§2
*R
I
••*
W CD 50 S
c n ni S
n x HI
n HI
Z N» ,
M w i
^ o 31
SWS|
« : 1
*J H S
•»• ZZ
0 0
to •


M

fe^ L»
ha o S
> vo *
\o »
»•
n i
«Q N -
* M- ft
5 81
salts
>. 10699-1



W
M »a o
o»S
4|E O *
^8i
Ors "•
o* Ha
vo -g
\o w *
i -a 3.
»M
002
1 M
M *g
W H
-0 O
o\
c —
0) K
—*
S "
5 q
i S
I-
•n
!{ w
<•» «»
2|
»:
<» *!
S 3
a A
J
• 3"
1
8
<•
1
o
irefuUy
M
?

^»
S
I
2
I
f*
ons and supply
y
1
>»
s
i
i
3
?
«'
1






United £
REQUIRE*
i £
3 ft
W (D
s w
w »
H3 W M
^ T "^
i^j » 5
« H- <
2 3 H-
w 10 n
ft O
& 3 9
o - ft
»•» J»
SO O ft
w • »
CJ i-*
Wrj
W • 13
3 MO
5 o rt
SB *• (D
^3 0*0
* O ft
W H-
O
w >
M tQ
O &
01 O
*<



to -n
o ! i
I ? |
ffl O O
X -J <
•o 3 3
3 2
3 o
•j
r\>
M
<^
S


















13
ia
w
O
HI
N>

-------
S *• w  M —  n

III,*"  i
• ? ? S i 3  =.
~i&3ii  *
    .. 5. •
2 1 S 3 -. _.
3 ««.••»
— It  r*
<•> x o • n a
• Tl HN p» O
      «
    »  Tr
     ;?
ss=  ~
 i* —  »
5§S  S
| i 3  M
Jo—  o
^1 ^» f*  T
8 5 J  S
1 f  3
•*  0  **
8 _»  ?
   3  **

1  I  r
I  t  5
»  !  ;
I.  I  J

1  ?  1
?  ?  I

IJ  I
I  i  j

i  I  I

i  I  i
j  I  «
I  J  i
£52.
5  t  •<
a  *  o
5o»
*  S  S

if!
1  I  §
i  5  I
J  r  f
     M
      =S  §"» Q
      ^*S£.S8.I ?
      7173SR? •
          -.(•••
        i
 Se -. -. 1 •»
 3 •*• • 9 g
" » « "" *• 4
i'S?5*= 1
-,-0 * «» ^
B » *» B « (I
Si 8iSS O

-J 11 fr I I 1.

 IsiH £
 A A
                           8721SS3  f
                           n  n   jf ft  a
                          • « • a I & A "  &
                        „ _'S:8-s*?*-"8  ?
                        h*!iN^  ?
                        :?;i!&i&>  I
                              Jssa  B
            !!
             cr
                  S •  *
                  a
                  5  —
            no-
            •_
            » •»
            Is
            — ^
            is
            •"
->
:
    ^
  (> 3

  +3
                           S

                           i
                           S
                       SR  S
                       — r*  TJ
                       a   S
                       v n
                       ?g
                        &
                       H
                       frs

                       i S
                           •
                       11  a
                       !*
                       M
                       II
                       Si
                       5?

                       *
                        2.
                       frP
                       ?
        a ~ ° s s
        r -I • ^» B O

        f  | S'l

        J  !>l
        Q,  ** ^H *»
        M  S* 5
        s  3 i S*
        —*  ^ w 3
        TJ  ^*- M
        rr  on*)  i^*

        S  tfi?
           •* vn
        i  ,?s

        5  Si!
                                  o
                               0 -*
        8
        S
        B
      ;!
                               = ii
     i«;

-  «  s»J
.».  ^.  3 ft
|  —  S ^ 4
I  7  i§3
•  I  s-fr±
c  2  -S S
3  n  p» "» »»
•  i  Ssr
a  J  "i's.
«  n  » o —
-  -n  3*3
"  5  ?S2
   t2  3? i
   2.  a 2. 3
   a.  -«. a ft
j»  !T  o « »
     o 8 *
     * 5*
     22.fr
     •« B ft
      r s  •* t it
      S |  5 &a
      a
      3    I «
      rt ^k  —« ^ —
      i i  -i:

      I 8  ?"
      I I  *s^
      j 5  ^2«
      ^ O  u* oj n
      • 3  o» w ~

      I i  I'll
            30>. i
            IJ I
             5 „„»!
             0 •  • • n
             rt »»-.»
             § mi
             ft I - j 1
             ffl j f> f> »
             m •»  7 »
                          53*5
                          » « e*I
                                        i
l
f
op

                                          o «-

ch
ti
use pro
: If a
istered
t; PAI
I pe
ire
ing
s pur
repac
bject
t; PA
                          Sl?i
                          2
                          fa * a »
                           .   •'
                          a' O,'-B 1
                                                 -i cr
                                                 .1*
                                                             vQ
                                                             (D
                                              t
                                                                   t
                                                              N)

-------
ini I
fc r. 5. ? i a
^ 5*5? &
"JiS •
" s * 1 Q
SaS'* §
-.6*1 *
3 r- * _ **
*" * S "
3 JP 3
^ ft
Si i
31 s
§2 1
Of** "1
^ o S
^ • ^
»
n IT 5,
£3 ?
« 8 "
•II »
III
— o »
— . S »»
™ e> • <»
•B « «

ft
•H A
gj o-
Pi O w
SM rt
1 *
4k K £ »
s Environmen
ash ing ton, D
DBPINATIONS
and Naae: 4
s 2 • sr
SO g OM
_ *o
N 9 to n
H- H O O
9 n * ft
O S « (D
Ron
S£ "f*
* H-
H a o
ft M 3
gj
S tfi
C "
a o
















































•o
61
vfl
0)

N)

O
Hi
M

-------
            UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

                       WASHINGTON. O.C. 20460
                                                   JUL 291986
                         PR NOTICE 86-5
                                            orncc o»
                                     pc*ricio«» AMO TOXIC SUMTAMCC*
         NOTICE TO PRODUCERS, FORMULATORS,  DISTRIBUTORS
                        AND REGISTRANTS
 Attention:
 Subject:
Persons responsible for Federal  registration of
pesticides.

Standard format for data submitted under  the Federal
Insecticide, Fungicide, and Rodenticide Act (FIFRA)
and certain provisions of the Federal  Food, Drug,
and Cosmetic Act (FFDCA).
 I.   Purpose

      To require data to be submitted to the Environmental
 Protection Agency (EPA) in a standard format.   This Notice also
 provides additional guidance about,  and illustrations of,  the
 required formats.

 II.   Applicability

      This PR Notice applies to all data that are submitted to EPA
 to satisfy data requirements for granting or maintaining pesticide
 registrations,  experimental use permits, tolerances, and related
 approvals under certain provisions of FIFRA and FFDCA.  These
 data  are defined in FIFRA SlO(d)Q).  This Notice does not apply
 to commercial,  financial, or production information, which are,
 and must continue  to be, submitted differently under separate
 cover.

 III.  Effective  Date

      This notice is effective on November 1, 1986.  Data  formatted
 according to this  notice may be submitted prior to the effective
 date.   As of the effective date, submitted data packages  that do
 not conform to  these requirements may be returned to  the  submitter
 for necessary revision.

 IV.   Background

      On  September  26, 1984, EPA published proposed  regulations
 in the Federal  Register (49 FR 37956) which include  Requirements
 for Data Submission (40 CFR $158.32), and Procedures for  Claims
of Confidentiality of Data (40 CFR §158.33).  These  regulations

-------
  specify the  format for data submitted to EPA under section 3 of
  FIFRA and  Sections 408 and 409 of FFDCA, and procedures which
  must be followed to make and substantiate claims  of confiden-
  tiality.   NO entitlements to data confidentialit/ are changed,
  either by  the  proposed regulation or by this notice.

       OP? is making these requirements mandatory  through this
  Notice to  gain resource-saving benefits from their use before the
  entire proposed regulation becomes final.  Adequate lea.1 time is
  being provided for submitters to comply with the new requirements.

  v-    Relationship of this Notice to Other OPP Policy and Guidance

       While this Notice contains requirements Cor organizing and
  formatting submittals of supporting data, it does not address
  the  substance of test reports themselves.  "Data reporting*
  guidance is now under development in OPP, and will specify how
  the  study objectives/ protocol, observations, findings, and
  conclusions are organized and presented within the study report.
  The  data reporting guidance will be compatible with  submittal
  format requirements described in this Notice.

      OPP has also promulgated a policy (PR Notice 86-4 dated
 April 15,  1986} that provides for early screening of certain
 applications for registration under FIFRA S3.  The objective  of
 the screen  is to avoid the additional costs and prolonged  delays
 associated  with handling significantly incomplete application
 packages.   As of the effective date of this Notice,  the  screen
 will  include in its criteria for acceptance of application
 packages the data formatting requirements described  herein.

      OPP has also established a public docket which  imposes dead-
 lines for  inserting into the docket documents submitted  in con-
 nection with Special  Reviews and Registration standards  (see
 40  CFR S154.15  and  S1SS.32).  To meet these deadlines,  OPP is
 requiring an additional copy of any data submitted to  the  docket.
 Please refer  to Page)  10 for more information about this  requirement.
                                          •
      For several  years* OPP has required that each application for
 registration  or other action include a list of all applicable
 data  requirements and an indication of how each  is satisfied—the
 statement of  the  method of support for the application.   Typically,
 many  requirements are satisfied by reference to data previously
 submitted—either by  the applicant or by another party.   That re-
 quirement is  not  altered by this notice, which applies only to
 data  submitted  with an application.

 VI,   Format Requirements

      A more detailed  discussion of these  format  requirements
 follows  the  index on  the next page, and  samples  of sons of the
 requirements are  attached.   Except for  the  language of the  two
 alternative forms of  the Statement of Data Confidentiality Claims
 (shown  in Attachment  3) which cannot be  altered, these samples
 are illustrative.   As long as the required  information is  included
and clearly  identifiable, the form of  the samples may be  altered
 to reflect  the  submitter's preference.

-------
                          -  INDEX -
                                                         Text  Example
                                                               Page
A.
B.
C.

D.







E.
F.
G.



C.I Special Considerations for identifying Studies. .

D.I Study Title Page 	 .......
D.2 Statement of Data Confidentiality Claims
(based on PIFRA SlOfdHl)) 	 	

D.4 Supplemental Statement of Data Confidentiality
Claims (other than those based on FIPRA $10(d)(i)]
D.5 Good Laboratory Practice Compliance Statement . .

Physical Format Requirements & Number of Copies . . .
Special Requirements for Submitting Data to the Docket
3
4
4
5
6
7

8
8

8
9
9
9
10
17
11


17
12

13
15

14
" 16



                          *»*•*»**•»•»•*
A.   Organization of Subraittal Package

     A  'submittal package1 consists of all studies submitted  at
the same time for review in support of a single regulatory action,
along with a transmittal document and other related administrative
material (e.g. the method of support statement, EPA Forma 8570-1,
8570-4, 8570-20, etc.) as appropriate.

     Data submitters must organize each submittal package as
described in this notice*  The transraittal and any other admin-
istrative material must be grouped together in the first physical
volume.  Bach study included in the submittal package must then
be bound separately.

     Submitters sometimes provide additional materials that are
intended to clarify, emphasize, or otherwise comment to help
Product Managers and reviewers better understand the submittal.

  -  If such materials relate to one study, they should be
     included as an appendix to that study.

  -  If such materials relats to more than one study (as  for
     example a summary of all studies in a discipline) or to the
     submitted in general, they must be included in the submittal
     package as a separate study (with  title page  and statement
     of confidentiality claims).
l

-------
t
  B.    Transmittal Document

       The  first  item in each submittal  package must be a trans-
  mittal document.  This document identifies  the submitter or all
  joint submitters; the regulatory action  in  support of which the
  package is being submitted--!.e.,  a registration application,
  petition, experimental use permit (EUP),  $3(c)(2)(Br data call-in,
  $6(a){2)  submittal, or a special review;  the  transmittal date;
  and a list of all individual studies included in the package in
  the order of their appearance,  showing (usually by Guideline
  reference number) the data requirement!s) addressed by each one.
  The EPA-assigned number for the regulatory  action (e.g. the
  registration, EUP, or tolerance petition  number) should be
  included  in the transmittal document as well, if it is known to
  the submitter.  See Attachment 1 for an example of an acceptable
  transmittal document.

       The  list of included studies in the  transmittal of a data
  submittal package supporting a registration application should
  be subdivided by discipline, reflecting the order  in which data
  requirements appear in 40 CFR 158.

      The list of included studies in the  transmittal of a data
 submittal  package supporting a petition for tolerance or an
 application for an EUP should be subdivided into sections A,  B,
 C,.... of  the petition or application, as defined  in 40 CFR
 180.7  and  158.125, (petitions)  or Pesticide Assessment Guidelines,
 Subdivision I (EUPs)  as appropriate.

     when  a submittal package supports a  tolerance petition and
 an  application  for a  registration or an EUP,  list  the  petition
 studies  first,  then the balance of  the studies.  Within  these
 two groups of studies follow the instructions above.
     C.
      Individual  Studies
 s
     A  study  is the report of a single scientific investigation,
 including  all supporting analyses required for logical complete-
 ness.   A study should be identifiable and distinguishable by a
 conventional  bibliographic citation including author,  date, and
 title.  Studies generally correspond in scope to a single Guide-
 line requirement for supporting data, with some exceptions dis-
cussed  in  section C.I.   Each study included in a submittal package
must be bound as a separate entity.  (See comments on binding
studies on page 9.)

     Each  study must be  consecutively paginated, beginning from
the title  page  as page 1.   The total number of pages in the com-
plete study must be shown on the study title page.  In addition
 (to ensure that inadvertently separated pages can be reassociated
with the proper study during handling or review) use either of
the following:

     - Include  the total number of pages in  the complete  study
       on  each  page (ie.,  1 of 250, 2 of 250,  ...2SO of  250).

     - Include  a  company name or mark and study number on each
       page of  the study,  e.g.. Company Name-1986-23.  Never  reuse
       a study  number for marking the pages  of  subsequent studies.

-------
       When  a single study is extremely  long, binding it in multiple
  volumes  is permissible so long as the  entire study is paginated
  in a single series, and each volume  is plainly identified by the
  study tide and its position in the  multi-volume sequence.
  C*1  Special Considerations for Identifying Studies

      Some studies raise special problems  in study identification,
  because they address Guidelines of  broader than normal scope or
  for other reasons.

      a. Safety Studies*  Several Guidelines require testing for
 safety in more than one species. In  these cases each species
 tested should be reported as a separate study, and bound
 separately.

      Extensive supplemental reports of pathology reviews, feed
 analyses,  historical control data,  and the like are often assoc-
 iated with safety studies.   Whenever  possible  these should be
 submitted  with primary reports of the study, and bound with the
 primary study as appendices.  When  such supplemental  reports are
 submitted  independently of  the primary report, take care to fully
 identify the primary report to which  they pertain.

      Batteries of acute toxicity tests, performed on  the same  end
 use product  and covered by  a single title page, may be bound
 together and reported as a  single study,

      b.    Product Chemistry Studies.  All product chemistry data
 within  a submittal  package  submitted  in support of an end-use
 product produced from registered manufacturing-use products
 should  be  bound as  a single study under a single  title page.

      Product chemistry data submitted in  support  of a techni-
 cal  product,  other  manufacturing-use  product,  an  experimental
 use  permit,  an import tolerance petition, or  an end-use  prod-
 uct  produced from unregistered sourc* ingredients, should  be
 bound as a singls- study for each Guideline series (61, 62,
 and 63)  for  conventional pesticides,  or for the equivalent
 subject  range  for biorstional pesticides. The first  of  the
 three studies  in  a  complete product chemistry submittal  for
 a biochemical  pesticide would cover Guidelines 151*10,  151-11,
 and 151-12i  the second would cover  Guidelines 151-13, 151-15,
 and 151-16i  the third would cover Guideline 151-17.   The
 first study  Cor a nicrobial pesticide would cover Guidelines
 151-20, 151-21, and 151-22; the second would  cover Guidelines
 151-23 and 151*25;  the third would  cover  Guideline 151-26.

     Note particularly that product chemistry studies are
 likely  to contain Confidential Business  Information as defined
 in FIFRA $10(d)U)(A), (B), or (C), and if so must be handled
as described  in section 0.3. of this  notice.

-------
f
             c.   Residue Chemistry  Studies.  Guidelines 171-4, 153-3,
        and 153-4 are extremely  broad  in  scope; stjdies addressing
        residue chemistry requirements must chus be defined at a
        level below that of  the  Guideline code.  The general principle,
        however, of limiting a study to the report of a single inves-
        tigation still applies fully.  Data should be treated as a
        single study and bound separately for each analytical method,
        each report of the nature of the  residue in a single crop or
        animal species,  and  for  each report of the magnitude of resi-
        dues resulting from  treatment of  a single crop or from proces-
        sing a single crop.   When more than one commodity is derived
        from a single crop (such as  beet  tops and beet roots) residue
        data on all such commodities should be reported as a single
        study.   When multiple field  trials are associated with a
        single crop,  all such trials should be reported as a single
        study.

        D.    Organization  of  Each Study Volume

             Cach complete study must include all applicable elements in
        the  list below,  in the order indicated.  (Also see Page 17.)
        Several of  these elements are further explained in the  following
        paragraphs.   Entries  in  the  column headed 'example' cite the
        page  number of this  notice where  the element is illustrated.
Element

Study Title Page

Statement of Data
Confidentiality
Claims

Certification of Good
Laboratory Practice
       Flagging statements
       Body of Study
       Study Appendices

       Cover Sheet to Conf i«
       dential  Attachment

       CBI  Attachment
      Supplemental Statement
      of  Data  Confidentiality
      Claims
When Required                    Example

Always                           Page 12

One of the two alternative       Page 13
forms of this statement
is always required.

If study reports laboratory      Page 16
work subject to GLP require-
ments

For certain toxicology studies.  (When
flagging requirements are finalized.)

Always - with an English language
translation if required.

At submitter's option
                         If CBI  is  claimed  under FIFRA
                         510(d)(l)(A),  (B),  or (C)

                         If CBI  is  claimed  under FIFRA
                           *10(d)(l)(A),  (B),  or (C)

                         Only  if confidentiality is
                         claimed on a  basis other than
                         PIFRA S10{d)(l)(A), (B), or (C)
                                  Page IS


                                  Page 14

-------
  D.I  Title Page

       A title  page  is always required for «ach submitted study,
  published  or  unpublished.  The title page tiust always be  freely
  releasable to requestors; DO NOT INCLUDE CBI  ON THE  TITLS PAGE.
  An  example of an acceptable title page is on  page  12 of this
  notice.  The  following information must appear on  the title
  page:

  a.    Study title.  The study title should be  as descriptive as
  possible.   it must clearly identify the substance!s) tested and
  correspond to  the name of the data requirement as  it appears
  in  the Guidelines.

  b.    Data  requirement addressed.  Include on  the title  page the
  Guideline  number(s) of the specific requirements) addressed  by
  the study.

 c.   Author(s).  Cite only individuals with primary  intellectual
 responsibility for the content of the study.   Identify  them
 plainly as  authors, to distinguish them from  the performing
 laboratory, study sponsor, or other names that may also appear on
 the  title page.
 d.    Study Date.   The title page must include a single date for
 the study.  If parts of the study were performed at different
 times,  use only the date of the latest element in the study.
 e.    Performing Laboratory Identification.   If the study reports
 work done by one or more laboratories,Fnelude on the title page
 the  name and address of the performing laboratory or laboratories,
 and  the laboratory's internal project number(s) for the work.
 Clearly distinguish the laboratory's project identifier from any
 other reference numbers provided by the study sponsor or submitter.

 f.    Supplemental Submissions.  If the study is a commentary on
 or supplement to another previously submitted study, or if it
 responds to EPA questions raised with respect to an earlier study,
 include on the title page elements a. through d. for the previously
 submitted study, along with the EPA Haster Record Identifier (HRID)
 or Accession number of -the earlier study if you know these numbers.
 (Supplements submitted In the same submittal package as the primary
 study  should be appended to and bound with the primary study.   Do
 not  include supplements to more than one study under a single
 title  page).

g.   Facts of Publication.   If the study is a reprint of a pub-
 lished  document, identify on the title page all relevant facts
of publication,  such as the journal title, volume,  issue,  inclusive
page numbers,  and publication date.

-------
  D.2. Statements of Data Confidentiality  Claims Under FIFPA S10(d)(i>.

      Each submitted study must be accompanied by one of the two
  alternative forms of the Statement of  Data Confidentiality Claims
  specified in the proposed regulation  in  $158.33 {b) and (c).
  (See Attachment 3) These statements apply only to claims of data
  confidentiality based on FIFRA S10(d)(1)
-------
  D.5  Good  Laboratory Practice Compliance  Statement

       This  statement is required if the  study contains laboratory
  work  subject to GLP requirements specified  in  4-0 CFR 160.  Sam-
  ples  of  these statements are shown in Attachment 6.

  E.    Reference to Previously Submitted  Data

       DO  NOT RESUBMIT A STUDY THAT HAS PREVIOUSLY BEEN SUBMITTED
  FOR ANOTHER PURPOSE unless EPA specifically requests it.  A copy
  of  the title page plus the HRID number  (if  known)  is sufficient
  to  allow us to retrieve the study immediately  for  review.  This
  prevents duplicate entries in the Agency  files, and saves you
•.the cost of sending more copies of the  study.   References to pre-
  viously submitted studies should not be included  in the  transmit*
  tal document, but should be incorporated  into  the  statement of
  the method of support for the application.

 F.   Physical Format Requirements

      All elements in the data submittal package must  be on  uniform
 8 1/2 by 11 inch white paper, printed on  one  side only in black
 i'nk, with high contrast and good resolution.   Bindings for  indi-
 vidual studies must be secure, but easily removable to permit
 disassembly for microfilming.  Check with EPA for special
 instructions before submitting data in  any medium other than
 paper, such as film or magnetic media.

 Please be particularly attentive to the following points:

   o  Do not include frayed or torn pages.

   o  Do not include carbon copies, or copies in other than
      black  ink.

   o  Make sure that photocopies are clear, complete,  and fully
      readable.

   o   Do not include oversize computer printouts or fold-out pages.

   o   Do not bind any documents with glue or binding tapes.

   o   Make sure that all pages of each study, including  any attach-
     ments  or appendices, are present and  in correct sequence.

     Number of  Copies Required - All submittal packages except
 those  associated with a Registration standard or Special Review
 (see Part G below)  must be provided in three complete,  identical
 copies.   (The proposed regulations specified two copies? three
 are  now being required to expedite and reduce  the cost  of  proces-
 sing data into  the  OPP Pesticide Document  Management System and
 getting it  into review.)

-------
  G.    Special Requirements for Submitting Data  to  the Docket

       Data subraittal packages associated with a Registration Stan-
  dard  or Special Review must be provided in four copies, from one
  of  which all material claimed as CBI has been  excised.  This
  fourth cop/ will become part of the public docket for the RS or
  SR  case.  If no claims of confidentiality are  made  for the study,
  the fourth copy should be identical to the other  three.  When
  portions of a study submitted in support of an RS or SR are
  claimed as CBI, the first three copies will include the CBI
  material as provided in section D of this notice.   The following
  special preparation is,required Cor the fourth copy.

   o .Remove the 'Supplemental Statement of Data Confidentiality
      Claims'.

   o  Remove the 'Confidential Attachment'.

   o  Excise from the body of the study any information you claim
      as confidential,  even if it does not fall within the scope
      of FIFRA $10(d)(1)(A),  (B), or (C).   Do not  close up or
      paraphrase text remaining after this excision.

   o Mark  the fourth copy plainly on both its  cover and  its title
      page  with  the  phrase "Public Docket Material * contains  no
      information claimed  as  confidential".
 V.
For Further Information
      For  further information contact William C.  Grosse,  Chief,
 Information  Services  Branch, Program Management  and Support
 Division,  {703-557-2613).
                             anes W.  Akerman
                           Acting Director*
                           Registration Division
Attachment 1*
Attachment 2*
Attachment 3.
Attachment 4.
Attachment 5.
Attachment 6.
Attachment 7.
         Sample Transmittal Document
         Sample Title Page for a Newly Submitted  study
         Statements of Data Confidentiality  Claims
         Supplemental Statement of Data  Confidentiality Claims
         Samples of Confidential Attachments
         Sample Good Laboratory Practice Statements
         Format Diagrams for Submittal Packages and Studies
                                10

-------
                           ATTACHMENT 1.

        ELEMENTS  TO BE INCLUDED IN THE TRANSMITTAL DOCUMENT*
  1*  Name  and  address of submitter (or all joint  submitters**)

      rSmith Chemical Corporation         Jones Chemical Company
       1234 West Smith Street      -and-  567% Wilson  Blvd
       Cincinnati, OH 98765               Covington, KY 56789

      fSmith Chemical Corp. will act as sole agent for all  submitters.

 2. Regulatory action in support c£ which this package issubmitted

    Use the EPA identification number (e.g. 359-EUP-67)  if you
    know  it Otherwise describe the type of request (e.g. experi-
    mental use permit, data call-in - of xx-xx-xx date).

 3. Transmittal date

 4. List of submitted studies

    Vol 1.  Administrative materials - forms,  previous  corres-
            pondence with Project Managers, and so forth.

    Vol 2.  Title of first study in the submittal (Guideline No.)
    Vol n.   Title of nth study in the submittal (Guideline No.)

    *    Applicants commonly provide this information in a trans*
        mittal letter.   This remains an acceptable practice so
        long as all four element* are included.
    * *
        Indicate which of the joint submitters is empowered to
        act  on behalf of All joint submitters in any matter con-
        cerning data compensation or subsequent use or release
        of the data.
Company Officials


Company Nanei


Company Contacti
Name
Signature
                   Name
                                 Phone
                                11

-------
                   ATTACHMENT  2.
SAMPLE STUDY TITLE PAGE  FOR A  NEWLY SUBMITTED STUDY

                    Study  Title
  (Chemical name)  -  Magnitude of Residue on Corn
                  Data Requirement
                  Guideline 171-4
                      Author
                   John  C. Davis

                Study Completed On
                  January  5, 1979

              Performing  Laboratory
           ABC Agricultural Laboratories
                940  West  Bay  Drive
               Wilmington, CA 39897

              Laboratory  Project ID
                     ABC 47-79
                   Page  1  of  X
  (X is the total number of pages In the study)

-------
                                 ATTAOiMENr 3,

                   STATEMENTS OF DATA OONflLEVTIALITY CLAIMS
 1.   No claim of confidentiality under FIFRA $10(d)UHA) ,(B), or (C)
                    STATEMENT OF NO DATA OONFirENTIALITY CLAIMS
   No claim of confidentiality is made for any infocmation contained in this stjdy
   on the basis of its falling within the scope of FIFRA SlO(d)UMA), 
-------
                        ATTACHMENT 4.


    SUPPLEMENTAL STATEMENT OF DATA CONFIDENTIALITY CLAIMS
     For any portion of a submitted study  that  is not described
by FIFSA SlOtdHlMA),  (B),  or (C),  but  for which you claim
confidential treatment  on another basis, the  following informa-
tion must be included within a Supplemental Statement of Data
Confidentiality Claims:

  o  Identify specifically by page and line number(s) each
     portion of the study for which  you  claim confidentiality.

  o  Cite.the reasons why the cited  passage qualifies for
     confidential  treatment.

  o  Indicate the  length of  time--until  a  specific date or
     event,  or permanently—for which the  information should
     be  treated as confidential.

  o  Identify the  measures taken to  guard  against undesired
     disclosure of this information.

  o  Describe the  extent  to  which the information has been
     disclosed,  and what  precautions have  been  taken  in con-
     nection  with  those disclosures.

  o  Enclose  copies of  any pertinent determinations of confi-
     dentiality made  by EPA,  other Federal agencies,  or courts
     concerning  this  information.

 o   If you assert  that disclosure of this information would
     be likely  to  result  in  substantial  harmful effects to
    you, describe  those  harmful  effects and  explain  why  they
    should be viewed as  substantial.

 o  If you assert  that the  information  is voluntarily sub-
    mitted,  indicate whether you believe  disclosure  of this
    information might  tend  to lessen the  availability to
    EPA of similar information in the future,  and  if so, how.
                              14

-------
                                    ATTACHMENT S.

                      EXAMPLES Of SEVERAL CONFIDENTIAL ATTACHMENTS

  Exanple 1  (Confidential word or phrase that has been deleted  fro* the study)
  OOSS REFERENCE NUMBER _ 1
  DELETED WORDS OR PHRASE:
                      This cross reference number is used in the stjdy
                      in place of the  following words or phrase at the
                      indicated uDlune and page references.

                       Ethylene Glycol
PAGE  LINE   REASON FOR THE DELETION

             Identity of Inert Ingredient
                          •
                          •
     6
    28
   100
14
25
19
FIFRA REFERENCE

 SlO(d)UHC)
 Exanple 2  (Confidential paragraph (s) that have been deleted front the study)
 CROSS .HBFERENCE NUMBER
 DELSaBWBBAGPAPH (S):
                5     This cross reference  number is  used  in the  study
                     in place of the following  paragraph(s)  at the
                     indicated volume and  page  references.
                   Reproduce the deleted paragraph(s) here
   PAG8:-LItCS  REASON FOR TOE DELETION

    20.-  <§-T7    Description of the quality control process
                                                       HFRA REFERENCE
Exaipee 3  ^Confidential
                     that have been deleted from the study)
CPOS8.
      NUMBER   7    This cross  reference nurber noted on a place-holder
                    pege is  used in place of the following whole pages
                    at  the indicated volum and page references.

     i  an attached innediately behind this page.
                     grN
                                                                 FIFRA REFERENCE

               Description of product manufacturing process      S10(d)(l)(A)
                                         IS

-------
                          ATTACHMENT 6.
             SAMPLE  GOOD  LABORATORY PRACTICE STATEMENTS
 Example 1.
    This study meets  the  requirements for 40 CFR Part  160
       Submitter   	
       Sponsor ^_____^___^__^_^___^___^^__^^_^_
       Study  Director
 Example  2.
  This study does not meet the requirements of 40 CFR
  Part 160, and differs in the following ways:
  1.
  2.
  3.
     Submitter
     Sponsor
     Study Director
Example 3.
   The submitter of this study was neither the sponsor of this
   study nor conducted it* and does not know whether it has
   been conducted in accordance with 40 CPR Part 160*
     Submitter                            	
                               16

-------
                          ATTACHMENT 7.
                  FORMAT OF THE SUBMITTAL PACKAGE
LEGEND
                    Transmittal Document.

                       Related Administrative Materials
                       («.Q.» Method of Support Statement,  etc.)


                             Other materials about the aubmittal
                             (e.g., summaries of groups of  studies
                             to aid in their review).

                                    Studies, submitted as unique
                                    physical entities, according
                                    to the format below.
                   FORMAT OP SUBMITTED STUDIES
            Study title page.

                Statement of Confidentiality Claims.

                 „  CLP and flagging* statements - as appropriate.

                         Body of the study, with English
                         language translation if required.

                             Appendices to the study.
        -1 .
          '   ,      Title Page of the Confidantial
I     ^**     1 -•'•'  Attachment.
L--T          '
    I     ^-">~~n     .  Confidential Attachment.
    !	?         i-—
               *»> —1       Supplemental statement
       I    ^'       \"~~~*  of Confidentiality Claims.
                     •--1
                                ^ j
                                        When flagging requirements
                                        •re finalized.
                Documents  which must be submitted as
                appropriate  to saet established requirements.

                I     Documents submitted at submitter's option.

                              17

-------
y-">
                                ATTACHMENT D

                  EPA GROUPING OF END-USE PRODUCTS FOR MEETING
                     DATA REQUREMENTS FOR REREGISTRATION

-------
 EPA'S BATCHING TO FULFILL ACUTE TOWCITY DATA REQUIREMENTS FOR REREGISTRATION
 OF PRODUCTS CONTAINING THE FOLLOWING ZINC SALTS: ZINC OXIDE, ZINC CHLORIDE AND
 ZINC SULFATE

        In an effort to reduce the time, resources and number of animals needed to fulfill the acute toxicity
 data requirements for reregistration of products containing the active ingredients zinc oxide, zinc chloride
 and zinc sulfate, the Agency has batched products which can be considered similar for purposes of acute
 toxicity. Factors considered in the sorting process include each product's active and inert ingredients
 (identity, percent composition and biological activity), type of formulation (e.g., emulsrfiable concentrate,
 aerosol, wettable powder, granular, etc.), and labeling (e.g., signal word, use classification, precautionary
 labeling, etc.).  Note that the Agency is not describing batched products as "substantially similar* since
 some products within a batch may not be considered chemically similar or have identical use patterns.

        Batching has been accomplished using the readily available information described above, and
 frequently acute toxicity data on individual products has been found to be incomplete. Notwithstanding
 the batching process, the Agency reserves the right to require, at any time, acute toxicity data  for an
 individual product should the need arise.

        Registrants of products within a batch may choose to cooperatively generate, submit or cite a
 single battery of six acute lexicological studies to represent all the products within that batch. It is the
 registrants' option to participate in the process with all other registrants, only some of the other registrants,
 or only their own products within a batch, or to generate all the required acute lexicological studies for
 each of their own products. If a registrant chooses to generate the data for a batch, he/she must use one
 of the products within the batch as the test material.  If a registrant chooses to rely upon previously
 submitted acute toxicity data, he/she may do so provided that the data base is complete and valid by
 today's standards (see acceptance criteria attached), the formulation tested is considered by EPA to be
 similar for acute toxicity, and the formulation has not  been significantly altered since submission  and
 acceptance of the acute toxicity data.

       In deciding how to meet the product specific  data requirements, registrants must follow the
 directions given in the Data Call-In Notice and its attachments appended to the RED. The OCI  Notice
 contains two response forms which are to be completed and submitted to the Agency within 90 days of
 receipt.  The first form, 'Data Call-In  Response," asks whether  the  registrant will meet the data
 requirements for each product. The second form, 'Requirements Status and Registrant's Response,' lists
the product specific data required for each product, including the standard six acute toxicity tests.  A
 registrant who wishes to participate in a batch must decide whether he/she will provide the data or depend
on someone else to do so. If a registrant supplies the data to support a batch of products, he/she must
select one of the following options: Developing Data (Option 1). Submitting an Existing Study (Option 4),
 Upgrading an Existing Study (Option 5) or Citing an Existing Study (Option 6). If a registrant depends on
another's data, he/she must choose among: Cost Sharing (Option 2), Offers to Cost Share (Option 3) or
Citing an Existing Study (Option 6). If a registrant does not want to participate in a batch, the choices are
Options 1,  4,5  or 6. However, a registrant should know that choosing not to participate in a batch does
not preclude other registrants in the batch from citing his/her studies and offering to cost share (Option
3) those studies.

       Some products were excluded from the batching process. Products which were not included in
the following batches were either considered not to be similar for purposes of acute toxicity or the Agency
 lacked sufficient information for decision making purposes.   Registrants of products which were not
batched are responsible for meeting the acute toxicity data requirements for each product.

-------
4
                Table I.
Botch
1




EPA Reg. No.
524-354
3096-16
55500-1
58494-1
58509-1
% Zinc oxide
99.4
99.0
99.9
99.0
99.0
Formulation type
powder
pOWOer
•trip*
•trips
•trips
                Table II.
Batch
2

EPA Reg. No.
802-591
10699-1
% Zinc »utftf»
99.0
99.0
Formulation type
granular
du»t
                The following table show products that were either considered not to be similar for purposes of acute
                toxicity or the Agency lacked sufficient information for decision making and were not batched. Registrants
                of these products are responsible for meeting the acute toxicity data requirements for each product.

                Table III.
EPA Reg, No.
802-508
802-553
50019-1
* % Zinc oxide or
zinc chloride
29.6 Zinc eWorld*
8.2 Zinc eWorld*
20.76 Zinc oxide
2.35 Copper
Formulation typ*
liquid
liquid
powder
                 ' expressed as metallic equivalent

-------
     ATTACHMENT E




EPA ACCEPTANCE CRITERIA

-------
                           SUBDIVISION D
Guideline               Study Title

Series  61       Product  Identity and  Composition
Series  62       Analysis and Certification of Product  Ingredients
•Series  63       Physical and Chemical Characteristics

-------
               61 Product Identity and Composition
                       ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?

1.	 Name of technical material tested (include product name and
      trade name, if appropriate)
2.	 Name,  nominal  concentration, and certified limits (upper and
      lower) for each active ingredient and each intentionally-
      added inert ingredient
3.	 Name and upper certified limit for each impurity or each
      group of impurities present at > 0.1% by weight and for
      certain toxicologically significant impurities (e.g.,
      dioxins, nitrosamines) present at <0.1%
4.	 Purpose of each active ingredient and each intentionally-
      added inert
5.	 Chemical name from Chemical Abstracts index of Nomenclature
      and Chemical Abstracts Service (CAS) Registry Number for each
      active ingredient and, if available, for each intentionally-
      added inert
6.	 Molecular, structural, and empirical formulas, molecular
      weight or weight range, and any company assigned experimental
      or internal code numbers for each active ingredient
7.	 Description of each beginning material in the manufacturing
      process
      	 EPA Registration Number if registered; for other
           beginning materials,  the following:
      	 Name and address of manufacturer or supplier
      	 Brand name,  trade name or commercial designation
      	 Technical specifications or data sheets by which
           manufacturer or supplier describes composition,
           properties or toxicity
8.	 Description of manufacturing process
      	._ Statement of whether batch or continuous process
      	 Relative amounts of beginning materials and order in
           which they are added
      	 Description of equipment
      	 description of physical conditions (temperature,
           pressure, humidity) controlled in each step and the
           parameters that are maintained
      	 Statement of whether process involves intended chemical
           reactions

-------
8. (continued)
9.
	 Flow chart with chemical equations for each intended
     chemical reaction
	 Duration of each step of process
	 Description of purification procedures
	Description of measures taken to assure quality of final
     product

Discussion of formation of impurities based on established
chemical theory addressing (1) each impurity which may be
present at > 0.1% or was found at > 0.1% by product analyses
and (2) certain toxicologically significant impurities
(see #3)

-------
               61 Product Identity and Composition
               GUIDANCE FOR SUMMARIZING STUDIES
The following criteria apply to the technical grade of the active
ingredient  being reregistered.   Items  1,  2,  3,  and  5 can  be
satisfied  for  most  registered  products  by submission of  the
Certified Statement of Formula  Ingredients Page  (EPA Form 8570-4).
Items. 7  and 8 can be  satisfied  for most technical  grade active
ingredients  (TGAIs)  by submission of a flow  chart with chemical
equations  for  each intended chemical  reaction.   The  flow chart
should include  complete chemical  structures  and  names  for each
reactant and product of all the reactions.
1. Name of technical material (include product name and trade name,
   if appropriate).
2. Description of each active and intentionally-added inert
   ingredient, including name, concentration, and certified limits.
3. Name and upper limit for all impurities present at > 0.1% and
   those toxicologically significant impurities present at <0.1%.
4. The purpose of each active and intentionally-added inert
   ingredient.
5. Chemical name and Registry Number for each active and
   intentionally-added inert ingredient (if available).
6. Molecular,  structural, and empirical formulas, molecular weight,
   and any experimental or internal code number for each active
   ingredient.
7. Description of each beginning material in the manufacturing
   process.
8. Description of manufacturing process.
9. Discussion of formation of impurities based on established
   chemical theory.

-------
       62  Analysis  and Certification of Product  Ingredients
                       ACCEPTANCE CRITERIA

The following criteria apply to the technical grade of the active
ingredient  being  reregistered.    Use  a  table to  present  the
information in items 6, 7, and 8.

Does your study meet the following acceptance criteria?

 1.	 Five or more representative samples (batches in case of
       batch process) analyzed for each active ingredient and all
      . impurities present at > 0.1%
 2.	 Degree of accountability or closure > ca 98%
 3.	 Analyses conducted for certain trace toxic impurities at
       lower than 0.1% (examples, nitrosamines in the case of
       products containing dinitroanilines or containing secondary
       or tertiary amines/alkanolamines plus nitrites;
       polyhalogenated dibenzodioxins and dibenzofurans) [Note
       that in the case of nitrosamines both fresh and stored
       samples must be analyzed.]
 4.	Complete and detailed description of each step in analytical
       method used to analyze above samples
 5.	 Statement of precision and accuracy of analytical method
       used to analyze above samples
 6.	 Identities and quantities (including mean and standard
       deviation) provided for each analyzed ingredient
 7.	 Upper and lower certified limits proposed for each active
       ingredient and intentionally added inert along with
       explanation of how the limits were determined
 8.	 Upper certified limit  proposed for  each  impurity present at
       > 0.1% and for certain toxicologically significant
       impurities at <0.1% along with explanation of how limit
       determined
 9.	 Analytical methods to verify certified limits of each
       active ingredient and impurities (latter not required if
       exempt from requirement of tolerance or if generally
       recognized as safe by FDA) are fully described
10.	 r-.rs?.lyti.-=l r.othods (as discussed  in *c-  *•.? virify --?rtifisd
       limits validared as to rheir precision and accuracy

-------
       62  Analysis and Certification  of Product  Ingredients
                 GUIDANCE FOR SUMMARIZING  STUDIES
The following criteria apply to the technical grade of the active
ingredient being reregistered.
 1. Number of representative samples analyzed for all active
    ingredients and all impurities at > 0.1%.

 2. Degree of accountability or closure in analyses in item #1.

 3. Chemical names of toxic impurities which were analyzed for
    levels <0.1%.

 4. Brief description(s) of analytical method(s) used to measure
    active ingredients and impurities in items #1 and #3.

 5. Statement of precision and accuracy of method(s) in item #4.

 6. Chemical name and quantities observed (range, mean, standard
    deviation) for each ingredient (actives and impurities)
    analyzed in item #1.

 7. Proposed upper and lower certified limits for each active
    ingredient and intentionally added inert with brief explanation
    of how limits were determined.

 8. Proposed upper certified limit for each impurity present at
    >=0.1% and certain toxicologically significant impurities at
    
-------
             63 Physical and Chemical  Characteristics
                       ACCEPTANCE CRITERIA
The following criteria apply to the technical grade of the active
ingredient being reregistered.

Does your study meet the following acceptance criteria?

63-2 Color
     _ Verbal description of coloration (or lack of it)
     _ Any intentional coloration also reported in terms of
         Munsell color system

63-3 Physical State
     _ Verbal description of physical state provided using terms
         such as "solid, granular, volatile liquid11
     _ Based on visual inspection at about 20-25° C

63-4 Odor
     _ Verbal description of odor (or lack of it) using terms
         such as "garlic-like, characteristic of aromatic
         compounds"
     _ Observed at room temperature

63-5 Melting Point
     _ Reported in C*
     _ Any observed decomposition reported

63-6 Boiling Point
     _ Reported in C°
     _ Pressure under which B.P. measured reported
     _ Any observed decomposition reported

63-7 Density, Bulk Density, Specific Gravity
     _ Measured at about 20-25° C
     _ Density of technical grade active ingredient reported in
         g/ml or the specific gravity of liquids reported with
rafersr.ce to water at 20° C. p:ote:
registered products may be reported in Ibs/ft
Ibs/gallon.]
                                                        or

-------
63-8 solubility
     	Determined in distilled water and representative polar and
         non-polar solvents, including those used in formulations
         and analytical methods for the pesticide
     	 Measured at about 20-25« C
     	 Reported in g/100 ml (other units like ppm acceptable if
         sparingly soluble)

63-9 Vapor Pressure
     	 Measured at 25° C {or calculated by extrapolation from
         measurements made at higher temperature if pressure too
         low to measure at 25° C)
     	 Experimental procedure described
     	 Reported in mm Hg (torr) or other conventional units

63-10 Dissociation Constant
     	 Experimental method described
     	 Temperature of measurement specified (preferably
         about 20 - 25° C)

63-11 Octanol/water Partition Coefficient
     	 Measured at about 20-25° C
     	 Experimentally determined and description of procedure
         provided (preferred method-45 Fed. Register 77350)
     	 Data supporting reported value provided

63-12 pH
     	 Measured at about 20 - 25° C
     	 Measured following dilution or dispersion in distilled
         water

63-13 Stability
     	 Sensitivity to metal ions and metal determined
     	 Stability at normal and elevated temperatures
     	 Sensitivity to sunlight determined

-------
             63  Physical  and  Chemical Characteristics
                 GUIDANCE  FOR  SUMMARIZING STUDIES
The following criteria apply to the technical grade of the active
ingredient being reregistered.
 1. Description of color.
 2. Description of physical state.
 3. Description of odor.
 4. Indication of melting point (in C").
 5. Indication of boiling point (in C°).
 6. Indication of density, bulk density, and specific gravity.
 7. Indication of solubility.
 8. Indication of vapor pressure.
 9. Indication of dissociation constant.
10. Indication of octanol/water partition coefficient.
11. Indication of PH.
12. Description of stability.

-------
                          SUBDIVISION F
Guideline              Study Title

  81-1      Acute Oral Toxicity in the Rat
  81-2      Acute Dermal Toxicity in the Rat, Rabbit or Guinea Pig
  81-3      Acute Inhalation Toxicity in the Rat
  81-4      Primary Eye Irritation in the Rabbit
  81-5      Primary Dermal Irritation Study
  81-6      Dermal Sensitization in the Guinea Pig
  81-7      Acute Neurotoxicity in the Hen
                                                                     t

-------
               81-1 Acute Oral Toxicity in the Rat
                       ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?

 1.	 Identify material tested (technical, end-use product, etc)
 2.	 At least 5 young adult rats/sex/group
 3.	 Dosing, single oral may be administered over 24 hrs.
 4.*.	 Vehicle control if other than water.
 5.	 Doses tested, sufficient to determine a toxicity category
        or a limit dose (5000 rag/kg).
 6.	 Individual observations at least once a day.
 7.	 Observation period to last at least 14 days, or until all
        test animals appear normal whichever is longer.
 8.	 Individual daily observations.
 9.	 Individual body weights.
10.	 Gross necropsy on all animals.
Criteria marked with a * are supplemental and may not be required
for every study.

-------
              81-1 Acute Oral Toxicity in the Rat
                GUIDANCE  FOR  SUMMARIZING STUDIES
1. The form of pesticide tested, e.g. solid, liquid, percent
   AI in technical, end-use product, etc.
2. The number of animals/dose/sex tested.
3. Dosing route and regimen.
4. Vehicle used
5. Doses tested and results
6. Individual observations on day of dosing and for at
   least 14 days.
7. Summarization of body weights
8. Summarization of gross necropsy
9. Significance of changes from the Acceptance Criteria
                                                                     t

-------
   81-2 Acute Dermal toxicity in the Rat, Rabbit or Guinea Pig
                       ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?

 l.	Identify material tested (technical,  end-use product, etc)

         At least 5 animals/sex/group
         Rats 200-300 gm, rabbits 2.0-3.0 kg or guinea pigs 350-
         450 gm.
 4.	 Dosing, single dermal.
 5.      Dosing duration at least 24 hours.
 6.±	 Vehicle control, only if toxicity of vehicle is unknown.
 7.	 Doses tested,  sufficient to determine a toxicity category
         or a limit dose (2000 mg/kg).
 8.	 Application site clipped or shaved at least 24 hours
         before dosing
         Application site at least 10%  of body surface area.
         Application site covered with a porous nonirritating cover
         to retain test material and to prevent ingestion.
         Individual observations at least once a day.
         Observation period to last at least 14 days.
         Individual body weights.
         Gross necropsy on all animals.
 9.
10."

11.
12."
13."
14."
Criteria narked with a * are supplemental and may not be required
for every study.

-------
   81-2 Acute Dermal Toxicity in the Rat,  Rabbit or Guinea Pig
                GUIDANCE FOR SUMMARIZING STUDIES
 1. The form of pesticide tested, e.g.,  solid,  liquid,  percent AI
    in technical, end-use product, etc.
 2. The number of animals/sex/dose
 3. Weight range of animals
 4. Verification of single, dermal exposure
 5. Duration of dermal exposure
 6. Statement of vehicle control
 7. Doses tested and results
 8. Preparation of application site
 9. Area of application site (percent body surface)
10. Occlusion of test material on application site
11. Individual observations on day of dosing and for at
    least 14 days or until  all animals.appear normal (whichever is
    longer).
12. Summarization of body weights
13. Summarization of gross necropsy
14. Significance of changes from Acceptance Criteria

-------
            81-3 Acute Inhalation Toxicity in the Rat
                       ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?
 l.
 2.
 3.
 4."
 5.'

 6.
 7."
 9.
10."
11.
12.'
13."
14."
Identify material tested (technical,  end-use product, etc)
Product is a gas, a solid which may produce a significant
vapor hazard based on toxicity and expected use or contains
particles of inhalable size for man  (aerodynamic diameter
15 urn or less).
At least 5 young adult rats/sex/group
Dosing, at least 4 hours by inhalation.
Chamber air flow dynamic,  at least 10 air changes/hour, at
least 19% oxygen content.
Chamber temperature, 22° C (±2), relative humidity 40-60%.
Monitor rate of air flow
Monitor actual concentrations of test material in breathing
zone.
Monitor aerodynamic particle size  for aerosols.
Doses tested,  sufficient to determine a toxicity category
or a limit dose (5 mg/L actual  concentration of  respirable
substance).
Individual observations at least once a day.
Observation period to last at  least  14 days.
Individual body weights.
Gross necropsy on all animals.

-------
           81-3 Acute Inhalation Toxicity in the Rat


                 GUIDANCE FOR SUMMARIZING STUDIES


 1. The form of pesticide tested, e.g., solid, liquid, percent AI
    in technical, end-use product, etc.
 2. Statement of the inhalability of test substance
 3. The number of animals/sex/dose
 4. Duration of inhalation exposure
 5. Number of chamber air changes/hour and the percent oxygen
    content of chamber air
 6. Ranges for chamber air temperature and relative humidity
 7. Air flow rate
. 8. Analytical concentrations of test material in breathing zone
 9. Results of aerosol particle-size determination
10. Doses tested (or limit dose of 5mg/L or highest attainable)
11. Individual observations on day of dosing and for at least 14
    days.
12. Summarization of body weights
13. Summarization of gross necropsy
14. Significance of changes from Acceptance Criteria

-------
            81-4 Primary Eye Irritation in the Rabbit
                       ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?

 1.	 Identify material tested (technical,  end-use product, etc)
 2.	 Study not required if material  is corrosive, causes severe
        dermal irritation or has a pH of < 2 or > 11.5.
 3.	 6 adult rabbits
 4.	 Dosing, instillation into the conjunctival sac of one eye
        per animal.
 5.	 Dose, O.l ml if a liquid; 0.1 ml or not more than  100 mg if
        a solid, paste or particulate substance.
 6.	 Solid or granular test material ground to a fine dust.
 7.	 Eyes not washed for at least 24 hours.
 8.	 Eyes examined and graded for irritation before dosing and
        at 1, 24,  48 and 72 hr, then daily until eyes are  normal or
        21 days (whichever is shorter).
 9..*	 individual daily observations.
Criteria marked with a * are supplemental and may not be required
for every study.

-------
           81-4 Primary  Eye  Irritation in the Rabbit


                GUIDANCE FOR SUMMARIZING STUDIES


 1. The form of pesticide tested, e.g.,  solid,  liquid,  percent AI
    in technical,  end-use product, etc.
 2. State if material  is corrosive, cause severe dermal irritation
    or has a pH of <2 or >11.5
 3. Number of adult rabbits tested
 4. State method of dosing,  i.e., instillation into the
    conjunctival sac of one eye per animal
 5. Dose administered
 6. Note whether solid or granular test material has been ground to
    a fine dust
 7. State whether eyes were washed and at what time post
    instillation (not less than 24 hours)
 8. State whether eyes were examined and graded for irritation
    before dosing and at what periods after dosing
 9. Individual daily observations afterwards, until eyes are normal
    or for 21 days
10. Significance of changes from Acceptance Criteria

-------
               81-5 Primary Dermal Irritation study
                       ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?

 1.	Identify material tested (technical, end-use product, etc)
 2.	 Study not required if material is corrosive or has a
         pH of <2 or > U.S.
 3.	 6 adult animals.
 4.	 Dosing, single dermal.
 5;	 Dosing duration 4 hours.
 6.	Application site shaved or clipped at least 24 hours prior
         to dosing
 7.	 Application site approximately 6 cm.
 8.	 Application site covered with a gauze patch held in place
         with nonirritating tape
 9.	 Material removed,  washed with water, without trauma to
         application site
10.	 Application site examined and graded for  irritation at l,
         24, 48 and 72 hr,  then daily until normal  or 14 days
         (whichever is shorter).
11.*.	 Individual daily observations.
Criteria marked with a * are supplemental and may not be required
for every study.

-------
               81-5  Primary Dermal Irritation Study


                GUIDANCE FOR SUMMARIZING STUDIES


 1. The form of pesticide tested,  e.g.,  solid,  liquid,  percent AI
    in technical,  end-use product,  etc.
 2. State if material is corrosive, has a pH <2 or >11.5, or has a
    dermal LD 50 <200 mg/kg
 3. Number of adult animals tested
 4. Amount applied
 5. Duration of dermal exposure
 6. Preparation of application site (shaved or clipped at specified
    time before dosing)
 7. Area of application site
 8. Method for occlusion of application site
 9. Note removal of  test material and if  skin was washed with water
10. State times post application when site was graded for
    irritation
11. Individual observations for day of dosing and individual
    daily observations thereafter
12. Significance of changes from Acceptance Criteria.

-------
           81*6 Dermal Sensitization in the Guinea  Pig
                       ACCEPTANCE CRITERIA
dose your study meet the following acceptance criteria?

1.	 Identify material tested (technical, end-use product, etc)
2.	 Study not required if material is corrosive or has a
       pH of <2 or > 11.5.
3.	 One of the following methods is utilized;
       	 Freund's complete adjuvant test
       	 Guinea pig maximization test
       	 Split adjuvant technique
       	 Buehler test
       	 Open epicutaneous test
       	 Hauer optimization test
       	 Footpad technique in guinea pig
4.	 Complete description of test
5.*.	 Reference for test.
6.	 Test followed essentially as described in reference
       document.
7.	 Positive control included (may provide historical data
       conducted within the last 6 months)
Criteria marked with a * are supplemental and may not be required
for every study.

-------
t /-.
                    81-6 Dermal Sensitization in the Guinea Pig


                          GUIDANCE FOR SUMMARIZING STUDIES
          1.  The  form of  pesticide tested,  e.g.,  solid,  liquid, percent AI
             in technical,  end-use product,  etc.
          2.  State  if material  is  corrosive or has pH  <2 or  >ll,5.
          3.  State  specific method utilized
          4.  Complete description  of  specific method
          5.  Reference for  the  specific  method employed
          6.  Note adherence of  the protocol to that in the reference  for
             the  specific method utilized
          7.  State  the positive control  tested
          8.  Significance of changes  from Acceptance Criteria

-------
 3.*
 8.*
               81-7 Acute Neurotoxicity in the Hen

                       ACCEPTANCE CRITERIA

Does your study meet the following acceptance criteria?

 1.	 Study performed on an organophosphate cholinesterase
        inhibiting compound.
        Technical form of the active ingredient tested.
        Positive control utilized.
        Species utilized, domestic laying hen 8-14 months of age,
        Dosing oral by gavage or capsule (dermal or inhalation
        may be used).
        An acute oral LD is determined.
        Dose tested equal to an acute oral LD or a limit test of
        5000 mg/kg.
        Dosed animals may be protected with atropine and/or 2-
        PAM.
        Sufficient test animals so that at least 6 survive.
        Negative (vehicle)  control group of at least 6 hens
        Positive control of at least 4 hens, (if used)
        Test dose repeated if no signs of delayed neurotoxicity
        observed by 21 days after dosing.
        Observation period 21 days after each dose.
        Individual daily observations.
        Individual body weights.
        Individual necropsy not required.
        Histopathology performed on all animals.  Tissue to be
        fixed in sin preferably using whole animal perfusion
        techniques.  At least three sections of each of the
         following tissues:
        	brain, including medulla oblongata
        	spinal cord; upper cervical, mid-thoracic and
             lumbro-sacral regions
        	tibial nerve;  proximal regions and branches
             sciatic nerve
Criteria marked with a * are supplemental and may not be required
for every study.

-------
                  ATTACHMENT F




LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICE

-------
assaggg
8 R S 8 e 5 S
8 £ 8 3 S § K

IHlpl
?• r> » at i i
. S m < t- o
59 -» • S — O
3m— ^ o
i- 8 » m §• r- .
|p*i*
8 3 •• 5
3 g n
M



e
S
»
*
1C
M
09
S
m
K
-4


- V. £ . - y ;*
S tii 3S s li
§ —
*** * 5
-^1 2=3
*" 3 S *" m
o> « n*
". ! ISP
SI -4
S •§
m
_
8

5 523S!
'


||§lf^l
?o2sss§


o
p

Z
o
§
•0
0»
•<
a
o






>
S
H-
ft
t- *-
r**
0
3
0)
Z
0>
I

>
ft
ft
^f
A
U
CO





0
H-
*
ft
\

H"
•a













E
O 3

ft
tag ffl
E a
Q> CO
O M 0>
4b H £ A
10 D» W
3 SO tr M
ft > H- 3
i 3 <
Z « U3 h»-
a M rt ^
i oo
» W 3 3
•• H - g
Z A
* H O 3
O • ft
S 3 o£
H •
CO T3
N (0 h(
5" 5 28-
0 53 SS
Set
Q E'
M > O
B Y >
W uQ
Z A
3

M
















































fi)
A

O
Ml
M

-------
            ATTACHMENT G




COST SHARE AND DATA COMPENSATION FORMS
                                                  t

-------
     ?/EPA
United States Environmental Proitctlon  Agency
            Washington, OC 20460
   CERTIFICATION OF OFFER TO  COST
SHARE IN THE  DEVELOPMENT OF  DATA
Perm

OVI N». 1070-0101

Ap»r**»l
  Public reporting burden for this collection ol information la estimated to tvtragt 15 minutes per response, including
  Umt tor reviewing instruction*, lurching existing data sources, gathering and maintaining the data needed, and
  completing and reviewing the oooectonot information.  Send comments regarding the burden estimate or any other
  aspect of this collection of information, including suggestions for reducing this burden, to Chief, information Policy
  Branch, PM-223, U.S. Environmental Protection Agency, 401 M St., S.W.. Washington, DC 20460; and to the Office
  of Management and Budget. Paperwork Reduction Project (2070-0106). Washington, DC 20503.

        fill  In blanks below.
  Produce N«mt
                                               EPA R«g.  No.
 I Certify that:

 My company is willing to develop and submit the data required by EPA under the authority of the Federal
 Insecticide, Fungicide and Rodenticide Act (FIFRA), if necessary. However, my company would prefer to
 tntar into an agreement with one or more registrants to develop jointly or share in the cost of developing
 data.

 My firm hat offered In writing to tntar bite such an agreement.  That offer was irrevocable and included an
 offer to be bound by arbitration decision under section 3(c)(2)(B)(iii) of FIFRA If final agreement on ail
 terms could not be reached otherwise.  This offer was made to  the following firm(s) on the following
 date(s):
                                                                           Oat* ef Ofta
*
\

C*nrfnmion:
losfiJryfJia^ SOT duty authorized to rfprtterYM have made on
tnisformandal aifJCfimertttheftlneAtiue.aoairate, and complete. lactaowMgethM any taowirigfy false or
misleading statement may be punishable by fine or Imprisonment or both under applicable law.
aiaaatm *f e*«paiiy*t AudiertM* MtprttMtttfve
Om
ItoM Mi TIM (?!•••• Typ* •* Print)
fJPA ftm SS7941

-------
r

-------